{"title":"Urology","description":null,"products":[{"product_id":"operative-techniques-in-gynecologic-surgery-urogynecology-original-pdf-from-publisher","title":"Operative Techniques in Gynecologic Surgery: Urogynecology (Original PDF from Publisher)","description":"\u003cheader class=\"section__headings section__headings___edc6e\"\u003e\r\n\u003cdiv class=\"form-group\"\u003e\r\n\u003cdiv class=\"form-control-plaintext\"\u003e\r\n\u003cdiv class=\"form-group\"\u003e\r\n\u003cdiv class=\"field field-name-field-course-summary field-type-text-with-summary field-label-hidden\"\u003e\r\n\u003cdiv class=\"field-items\"\u003e\r\n\u003cdiv class=\"field-item even\"\u003e\r\n\u003cdiv class=\"card-header bg-transparent py-4 px-3\"\u003e\r\n\u003cdiv class=\"form-group\"\u003e\r\n\u003cdiv class=\"form-control-plaintext\"\u003e\r\n\u003cdiv class=\"form-group\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"prod-title\"\u003e\r\n\r\n\u003cstrong\u003eBy Christopher Tarnay, Jonathan S. Berek MD MMS\u003c\/strong\u003e\r\n\r\nThird in a new four-volume series, Operative Techniques in Gynecologic Surgery: Urogynecology provides superbly illustrated, authoritative guidance on operative techniques along with a thorough understanding of how to select the best procedure, how to avoid complications, and what outcomes to expect. Easy to follow, up to date, and highly visual, this step-by-step reference covers the most common operations in gynecology and is ideal for residents and physicians in daily practice.\r\n\u003cul class=\"a-unordered-list a-vertical\"\u003e\r\n \t\u003cli\u003eSuccinct text, bulleted points, and quick-reference tables allow you to review information quickly and understand best practices and potential complications for each procedure.\u003c\/li\u003e\r\n \t\u003cli\u003eHundreds of full-color intraoperative photographs and illustrations, as well as numerous high-quality videos, capture procedures step by step and help you immediately apply your knowledge.\u003c\/li\u003e\r\n \t\u003cli\u003eEach clinical problem is discussed in the same templated format: general principles, anatomy and differential diagnosis, imaging and other diagnostics, preoperative planning, surgical management, procedures and techniques, pearls and pitfalls, postoperative care, outcomes, and complications.\u003c\/li\u003e\r\n \t\u003cli\u003eCoverage consists of the need-to-know urogynecologic procedures including, cytoscopy, vaginal wall repair, and continence repairs.\u003c\/li\u003e\r\n \t\u003cli\u003ePerfect for a quick preoperative review of the steps of a procedure.\u003c\/li\u003e\r\n \t\u003cli\u003eVolume and series editor, as well as contributors are thought leaders in their respective subspecialties and are well respected for their surgical expertise.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nLook for other volumes in the Operative Techniques in Gynecology series:\r\n\u003cul class=\"a-unordered-list a-vertical\"\u003e\r\n \t\u003cli\u003eGynecology\u003c\/li\u003e\r\n \t\u003cli\u003eReproductive Endocrinology and Infertility\u003c\/li\u003e\r\n \t\u003cli\u003eGynecologic Oncology\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nEnhance Your eBook Reading Experience\r\n\u003cul class=\"a-unordered-list a-vertical\"\u003e\r\n \t\u003cli\u003eRead directly on your preferred device(s), such as computer, tablet, or smartphone.\u003c\/li\u003e\r\n \t\u003cli\u003eEasily convert to audiobook, powering your content with natural language text-to-speech.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003eProduct Details\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003ePublisher ‏ : ‎ LWW; 1st edition (September 29, 2018)\u003c\/li\u003e\r\n \t\u003cli\u003eLanguage ‏ : ‎ English\u003c\/li\u003e\r\n \t\u003cli\u003eHardcover ‏ : ‎ 288 pages\u003c\/li\u003e\r\n \t\u003cli\u003eISBN-10 ‏ : ‎ 1496321065\u003c\/li\u003e\r\n \t\u003cli\u003eISBN-13 ‏ : ‎ 978-1496321060\u003c\/li\u003e\r\n \t\u003cli\u003eISBN-13 ‏ : ‎ 9781496321060\u003c\/li\u003e\r\n \t\u003cli\u003eeText ISBN: 9781975118006\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/header\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539051337,"sku":"MED-AMB07776","price":35.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/9781496321060.jpg?v=1781873803"},{"product_id":"mayo-clinic-southeastern-clinical-update-in-nephrology-hypertension-and-kidney-transplantation-2021","title":"Mayo Clinic Southeastern Clinical Update in Nephrology, Hypertension and Kidney Transplantation 2021","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"outer-wrapper\"\u003e\n\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\n\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\n\u003csection class=\"product\"\u003e\n\u003csection class=\"content-item-container-section\"\u003e\n\u003csection class=\"content\"\u003e\n\u003cdiv class=\"description\"\u003e\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\n\u003cdiv class=\"outer-wrapper\"\u003e\n\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\n\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\n\u003csection class=\"product\"\u003e\n\u003csection class=\"content-item-container-section\"\u003e\n\u003csection class=\"content\"\u003e\n\u003cdiv class=\"description\"\u003e\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\n\u003ch3\u003eMayo Clinic Southeastern Clinical Update in Nephrology, Hypertension and Kidney Transplantation 2021\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eInclude: 15 videos + 1 pdf, size: 3.84 GB\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Target Audience: nephrologist\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMODULE 1 COVID-19 – COVID Associated AKI The Experience from the Epicenter in NY.mp4\u003cbr\u003e\nMODULE 1 COVID-19 – COVID-19 in Kidney Transplant Recipients What did we learn.mp4\u003cbr\u003e\nMODULE 1 COVID-19 – Mayo Clinic Florida’s Strategic, Tactical and Clinical Response to COVID-19.mp4\u003cbr\u003e\nMODULE 2 STEM CELL RESEARCH – Can We Treat Ischemic Nephropathy with Stem Cell Therapy.mp4\u003cbr\u003e\nMODULE 2 STEM CELL RESEARCH – Mesenchymal Stem Cell Therapy in Diabetic Nephropathy From Bench to Bedside.mp4\u003cbr\u003e\nMODULE 2 STEM CELL RESEARCH – SGLT2 Inhibitors in Diabetic Kidney Disease.mp4\u003cbr\u003e\nMODULE 3 TRANSPLANT – Diagnosis and Management of ABMR in 2021.mp4\u003cbr\u003e\nMODULE 3 TRANSPLANT – Frailty Assessment in Kidney Transplant recipients Fact or Fiction.mp4\u003cbr\u003e\nMODULE 3 TRANSPLANT – Updates in Kidney Allocation How Does it Affect Your Patient.mp4\u003cbr\u003e\nMODULE 4 ICU NEPHROLOGY – How Fluid Therapy During Shock Resuscitation Impacts Kidney.mp4\u003cbr\u003e\nMODULE 4 ICU NEPHROLOGY – Medication Management for Patients on CRRT.mp4\u003cbr\u003e\nMODULE 4 ICU NEPHROLOGY – Parenteral Nutrition for AKI CKD Patients in the ICU.mp4\u003cbr\u003e\nMODULE 5 POTPOURRI – Recurrent FSGS After Kidney Transplant.mp4\u003cbr\u003e\nMODULE 5 POTPOURRI – Secondary Hypertension An Update.mp4\u003cbr\u003e\nMODULE 5 POTPOURRI – What’s New and Hot in ADPKD.mp4\u003cbr\u003e\nOnline Agenda.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539149641,"sku":"MED-AMB07510","price":10.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Mayo-Clinic-Southeastern-Clinical-Update-in-Nephrology-Hypertension-and-Kidney-Transplantation-2021.png?v=1781873803"},{"product_id":"kidney-transplant-updates-2023-videos","title":"Kidney Transplant Updates 2023 (Videos)","description":"\u003ch1 class=\"product-title product_title entry-title\"\u003eKidney Transplant Updates 2023 (Videos)\u003c\/h1\u003e\n\u003cdiv id=\"tab-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" role=\"tabpanel\" aria-labelledby=\"tab-title-description\"\u003e\n\u003cdiv class=\"prod-desc\"\u003e\n\u003cp\u003eUpdates on recent advances and optimal management of kidney transplantation in a one-day course.\u003cb\u003e\u003cbr\u003e\n\u003c\/b\u003e\u003cbr\u003e\n\u003cb\u003eLearning Objectives\u003cbr\u003e\n\u003c\/b\u003e\u003cbr\u003e\n1. Describe the risk of chronic kidney disease after nephrectomy and the latest advances in treatment options.\u003cbr\u003e\n2. Discuss current practice and recent advances for complications pre-and post-kidney transplant.\u003cbr\u003e\n3. List the most recent results of the new Kidney Allocation System.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProgram : \u003ca href=\"https:\/\/www.eventleaf.com\/e\/KidneyTransplant2023\"\u003eClick Here\u003c\/a\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539018569,"sku":"MED-AMB07073","price":30.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Kidney-Transplant-Updates-2023-Videos_2f9b3647-610a-4655-a663-ab4efab86f6c.png?v=1781873803"},{"product_id":"2023-econtouring-for-prostate-focal-boost-radiotherapy-webinar","title":"2023 ECONTOURING FOR PROSTATE – FOCAL BOOST RADIOTHERAPY – WEBINAR","description":"\u003cdiv class=\"field field-name-field-course-summary field-type-text-with-summary field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003ch1 class=\"product_title entry-title wd-entities-title\"\u003e2023 ECONTOURING FOR PROSTATE – FOCAL BOOST RADIOTHERAPY – WEBINAR\u003c\/h1\u003e\n\u003cp\u003e2023 ECONTOURING FOR PROSTATE – FOCAL BOOST RADIOTHERAPY – WEBINAR This covers the clinical evidence and rationale for focal dose escalation to the MRI-defined GTV in prostate cancer. We will also review real clinical cases to learn the best way to identify the GTV and contour for radiotherapy planning. Dosimetric constraints and pitfalls will be considered.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eThis Webinar Was Sponsored By The ROI Juan A. Del Regato Fund. The ROI Is ASTRO’s Research Foundation And More Information Can Be Found At \u003ca href=\"https:\/\/roinstitute.org\/\" target=\"_blank\" rel=\"noopener\"\u003eRoinstitute.Org\u003c\/a\u003e.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis activity is available from October 19, 2023, through 11:59 p.m. Eastern time on October 18, 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003ch2\u003eTARGET AUDIENCE\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-target-audience field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cp\u003eThis course is designed to meet the interest of radiation oncologists and radiation oncology residents.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-learning-objectives field-group-div\"\u003e\n\u003ch2\u003eLEARNING OBJECTIVES\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-learning-objectives field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cp\u003eUpon completion of this live activity, participants should be able to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDescribe the patient cohort most likely to benefit from a focal boost to the prostate.\u003c\/li\u003e\n\u003cli\u003eHave a framework for assessing multiparametric prostate MRIs for the purposes of defining a boost.\u003c\/li\u003e\n\u003cli\u003ePractice boost delineation with the opportunity for peer feedback.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662538985801,"sku":"MED-AMB06822","price":15.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/2023-ECONTOURING-FOR-PROSTATE-FOCAL-BOOST-RADIOTHERAPY-WEBINAR_0dfcab6c-873d-4784-8787-1ad9cd2ae25b.jpg?v=1781873803"},{"product_id":"uchicago-medicine-fredric-l-coe-symposium-on-kidney-stone-disease-and-mineral-metabolism-2025","title":"UChicago Medicine Fredric L. Coe Symposium on Kidney Stone Disease and Mineral Metabolism 2025","description":"\u003ch3 class=\"product_title entry-title\"\u003eUChicago Medicine Fredric L. Coe Symposium on Kidney Stone Disease and Mineral Metabolism 2025\u003c\/h3\u003e\r\n\u003cstrong\u003e+ Include: 10 Videos (.mp4) + 10 Audios (.mp3) + 10 Subtitles (.vtt) + 9 PDFs, size: 1.47 GB\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Target Audience: nephrologists and urologists\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\u003ch2 data-path-to-node=\"0\"\u003e1. Overview\u003c\/h2\u003e\r\n\u003cp data-path-to-node=\"1\"\u003eThe UChicago Medicine Fredric L. Coe Symposium on Kidney Stone Disease and Mineral Metabolism 2025 provides an in-depth clinical review of kidney stone pathophysiology, prevention, and management. The program explores mineral metabolism, idiopathic hypercalciuria, kidney stone compositional analysis, and the impact of acid balance on overall stone risk.\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"1\"\u003e\u003cb data-path-to-node=\"1\" data-index-in-node=\"356\"\u003eCourse Date:\u003c\/b\u003e October 9, 2025\u003c\/p\u003e\r\n\r\n\u003cdiv class=\"field field-name-field-course-summary field-type-text-with-summary field-label-hidden\"\u003e\r\n\u003cdiv class=\"field-items\"\u003e\r\n\u003cdiv class=\"field-item even\"\u003e\r\n\u003cdiv\u003eThis activity brings together national leaders in the field to explore recent advancements in the understanding of renal physiology, pathophysiology, and mechanisms underlying kidney stone formation. It addresses key knowledge gaps, such as those related to hypercalciuria and acid-base disorders, by fostering discussion on current research findings and treatment approaches. Participants will gain up-to-date insights into kidney stone disease and its clinical implications.\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003ch2 data-path-to-node=\"2\"\u003e2. Learning Objectives\u003c\/h2\u003e\r\n\u003cul data-path-to-node=\"3\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,0,0\"\u003eEvaluate the relationship between bone health, mineral metabolism, and the development of kidney stones.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,1,0\"\u003eUtilize comprehensive kidney stone compositional analysis to guide targeted treatment and prevention strategies.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,2,0\"\u003eAnalyze the pathophysiological connection between idiopathic hypercalciuria and papillary mineral deposits.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,3,0\"\u003eAssess the impact of systemic acid-base balance and urine acidity on clinical kidney stone risk.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"3,4,0\"\u003eImplement evidence-based approaches to diagnose, manage, and prevent brushite stones in clinical practice.\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-path-to-node=\"4\"\u003e3. Target Audience\u003c\/h2\u003e\r\nBest for nephrologists and urologists who want specialized updates on kidney stone disease, mineral metabolism, and compositional analysis.\r\n\u003ch2 data-path-to-node=\"6\"\u003e4. Topics\u003c\/h2\u003e\r\n\u003col start=\"1\" data-path-to-node=\"8\"\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,0,0\"\u003e01 2025 Symposium Welcome\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,1,0\"\u003e02 Opening Remarks\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,2,0\"\u003e03 Chairman’s Remarks\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,3,0\"\u003e04 Bones and Stones – Almost a Decade with Fred and Where it Led\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,4,0\"\u003e05 Kidney Stone Compositional Analysis – The Other Half of the Pliers\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,5,0\"\u003e06 Idiopathic Hypercalciuria and Papillary Mineral Deposits – What is the Connection\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,6,0\"\u003e07 Acid and Stone Risk\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,7,0\"\u003e08 The Brushite Story\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,8,0\"\u003e09 The Stone Clinic as a Living Laboratory – A Legacy of Education Based in Clinical Care\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003cp data-path-to-node=\"8,9,0\"\u003e10 2025 Symposium Concluding Remarks\u003c\/p\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539116873,"sku":"MED-AMB07923","price":10.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/UChicago-Medicine-Fredric-L.-Coe-Symposium-on-Kidney-Stone-Disease-and-Mineral-Metabolism-2025.jpg?v=1781873803"},{"product_id":"kidney-disease-clinical-trialists-workshop-9th-edition-2025","title":"Kidney Disease Clinical Trialists Workshop 9th Edition 2025","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"outer-wrapper\"\u003e\n\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\n\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\n\u003csection class=\"product\"\u003e\n\u003csection class=\"content-item-container-section\"\u003e\n\u003csection class=\"content\"\u003e\n\u003cdiv class=\"description\"\u003e\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\n\u003ch3\u003e\u003cstrong\u003e Kidney Disease Clinical Trialists Workshop 9th Edition 2025\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eInclude: 4 videos, size: 57.5 GB\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Target Audience: nephrologists, internists\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eApril 4-5, 2025\u003cbr\u003e\nEmbassy of France, Washington DC\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe Kidney Disease Clinical Trialists (KDCT) Workshop is a high level think-tank, with an exceptional expert faculty. It involves a limited number of attendees (up to 130) and includes distinguished nephrologists, clinical trialists, principal investigators and statisticians from academia, R\u0026amp;D pharma, patient representatives and device companies, NIH, EMA, PMDA and FDA experts.\u003c\/p\u003e\n\u003cp\u003eThe KDCT Workshop aims to foster an international exchange of ideas where we will brainstorm on trial design, conduct, ethics, interpretation, approvability and implementation encompassing drugs, devices, biomarkers and therapeutic strategies for kidney disease.\u003c\/p\u003e\n\u003cp\u003eOur objectives are to produce relevant data from controlled kidney disease clinical trials (beyond cardiovascular outcomes trials) that will contribute to better clinical care and to understand the problems associated with making decisions about what constitutes relevant information, how to improve kidney disease clinical trials, and, as is commonly the case, how to satisfy regulatory authorities and payers.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003e9th Edition of the Kidney Disease Clinical Trialists (KDCT) Workshop 2025\u003c\/strong\u003e is tailored for a highly specialized group of physicians and researchers involved in kidney disease clinical trials. The core physician audience includes:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eNephrologists\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinical trialists\u003c\/strong\u003e and \u003cstrong\u003eprincipal investigators\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAcademic researchers\u003c\/strong\u003e in nephrology and internal medicine\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePhysicians from regulatory bodies\u003c\/strong\u003e (e.g., NIH, EMA, PMDA, FDA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMedical professionals\u003c\/strong\u003e from R\u0026amp;D in pharma and device companies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis workshop is a \u003cstrong\u003ehigh-level think tank\u003c\/strong\u003e with a limited number of attendees (up to 130), designed to foster international collaboration on trial design, ethics, biomarkers, and regulatory strategies for kidney disease interventions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eApril 4 Initial Track.mp4\u003cbr\u003e\nApril 4 Parallel Track.mp4\u003cbr\u003e\nApril 5 Initial Track.mp4\u003cbr\u003e\nApril 5 Parallel Track.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e* Detail:\u003c\/p\u003e\n\u003cp\u003e\u003cimg src=\"https:\/\/images.squarespace-cdn.com\/content\/v1\/5a7c1cb78dd041a5e11c9f6b\/6ead8374-fe8e-42e8-bed6-7abf31b1dd3b\/KDCT+2025+Preliminary+Program+at+a+glance+%285%29.png\"\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539084105,"sku":"MED-AMB06444","price":40.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Kidney-Disease-Clinical-Trialists-Workshop-9th-Edition-2025.jpg?v=1781873803"},{"product_id":"campbell-walsh-wein-urology-13th-edition-original-pdf-from-publisher","title":"Campbell-Walsh-Wein Urology, 13th Edition (Original PDF from Publisher)","description":"\u003cstrong\u003eby Roger R. Dmochowski MD (ed.), Louis R. Kavoussi MD (ed.), Craig A. Peters MD (ed.)\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv\u003e\n\u003cdiv\u003e**Selected for 2025 Doody’s Core Titles® with \"Essential Purchase\" designation in Urology** \u003cbr\u003e\u003cbr\u003eThe only reference of its kind for this complex specialty, Campbell-Walsh-Wein Urology, Thirteenth Edition, offers unsurpassed depth and breadth of coverage - from the basic science underpinnings to the most recent developments in medical and surgical care. Three manageable volumes deliver must-know information for students, residents, and seasoned practitioners, with authoritative, up-to-date content in an intuitively organized, easy-to-read format featuring key points, quick-reference tables, and handy algorithms throughout.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eFeatures concise, practical chapters that help you find key information quickly\u003c\/li\u003e\n\u003cli\u003eIncludes new chapters on Personal and Professional Development for the Urologist, MRI Introduction, Occupational Health in Urology, Fundamentals of Intraoperative Patient Safety, Sutures and Suturing, Urethral Stricture Disease, Renal Transplantation, Surgical Management of Upper Urinary Tract Calculi, Prevention of Urinary Stone Disease, Male to Female Gender Affirming Surgery, and Special Considerations for Transmasculine Individuals\u003c\/li\u003e\n\u003cli\u003eCovers hot topics such as new technologies in robotic urologic surgery; infections of the urinary tract; neoplasms of the testis; benign prostatic hyperplasia; urologic evaluation of the child; urinary lithiasis; inflammatory and pain conditions of the male genitourinary tract; cutaneous diseases of the external genitalia; and more\u003c\/li\u003e\n\u003cli\u003eIncorporates current AUA\/EAU guidelines in each chapter as appropriate\u003c\/li\u003e\n\u003cli\u003eUpdates all chapters with new content, new advances, current readings and references, and best practices\u003c\/li\u003e\n\u003cli\u003eFeatures more than 175 video clips, including all-new lectures that accompany select chapters\u003c\/li\u003e\n\u003cli\u003eServes as the cornerstone title for the Campbell-Walsh-Wein Urology product suite, which includes the Campbell-Walsh-Wein Urology Review and the Campbell-Walsh-Wein Handbook of Urology\u003c\/li\u003e\n\u003cli\u003eWritten and edited by key opinion leaders in urology, with four new associate editors who contribute additional knowledge and expertise on essential changes in the field\u003c\/li\u003e\n\u003cli\u003eChapters serve as the source material for an all-new podcast series, Campbell’s Urology: Expert Insights, found on all major podcast platforms, including Spotify and Apple Podcasts\u003c\/li\u003e\n\u003cli\u003eAn eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish several weeks following the publication date\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539379017,"sku":"MED-AMB05860","price":50.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Campbell-Walsh-Wein-Urology-13th-Edition-Original-PDF-from-Publisher.jpg?v=1781873804"},{"product_id":"society-of-urologic-oncology-25th-annual-meeting-2024","title":"Society of Urologic Oncology 25th Annual Meeting 2024","description":"\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection class=\"content-item-container-section\"\u003e\u003csection class=\"content\"\u003e\r\n\u003cdiv class=\"description\"\u003e\r\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\r\n\u003cdiv class=\"prod-edition\"\u003e\r\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-id=\"bbb44b8\" data-element_type=\"widget\" data-widget_type=\"heading.default\"\u003e\r\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\r\n\u003cdiv class=\"row\"\u003e\r\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\r\n\u003cdiv class=\"outer-wrapper\"\u003e\u003csection id=\"main-container\" class=\"main-container\" role=\"main\"\u003e\u003csection class=\"course\" data-id=\"108054\" data-role=\"course\"\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539411785,"sku":"MED-AMB06441","price":40.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Society-of-Urologic-Oncology-25th-Annual-Meeting-2024.jpg?v=1781873804"},{"product_id":"michigan-medicine-advanced-genitourinary-malignancies-symposium-2025","title":"Michigan Medicine Advanced Genitourinary Malignancies Symposium 2025","description":"\u003cdiv\u003e\n\u003cdiv class=\"prod-edition\"\u003e\n\u003ch1 class=\"product_title entry-title\"\u003eMichigan Medicine Advanced Genitourinary Malignancies Symposium 2025\u003c\/h1\u003e\n\u003cstrong\u003e+ Include: 18 videos + 18 audios + 18 file sub vtt + 19 pdfs, size: 5.16 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: Physicians (Medical Oncologists, Urologists, Radiation Oncologists, Internists)\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp data-path-to-node=\"2\"\u003eThis one-day symposium is dedicated to the comprehensive management of genitourinary malignancies, including prostate, bladder, and kidney cancers. Hosted by the NCI-designated Rogel Cancer Center, the course emphasizes a transdisciplinary approach to reducing the cancer burden and advancing health equity. It serves as a critical update for clinicians, bridging the gap between cutting-edge research—such as novel biomarkers and cellular therapies—and standard clinical practice. The program highlights the University of Michigan’s role in leading groundbreaking clinical trials and refining standards of care for complex GU cases.\u003c\/p\u003e\n\u003ch3 data-path-to-node=\"3\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"3\"\u003e+ What You Will Learn\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp data-path-to-node=\"4\"\u003eAttendees will be able to:\u003c\/p\u003e\n\u003cul data-path-to-node=\"5\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"5,0,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"5,0,0\"\u003eUnderstand\u003c\/b\u003e and apply the latest diagnostic modalities for the classification and risk-stratification of genitourinary cancers.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"5,1,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"5,1,0\"\u003eAppreciate\u003c\/b\u003e the rapidly evolving therapeutic landscape, specifically the increasing use of targeted agents, immunomodulators, antibody-drug conjugates (ADCs), and cellular therapies.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"5,2,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"5,2,0\"\u003eIdentify\u003c\/b\u003e impactful research findings that drive future diagnostic and prognostic strategies.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"5,3,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"5,3,0\"\u003eNavigate\u003c\/b\u003e clinical nuances in managing “in-between” cases, such as localized prostate cancer with nodal PSMA avidity.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"5,4,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"5,4,0\"\u003eEvaluate\u003c\/b\u003e the role of circulating tumor DNA (ctDNA) in risk-stratifying patients with Muscle-Invasive Bladder Cancer (MIBC).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-path-to-node=\"6\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"6\"\u003e+ Event Details\u003c\/b\u003e\u003c\/h3\u003e\n\u003cul data-path-to-node=\"7\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"7,0,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"7,0,0\"\u003eDate:\u003c\/b\u003e Saturday, November 22, 2025\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"7,1,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"7,1,0\"\u003eTime:\u003c\/b\u003e 8:30 AM – 3:30 PM ET\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"7,2,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"7,2,0\"\u003eLocation:\u003c\/b\u003e The Sheraton Ann Arbor, 3200 Boardwalk Dr, Ann Arbor, Michigan\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-path-to-node=\"8\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"8\"\u003e+ Who Should Attend\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp data-path-to-node=\"9\"\u003eThis course is designed for the interdisciplinary team involved in GU oncology:\u003c\/p\u003e\n\u003cul data-path-to-node=\"10\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"10,0,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,0,0\"\u003ePhysicians\u003c\/b\u003e (Medical Oncologists, Urologists, Radiation Oncologists, Internists)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"10,1,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,1,0\"\u003eHouse Officers\u003c\/b\u003e (Residents and Fellows)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"10,2,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,2,0\"\u003ePhysician Assistants\u003c\/b\u003e and Nurse Practitioners\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"10,3,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,3,0\"\u003eNurses\u003c\/b\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"10,4,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,4,0\"\u003eOther Healthcare Professionals\u003c\/b\u003e involved in cancer care\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-path-to-node=\"11\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"11\"\u003e+ Why Attend\u003c\/b\u003e\u003c\/h3\u003e\n\u003cul data-path-to-node=\"12\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"12,0,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"12,0,0\"\u003eEmerging Therapies:\u003c\/b\u003e Gain specific insights into the “nuance” of using Antibody-Drug Conjugates (ADCs) in bladder cancer, moving beyond simple prescription to understanding toxicity and sequencing.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"12,1,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"12,1,0\"\u003ePrecision Medicine:\u003c\/b\u003e Learn how new tools like PSMA PET and ctDNA are redefining “localized” versus “metastatic” disease, directly impacting treatment decisions for prostate and bladder cancer patients.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"12,2,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"12,2,0\"\u003eExpert Faculty:\u003c\/b\u003e Hear directly from Michigan Medicine leaders who are driving the research on SBRT for renal cell carcinoma and immunotherapy strategies.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eImmunotherapy for Localized Bladder Cancer – Universal Strategy or Tailored Approach\u003c\/li\u003e\n\u003cli\u003eRisk Stratification in MIBC – The Emerging Role of ctDNA\u003c\/li\u003e\n\u003cli\u003eFrom Targets to Toxicity – Clinical Nuance in ADC Therapy for Bladder Cancer\u003c\/li\u003e\n\u003cli\u003eMetastatic Body Radiotherapy for Localized RCC – Emerging Evidence, Evolving Role\u003c\/li\u003e\n\u003cli\u003eChoosing Wisely – Patient Selection for Adjuvant IO in Kidney Cancer\u003c\/li\u003e\n\u003cli\u003eMetastatic RCC with Bulky Primary – Navigating the Balance Between Local and Systemic Therapy (Sarah Elizabeth Yentz, MD)\u003c\/li\u003e\n\u003cli\u003eMetastatic RCC with Bulky Primary – Navigating the Balance Between Local and Systemic Therapy (Udit Singhal, MD)\u003c\/li\u003e\n\u003cli\u003eManaging the ‘In-Between’ – Localized Prostate Cancer with Nodal PSMA Avidity\u003c\/li\u003e\n\u003cli\u003eWhen to Scan and What to Use – Imaging the Biochemically Recurrent Prostate Cancer Patient\u003c\/li\u003e\n\u003cli\u003eWhen to Scan and What to Use – Imaging the Biochemically Recurrent Prostate Cancer Patient\u003c\/li\u003e\n\u003cli\u003eWhen to Radiate – Managing the Primary and Metastases in Low-Volume Metastatic Castrate Sensitive Prostate Cancer\u003c\/li\u003e\n\u003cli\u003eTailoring Systemic Treatment in Low-volume mCSPC – How Long and What to Choose\u003c\/li\u003e\n\u003cli\u003eTo PET or Not – Deciding the Best Imaging for Metastatic Prostate Cancer\u003c\/li\u003e\n\u003cli\u003ePluvicto and Docetaxel in Metastatic Castrate Resistant Prostate Cancer – Making the Right Choice for Your Patient (Sarah Elizabeth Yentz, MD)\u003c\/li\u003e\n\u003cli\u003ePluvicto and Docetaxel in Metastatic Castrate Resistant Prostate Cancer – Making the Right Choice for Your Patient (Sean R. Miller, MD)\u003c\/li\u003e\n\u003cli\u003eBeyond Symptom Control The Evolving Role of Radiation in Metastatic Castrate Resistant Prostate Cancer\u003c\/li\u003e\n\u003cli\u003eGermline Testing in Prostate Cancer What the Oncologist Needs to Know\u003c\/li\u003e\n\u003cli\u003eNext Generation Sequencing in Metastatic Prostate Cancer When, Who, and Why\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539444553,"sku":"MED-AMB05806","price":25.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Michigan-Medicine-Advanced-Genitourinary-Malignancies-Symposium-2025.jpg?v=1781873805"},{"product_id":"michigan-medicine-state-of-the-art","title":"Michigan Medicine State of the Art Kidney and Pancreas Transplantation 2025","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"bbb44b8\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003ch3\u003eMichigan Medicine State of the Art Kidney and Pancreas Transplantation 2025\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 11 videos + 11 audios + 11 file sub vtt + 12 pdfs, size: 5.07 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: nephrologists, transplant surgeons, primary care physicians, internists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp data-path-to-node=\"2\"\u003eHosted by the University\u003cb data-index-in-node=\"14\" data-path-to-node=\"2\"\u003e of Michigan Transplant Center\u003c\/b\u003e, this hybrid event (offering both in-person and virtual attendance) addresses the critical challenges in kidney and pancreas transplantation. The 2025 curriculum moves beyond standard protocols to explore “The Frailty Factor,” the financial intricacies of modern healthcare coverage (including Medicare Advantage), and the strategic management of deceased donor offers in a changing allocation system. It emphasizes a multidisciplinary approach to improving outcomes for both elderly recipients and living donors over the age of 50.\u003c\/p\u003e\n\u003ch3 data-path-to-node=\"3\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"3\"\u003e+ What You Will Learn\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp data-path-to-node=\"4\"\u003eAttendees will be able to:\u003c\/p\u003e\n\u003cul data-path-to-node=\"5\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"5,0,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"5,0,0\"\u003eManage\u003c\/b\u003e the impact of frailty, deconditioning, and sarcopenia on chronic kidney disease (CKD) patients and transplant outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"5,1,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"5,1,0\"\u003eEvaluate\u003c\/b\u003e living donor candidates over the age of 50, understanding specific acceptance criteria and long-term outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"5,2,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"5,2,0\"\u003eNavigate\u003c\/b\u003e the “Good, the Bad \u0026amp; the Ugly” of current deceased donor kidney offers to maximize access and minimize non-utilization.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"5,3,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"5,3,0\"\u003eIdentify\u003c\/b\u003e hidden financial costs and billing differences for transplant patients, specifically regarding \u003cb data-index-in-node=\"104\" data-path-to-node=\"5,3,0\"\u003eMedicare Advantage\u003c\/b\u003e plans.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"5,4,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"5,4,0\"\u003eImplement\u003c\/b\u003e strategies for medication management in elderly transplant recipients to reduce complications.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"5,5,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"5,5,0\"\u003eOutline\u003c\/b\u003e the logistics of the “direct to pre-op” pathway and what patients should expect when called in for a transplant.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-path-to-node=\"6\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"6\"\u003e+ Event Details\u003c\/b\u003e\u003c\/h3\u003e\n\u003cul data-path-to-node=\"7\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"7,0,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"7,0,0\"\u003eDate:\u003c\/b\u003e Friday, September 19, 2025\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"7,1,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"7,1,0\"\u003eTime:\u003c\/b\u003e 7:30 a.m. – 3:50 p.m. ET\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"7,2,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"7,2,0\"\u003eLocation:\u003c\/b\u003e Sheraton Detroit Novi Hotel, Novi, Michigan (and Virtual via Zoom)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-path-to-node=\"8\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"8\"\u003e+ Who Should Attend\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp data-path-to-node=\"9\"\u003eThe course is tailored for the entire transplant care continuum:\u003c\/p\u003e\n\u003cul data-path-to-node=\"10\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"10,0,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,0,0\"\u003eNephrologists\u003c\/b\u003e and Transplant Surgeons\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"10,1,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,1,0\"\u003ePrimary Care Physicians\u003c\/b\u003e and Internists\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"10,2,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,2,0\"\u003eNurse Practitioners\u003c\/b\u003e and Physician Assistants\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"10,3,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,3,0\"\u003eTransplant Coordinators\u003c\/b\u003e and Nurses\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"10,4,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,4,0\"\u003eSocial Workers\u003c\/b\u003e and Dialysis Unit Staff\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"10,5,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"10,5,0\"\u003eAdministrators\u003c\/b\u003e handling transplant finance and logistics\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-path-to-node=\"11\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"11\"\u003e+ Why Attend\u003c\/b\u003e\u003c\/h3\u003e\n\u003cul data-path-to-node=\"12\"\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"12,0,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"12,0,0\"\u003eAge-Specific Focus:\u003c\/b\u003e Unlike general updates, this year’s agenda specifically tackles the “Silver Tsunami” in transplant—managing older recipients and donors—which is a growing demographic challenge.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"12,1,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"12,1,0\"\u003eFinancial Literacy:\u003c\/b\u003e The inclusion of a dedicated session on “Hidden Finance Costs” and insurance nuances provides practical knowledge often missing from clinical CME but vital for patient advocacy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp data-path-to-node=\"12,2,0\"\u003e\u003cb data-index-in-node=\"0\" data-path-to-node=\"12,2,0\"\u003eAllocation Strategy:\u003c\/b\u003e Gain insider insight into how Michigan Medicine navigates the complex new world of deceased donor offers, helping you counsel patients on which offers to accept.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThe Frailty Factor – Unraveling Hidden Impact on Chronic Kidney Disease and Transplant\u003c\/li\u003e\n\u003cli\u003eFighting Frailty\u003c\/li\u003e\n\u003cli\u003eIt’s Go Time! – What to Expect When Getting Called in for Kidney Transplant\u003c\/li\u003e\n\u003cli\u003eWait List Management – How to Maximize Successful Transplant\u003c\/li\u003e\n\u003cli\u003eMedication Considerations in Elderly Transplant Recipients\u003c\/li\u003e\n\u003cli\u003eMedicare Advantage – Potential Hidden Finance Costs\u003c\/li\u003e\n\u003cli\u003eThe Good, the Bad \u0026amp; the Ugly – Our Changing Landscape of Deceased Donor Kidney Transplant Offers\u003c\/li\u003e\n\u003cli\u003eKeynote – Older Patients and Kidney Transplant\u003c\/li\u003e\n\u003cli\u003eExpanding Living Donation – Pushing the Boundaries on Age\u003c\/li\u003e\n\u003cli\u003eUnderstanding the Complex Psychosocial Needs of Older Adults Post-Kidney Transplant\u003c\/li\u003e\n\u003cli\u003ePatient Perspective – Transplant and Living Donations After 70\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539477321,"sku":"MED-AMB05681","price":30.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/file_00000000b6f071f4854ecaa1e40990dc.png?v=1781873807"},{"product_id":"keck-usc-9th-annual-southern-california-kidney-symposium-2025","title":"Keck USC 9th Annual Southern California Kidney Symposium 2025","description":"\u003cdiv class=\"grid-x grid-margin-x\"\u003e\n\u003cdiv class=\"cell initial-12 medium-8\"\u003e\n\u003cdiv class=\"pnllearningActivityInformationClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnllearningActivityInformation_0\"\u003e\n\u003cdiv class=\"pnlLearningActivityInformationDescriptionClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnlLearningActivityInformationDescription_0\"\u003e\n\u003cdiv class=\"pnllearningActivityInformationClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnllearningActivityInformation_0\"\u003e\n\u003cdiv class=\"pnlLearningActivityInformationDescriptionClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnlLearningActivityInformationDescription_0\"\u003e\n\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"bbb44b8\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-371ff86 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"371ff86\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"custom-single-product product type-product post-465185 status-publish first instock product_cat-hot-books product_cat-anesthesiology product_cat-cardiology product_cat-hematology product_cat-medical-reference-terminology product_cat-vascular-medicine has-post-thumbnail sale downloadable virtual taxable purchasable product-type-simple\" id=\"product-465185\"\u003e\n\u003cdiv class=\"afk-single-product-outer\"\u003e\n\u003cdiv class=\"akf-p-f-box d-flex f-wrap j-c-b\"\u003e\n\u003cdiv class=\"akf-right\"\u003e\n\u003cdiv class=\"woo-tab-container custom woo-tc-j\"\u003e\n\u003cdiv class=\"tabcontent active\" id=\"descriptionTab\"\u003e\n\u003cdiv class=\"prod-desc\"\u003e\n\u003ch3\u003eKeck USC 9th Annual Southern California Kidney Symposium 2025\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 11 videos + 11 audios + 11 file sub vtts + 2 pdfs, size: 4.32 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: nephrologists, internists, hospitalists, advanced practice providers\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location: Friday, June 6, 2025, 8:00 AM – 4:00 PM, Aresty Conference Center – USC Health Sciences Campus, Los Angeles, CA\u003c\/div\u003e\n\u003cbr\u003eThis is the ninth annual Southern California Kidney Symposium with the theme “Updates on Biologics and Novel Therapeutics for Kidney Diseases.” Invited faculty from USC and several other U.S. academic institutions will present in person or virtually before a live audience of clinical and research faculty and trainees. New clinical and research findings will be presented on topics in several broad areas, including new management strategies in hypertension, advanced CKD, and ESKD, new targets and therapies in the management of glomerular and other progressive kidney diseases, and the impacts of new therapeutics and biologics on onco-nephrology and kidney transplantation.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003eBy the end of the course, participants will be able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eDiscuss the roles of new drug therapies in the management of hypertension, hyperphosphatemia, and anemia in CKD and compare them with more established therapies.\u003c\/li\u003e\n\u003cli\u003eCompare the differences, strengths, and weaknesses among newly emerging therapies for IgA nephropathy.\u003c\/li\u003e\n\u003cli\u003eOutline new diagnostic and therapeutic options in the management of membranous nephropathy.\u003c\/li\u003e\n\u003cli\u003eSummarize newly emerging therapeutic options and targets for the treatment of lupus nephritis and C3 glomerulopathy.\u003c\/li\u003e\n\u003cli\u003eIdentify and assess new therapies and mechanisms of APOL1-mediated chronic kidney disease.\u003c\/li\u003e\n\u003cli\u003eRecognize the renal side effects associated with newer targeted cancer therapies.\u003c\/li\u003e\n\u003cli\u003eAnalyze treatment strategies for antibody-mediated kidney transplant rejection and recurrence of primary disease in kidney transplant patients.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cbr\u003eThe \u003cem\u003eKeck USC 9th Annual Southern California Kidney Symposium 2025\u003c\/em\u003e is best for nephrologists, internists, hospitalists, advanced practice providers, and researchers who want updates on biologics and novel therapeutics for kidney diseases, with a focus on translating cutting‑edge science into clinical practice.\u003cbr\u003e\u003ch3\u003e👩‍⚕️ Who Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eNephrologists and kidney specialists managing chronic kidney disease, glomerular disorders, and transplant patients.\u003c\/li\u003e\n\u003cli\u003eInternal medicine physicians and hospitalists who co‑manage patients with renal complications.\u003c\/li\u003e\n\u003cli\u003eAdvanced practice providers (NPs, PAs) working in nephrology or internal medicine.\u003c\/li\u003e\n\u003cli\u003eResearchers and translational scientists studying biologics and novel therapeutics in renal medicine.\u003c\/li\u003e\n\u003cli\u003eResidents and fellows in nephrology or internal medicine preparing for board exams or expanding their clinical knowledge.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e01 Microangiopathic Hemolytic Anemia Focus on Thrombotic Thrombocytopenic Purpura aTypical Hemolytic Uremic Syndrome\u003c\/li\u003e\n\u003cli\u003e02 Novel Therapies in APOL-Mediated Kidney Disease – From Molecular Pathways to Therapeutic Options\u003c\/li\u003e\n\u003cli\u003e03 Hypertension and Endothelin Inhibition – A New Option for Resistant Hypertension\u003c\/li\u003e\n\u003cli\u003e04 New Therapeutic Options in ESKD Patients for Hyperphosphatemia\u003c\/li\u003e\n\u003cli\u003e05 Hypoxia-Inducible Factor Activation in Anemia Due to Chronic Kidney Disease\u003c\/li\u003e\n\u003cli\u003e06 Overview of New Therapies for Glomerular Diseases and the Treatment of IgA Nephropathy\u003c\/li\u003e\n\u003cli\u003e07 Emerging Therapies and Strategies for the Management of Membranous Nephropathy\u003c\/li\u003e\n\u003cli\u003e08 Expanded Therapeutic Options and Targets for the Treatment of Lupus Nephritis\u003c\/li\u003e\n\u003cli\u003e09 Importance of Genetic Factors and Emerging Therapeutic Options for C3 Glomerulopathy\u003c\/li\u003e\n\u003cli\u003e10 Immune Checkpoint Inhibitor Induced AKI (ICI-AKI)\u003c\/li\u003e\n\u003cli\u003e11 Emerging Biologics for Antibody Mediated Rejection in Kidney Transplantation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539542857,"sku":"MED-AMB05589","price":20.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Keck-USC-9th-Annual-Southern-California-Kidney-Symposium-2025.jpg?v=1781873805"},{"product_id":"harvard-testosterone-therapy-and-sexual-dysfunction-2026","title":"Harvard Testosterone Therapy and Sexual Dysfunction 2026","description":"\u003cdiv class=\"grid-x grid-margin-x\"\u003e\n\u003cdiv class=\"cell initial-12 medium-8\"\u003e\n\u003cdiv class=\"pnllearningActivityInformationClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnllearningActivityInformation_0\"\u003e\n\u003cdiv class=\"pnlLearningActivityInformationDescriptionClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnlLearningActivityInformationDescription_0\"\u003e\n\u003cdiv class=\"pnllearningActivityInformationClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnllearningActivityInformation_0\"\u003e\n\u003cdiv class=\"pnlLearningActivityInformationDescriptionClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnlLearningActivityInformationDescription_0\"\u003e\n\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"bbb44b8\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-371ff86 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"371ff86\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"custom-single-product product type-product post-465185 status-publish first instock product_cat-hot-books product_cat-anesthesiology product_cat-cardiology product_cat-hematology product_cat-medical-reference-terminology product_cat-vascular-medicine has-post-thumbnail sale downloadable virtual taxable purchasable product-type-simple\" id=\"product-465185\"\u003e\n\u003cdiv class=\"afk-single-product-outer\"\u003e\n\u003cdiv class=\"akf-p-f-box d-flex f-wrap j-c-b\"\u003e\n\u003cdiv class=\"akf-right\"\u003e\n\u003cdiv class=\"woo-tab-container custom woo-tc-j\"\u003e\n\u003cdiv class=\"tabcontent active\" id=\"descriptionTab\"\u003e\n\u003cdiv class=\"prod-desc\"\u003e\n\u003ch3\u003eHarvard Testosterone Therapy and Sexual Dysfunction 2026\u003c\/h3\u003e\n\u003cb\u003e \u003c\/b\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: dermatologists, endocrinologists, family practice providers, geriatricians, gynecologists, PAs, primary care providers, psychiatrists, urologists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"column mcb-column mcb-item-aons02pf one laptop-one tablet-one mobile-one column_column vb-item\"\u003e\n\u003cdiv class=\"mcb-column-inner mfn-module-wrapper mcb-column-inner-aons02pf mcb-item-column-inner\"\u003e\n\u003cdiv class=\"column_attr mfn-inline-editor clearfix\"\u003e\n\u003ch3\u003eTestosterone Therapy \u003cspan class=\"db-font-light\"\u003eand\u003c\/span\u003e Sexual Dysfunction January 16-17, 2026 • Hyatt Regency Grand Cypress, Orlando\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"wrap mcb-wrap mcb-wrap-b809032c0 one tablet-one laptop-one mobile-one vb-item clearfix\" data-desktop-col=\"one\" data-laptop-col=\"laptop-one\" data-mobile-col=\"mobile-one\" data-tablet-col=\"tablet-one\"\u003e\n\u003cdiv class=\"mcb-wrap-inner mcb-wrap-inner-b809032c0 mfn-module-wrapper mfn-wrapper-for-wraps\"\u003e\n\u003cdiv class=\"mcb-column-inner mfn-module-wrapper mcb-column-inner-32cc182ef mcb-item-heading-inner\"\u003e\n\u003cp class=\"title\"\u003eInnovative and Comprehensive Continuing Medical Education Course on Testosterone Deficiency and Sexual Issues\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"column mcb-column mcb-item-12196oqg one laptop-one tablet-one mobile-one column_heading vb-item\"\u003e\n\u003cdiv class=\"mcb-column-inner mfn-module-wrapper mcb-column-inner-12196oqg mcb-item-heading-inner\"\u003e\n\u003ch3 class=\"title\"\u003eTestosterone Therapy and Sexual Dysfunction – Demystifying the Hype with Science to Provide Cutting Edge Treatment for Your Patients\u003c\/h3\u003e\n\u003ch3 class=\"title\"\u003eUpdates, Best Practices, Tools and Optimized Strategies for Testosterone Therapy and Men’s Health\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"wrap mcb-wrap mcb-wrap-7186014da one-second tablet-one-second laptop-one-second mobile-one vb-item clearfix\" data-desktop-col=\"one-second\" data-laptop-col=\"laptop-one-second\" data-mobile-col=\"mobile-one\" data-tablet-col=\"tablet-one-second\"\u003e\n\u003cdiv class=\"mcb-wrap-inner mcb-wrap-inner-7186014da mfn-module-wrapper mfn-wrapper-for-wraps\"\u003e\n\u003cdiv class=\"column mcb-column mcb-item-78260934b one laptop-one tablet-one mobile-one column_column vb-item\"\u003e\n\u003cdiv class=\"mcb-column-inner mfn-module-wrapper mcb-column-inner-78260934b mcb-item-column-inner\"\u003e\n\u003cdiv class=\"column_attr mfn-inline-editor clearfix\"\u003e\n\u003cbr\u003e\u003cbr\u003eTestosterone therapy is one of the most controversial topics in medicine, yet multiple medical societies endorse its use, supported by level 1 evidence showing a variety of health benefits in men. \u003cstrong\u003eThis innovative and comprehensive course will focus on testosterone deficiency and its treatment in men and women and will also address several other sexual issues.\u003c\/strong\u003e Studies indicate that nearly 40% of men over the age of 45 have overtly low testosterone levels, yet education in this area is extremely limited. Similarly, there have been few educational opportunities to address sexual dysfunction in men and women. Approximately 40% of men and a similar percentage of women have one sexual dysfunction or another. Indeed, there have been several fascinating therapeutic advances in the treatment of sexual dysfunction in women that have received scant attention in other educational events.\u003cbr\u003e\u003cbr\u003eProgram Highlights Include:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNEW!\u003c\/strong\u003e Important FDA Labeling Updates\u003c\/li\u003e\n\u003cli\u003eThe importance of testosterone in male health\u003c\/li\u003e\n\u003cli\u003eCan testosterone be used in men with prostate cancer?\u003c\/li\u003e\n\u003cli\u003eCurrent evidence regarding HRT in women and how to start treatment\u003c\/li\u003e\n\u003cli\u003eThe who, when and why of testosterone therapy\u003c\/li\u003e\n\u003cli\u003eEvaluation of and cutting-edge treatment for ED\u003c\/li\u003e\n\u003cli\u003eThe TRAVERSE Trial results\u003c\/li\u003e\n\u003cli\u003eHair and hormones\u003c\/li\u003e\n\u003cli\u003eNon-medical strategies for managing couples with sexual complaints\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWho Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eDermatologists\u003c\/li\u003e\n\u003cli\u003eEndocrinologists\u003c\/li\u003e\n\u003cli\u003eFamily practice providers\u003c\/li\u003e\n\u003cli\u003eGeriatricians\u003c\/li\u003e\n\u003cli\u003eGynecologists\u003c\/li\u003e\n\u003cli\u003ePAs\u003c\/li\u003e\n\u003cli\u003ePrimary care providers\u003c\/li\u003e\n\u003cli\u003ePsychiatrists\u003c\/li\u003e\n\u003cli\u003ePsychologists\u003c\/li\u003e\n\u003cli\u003eNPs and nurses\u003c\/li\u003e\n\u003cli\u003eUrologists\u003c\/li\u003e\n\u003cli\u003eOther clinicians who treat low testosterone and male and female sexual health issues\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003csection class=\"section mcb-section mfn-default-section mcb-section-ae330574f no-margin-v\"\u003e\n\u003cdiv class=\"section_wrapper mfn-wrapper-for-wraps mcb-section-inner mcb-section-inner-ae330574f\"\u003e\n\u003cdiv class=\"wrap mcb-wrap mcb-wrap-33bf01085 five-sixth tablet-one laptop-one mobile-one vb-item clearfix\" data-desktop-col=\"five-sixth\" data-laptop-col=\"laptop-one\" data-mobile-col=\"mobile-one\" data-tablet-col=\"tablet-one\"\u003e\n\u003cdiv class=\"mcb-wrap-inner mcb-wrap-inner-33bf01085 mfn-module-wrapper mfn-wrapper-for-wraps\"\u003e\n\u003cdiv class=\"column mcb-column mcb-item-1dde7b408 one laptop-one tablet-one mobile-one column_heading vb-item\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"wrap mcb-wrap mcb-wrap-tmmmw5k one tablet-one laptop-one mobile-one vb-item clearfix\" data-desktop-col=\"one\" data-laptop-col=\"laptop-one\" data-mobile-col=\"mobile-one\" data-tablet-col=\"tablet-one\"\u003e\n\u003cdiv class=\"mcb-wrap-inner mcb-wrap-inner-tmmmw5k mfn-module-wrapper mfn-wrapper-for-wraps\"\u003e\n\u003cdiv class=\"wrap mcb-wrap mcb-wrap-5vbj01859 one-third tablet-two-fifth laptop-one-third mobile-one mfn-nested-wrap vb-item clearfix\" data-desktop-col=\"one-third\" data-laptop-col=\"laptop-one-third\" data-mobile-col=\"mobile-one\" data-tablet-col=\"tablet-two-fifth\"\u003e\n\u003cdiv class=\"mcb-wrap-inner mcb-wrap-inner-5vbj01859 mfn-module-wrapper mfn-wrapper-for-wraps\"\u003e\n\u003cdiv class=\"column mcb-column mcb-item-lh40zawr one laptop-one tablet-one mobile-one column_column vb-item\"\u003e\n\u003cdiv class=\"mcb-column-inner mfn-module-wrapper mcb-column-inner-lh40zawr mcb-item-column-inner\"\u003e\n\u003cdiv class=\"column_attr mfn-inline-editor clearfix\"\u003e\n\u003ch3\u003eFEATURING:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eInnovative \u003cstrong\u003electures\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eValuable \u003cstrong\u003ecase-based sessions\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eLive \u003cstrong\u003edemonstrations\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuestion-and-answer\u003c\/strong\u003e panels\u003c\/li\u003e\n\u003cli\u003eInteractive \u003cstrong\u003ediscussions\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003csection class=\"section mcb-section mfn-default-section mcb-section-a2f9ab29e no-margin-v\" id=\"remote\"\u003e\n\u003cdiv class=\"section_wrapper mfn-wrapper-for-wraps mcb-section-inner mcb-section-inner-a2f9ab29e\"\u003e\n\u003cdiv class=\"wrap mcb-wrap mcb-wrap-gik9jptm four-fifth tablet-one laptop-four-fifth mobile-one vb-item clearfix\" data-desktop-col=\"four-fifth\" data-laptop-col=\"laptop-four-fifth\" data-mobile-col=\"mobile-one\" data-tablet-col=\"tablet-one\"\u003e\n\u003cdiv class=\"mcb-wrap-inner mcb-wrap-inner-gik9jptm mfn-module-wrapper mfn-wrapper-for-wraps\"\u003e\n\u003cdiv class=\"column mcb-column mcb-item-bpe0lm8 one laptop-one tablet-one mobile-one column_column vb-item\"\u003e\n\u003cdiv class=\"mcb-column-inner mfn-module-wrapper mcb-column-inner-bpe0lm8 mcb-item-column-inner\"\u003e\n\u003cdiv class=\"column_attr mfn-inline-editor clearfix\"\u003e\n\u003ch3\u003eProgram Highlights\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"wrap mcb-wrap mcb-wrap-0c3df909f one-second tablet-one-second laptop-one-second mobile-one mfn-nested-wrap vb-item clearfix\" data-desktop-col=\"one-second\" data-laptop-col=\"laptop-one-second\" data-mobile-col=\"mobile-one\" data-tablet-col=\"tablet-one-second\"\u003e\n\u003cdiv class=\"mcb-wrap-inner mcb-wrap-inner-0c3df909f mfn-module-wrapper mfn-wrapper-for-wraps\"\u003e\n\u003cdiv class=\"column mcb-column mcb-item-afi0dud4i one laptop-one tablet-one mobile-one column_column vb-item\"\u003e\n\u003cdiv class=\"mcb-column-inner mfn-module-wrapper mcb-column-inner-afi0dud4i mcb-item-column-inner\"\u003e\n\u003cdiv class=\"column_attr mfn-inline-editor clearfix\"\u003e\n\u003cul class=\"list_check\"\u003e\n\u003cli\u003e\u003cstrong\u003eThe importance of testosterone in male health\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eThe ABCs of testosterone\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCan testosterone be used in men with prostate cancer?\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTestosterone and the risk of breast cancer in women\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManaging risks\u003c\/strong\u003e, including cardiovascular disease\u003c\/li\u003e\n\u003cli\u003eEffective and safe \u003cstrong\u003einterventions to preserve fertility\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eThe who, when and why of testosterone replacement therapy\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAdvising patients on testosterone myths and facts\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCurrent evidence regarding HRT in women and how to start treatment\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAddressing “hormonophobia”:\u003c\/strong\u003e What’s the truth?\u003c\/li\u003e\n\u003cli\u003eEvidence-based solutions for \u003cstrong\u003eimproving male sexual problems\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"wrap mcb-wrap mcb-wrap-bzmsvhbe one-second tablet-one-second laptop-one-second mobile-one mfn-nested-wrap vb-item clearfix\" data-desktop-col=\"one-second\" data-laptop-col=\"laptop-one-second\" data-mobile-col=\"mobile-one\" data-tablet-col=\"tablet-one-second\"\u003e\n\u003cdiv class=\"mcb-wrap-inner mcb-wrap-inner-bzmsvhbe mfn-module-wrapper mfn-wrapper-for-wraps\"\u003e\n\u003cdiv class=\"column mcb-column mcb-item-qluva7ed one laptop-one tablet-one mobile-one column_column vb-item\"\u003e\n\u003cdiv class=\"mcb-column-inner mfn-module-wrapper mcb-column-inner-qluva7ed mcb-item-column-inner\"\u003e\n\u003cdiv class=\"column_attr mfn-inline-editor clearfix\"\u003e\n\u003cul class=\"list_check\"\u003e\n\u003cli\u003e\u003cstrong\u003eThe TRAVERSE Trial results\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHypoactive sexual desire disorder and other common sexual issues for women\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReal-world evidence – who’s a candidate for T therapy?\u003c\/strong\u003e Recent updates on society guidelines and recommendations\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eManagement of complex cases\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHow to handle adverse effects from treatment\u003c\/strong\u003e (i.e., erythrocytosis, rise in PSA)\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCommon female sexual issues and their treatment\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNon-medical strategies for managing couples with sexual complaints\u003c\/strong\u003e – expert advice from a clinical psychologist and sex therapist\u003c\/li\u003e\n\u003cli\u003eEvaluation of and \u003cstrong\u003ecutting-edge treatment for ED\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePractical pearls from Dr. Morgentaler\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"product-program__lesson\" data-v-9ad12abf=\"\"\u003e\n\u003cul class=\"ui-tabs-nav ui-corner-all ui-helper-reset ui-helper-clearfix ui-widget-header\" role=\"tablist\"\u003e\n\u003cli aria-controls=\"tab-697b8114e1ad2-1\" aria-expanded=\"true\" aria-labelledby=\"ui-id-1\" aria-selected=\"true\" class=\"ui-tabs-tab ui-corner-top ui-state-default ui-tab ui-tabs-active ui-state-active\" role=\"tab\" tabindex=\"0\"\u003e\u003cstrong\u003eFri. Jan. 16\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv aria-hidden=\"false\" aria-labelledby=\"ui-id-1\" class=\"ui-tabs-panel ui-corner-bottom ui-widget-content\" id=\"tab-697b8114e1ad2-1\" role=\"tabpanel\"\u003e\n\u003ctable align=\"left\" cellpadding=\"6\" cellspacing=\"6\" class=\"text\" width=\"1367\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\" width=\"15%\"\u003e7:15 AM\u003c\/td\u003e\n\u003ctd class=\"time\" width=\"15%\"\u003e8:00 AM\u003c\/td\u003e\n\u003ctd width=\"70%\"\u003e\u003cem\u003eREGISTRATION AND BREAKFAST\u003c\/em\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e8:00 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e8:15 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eIntroduction and Welcome\u003c\/strong\u003e\u003cbr\u003eMorgentaler\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e8:15 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e8:45 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eThe Importance of Testosterone in Men’s Health\u003c\/strong\u003e\u003cbr\u003eKhera\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e8:45 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e9:15 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eHistory of Testosterone Therapy: Where Have We Been and Where Are We Going?\u003c\/strong\u003e\u003cbr\u003eMorgentaler\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e9:15 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e9:30 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eWhat’s in a Name? Understanding the Terminology\u003c\/strong\u003e\u003cbr\u003eMorgentaler\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e9:30 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e10:00 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eTestosterone Physiology and Pathophysiology\u003c\/strong\u003e\u003cbr\u003eTraish\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e10:00 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e10:20 AM\u003c\/td\u003e\n\u003ctd\u003e\u003cem\u003eREFRESHMENT BREAK\u003c\/em\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e10:20 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e10:50 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eNavigating a Sea of Guidelines: What You Need to Know\u003c\/strong\u003e\u003cbr\u003eKhera\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e10:50 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e11:30 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eWho is a Candidate? The Marriage of Guidelines and Clinical Experience for Testosterone Therapy\u003c\/strong\u003e\u003cbr\u003eMorgentaler\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e11:30 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e12:00 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eTestosterone and Mental Health in Men and Women\u003c\/strong\u003e*\u003cbr\u003eCampbell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e12:00 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e1:00 PM\u003c\/td\u003e\n\u003ctd\u003e\u003cem\u003eLUNCH BREAK\u003c\/em\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e1:00 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e1:35 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eCurrent Treatments for Hair Loss in 2026\u003c\/strong\u003e\u003cbr\u003eAvram\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e1:35 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e2:10 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eHow to Treat: Injections, Topicals, Pellets, Orals\u003c\/strong\u003e\u003cbr\u003eMorgentaler\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e2:10 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e2:40 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eThe TRAVERSE Trial and Cardiovascular Risks\u003c\/strong\u003e*\u003cbr\u003eKhera\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e2:40 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e3:10 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eProstate Cancer and BPH Risks: What’s the Truth?\u003c\/strong\u003e*\u003cbr\u003eMorgentaler\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e3:10 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e3:30 PM\u003c\/td\u003e\n\u003ctd\u003e\u003cem\u003eREFRESHMENT BREAK\u003c\/em\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e3:30 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e4:00 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eOther Risks and Their Management: A Case-Based Interactive Session\u003c\/strong\u003e*\u003cbr\u003eMorgentaler\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e4:00 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e4:30 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eManaging Testosterone Deficiency in Men Wishing to Preserve Fertility: Effective and Safe Interventions\u003c\/strong\u003e*\u003cbr\u003eKhera\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e4:30 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e5:00 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eManagement of Complex Clinical Cases: A Case-Based Session\u003c\/strong\u003e\u003cbr\u003eMorgentaler\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e5:00 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e5:30 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eQuestion-and-Answer Session\u003c\/strong\u003e\u003cbr\u003ePanel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSat. Jan. 17\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ctable align=\"left\" cellpadding=\"6\" cellspacing=\"6\" class=\"text\" width=\"1174\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\" width=\"15%\"\u003e7:30 AM\u003c\/td\u003e\n\u003ctd class=\"time\" width=\"15%\"\u003e8:00 AM\u003c\/td\u003e\n\u003ctd width=\"70%\"\u003e\u003cem\u003eBREAKFAST\u003c\/em\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e8:00 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e8:30 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eSexual Health is the Best Barometer of Overall Health\u003c\/strong\u003e\u003cbr\u003eKhera\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e8:30 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e9:10 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eHow to Evaluate and Treat Men with Erectile Dysfunction: Pills, Injections, Surgery and More\u003c\/strong\u003e\u003cbr\u003eCampbell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e9:10 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e9:30 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eNew and Cutting-Edge Treatments for ED: Low-Intensity Shock Wave Therapy, PRP, and More\u003c\/strong\u003e\u003cbr\u003eKhera\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e9:30 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e9:50 AM\u003c\/td\u003e\n\u003ctd\u003e\u003cem\u003eREFRESHMENT BREAK\u003c\/em\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e9:50 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e10:20 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePremature and Delayed Ejaculation: Recommendations for Optimal Care\u003c\/strong\u003e\u003cbr\u003eCampbell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e10:20 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e10:40 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePractical Tricks of the Trade in Treating ED and Other Male Sexual Issues: An RN’s Perspective\u003c\/strong\u003e\u003cbr\u003eFlinn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e10:40 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e10:50 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eBringing It All Together: Questions and Discussion\u003c\/strong\u003e\u003cbr\u003ePanel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e10:50 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e11:20 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eHot Off the Press: FDA Labeling Changes and their Impact on Clinical Practice\u003c\/strong\u003e\u003cbr\u003eMorgentaler, Khera, Rubin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e11:20 AM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e12:00 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eKEYNOTE:\u003c\/strong\u003e \u003cstrong\u003eTestosterone, Science and Human Dignity\u003c\/strong\u003e\u003cbr\u003eMorgentaler\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e12:00 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e1:00 PM\u003c\/td\u003e\n\u003ctd\u003e\u003cem\u003eLUNCH BREAK\u003c\/em\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e1:00 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e1:30 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePhysiology and Pathophysiology of Women’s Sexual Function\u003c\/strong\u003e\u003cbr\u003eTraish\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e1:30 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e2:00 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eSociosexual Trends and Sex Therapy: Addressing Modern Intimacy\u003c\/strong\u003e*\u003cbr\u003eBrandon\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e2:00 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e2:30 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eKEYNOTE:\u003c\/strong\u003e \u003cstrong\u003eHormone Replacement Therapy in Women: Rationale and How I Do It\u003c\/strong\u003e\u003cbr\u003eRubin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e2:30 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e2:50 PM\u003c\/td\u003e\n\u003ctd\u003e\u003cem\u003eREFRESHMENT BREAK\u003c\/em\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e2:50 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e3:20 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eHypoactive Sexual Desire Disorder\u003c\/strong\u003e\u003cbr\u003eRubin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e3:20 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e3:50 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eThe X-Factor: Partner Dynamics and Its Effect on Treatment\u003c\/strong\u003e\u003cbr\u003eBrandon\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e3:50 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e4:20 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eOther Female Sexual Dysfunctions\u003c\/strong\u003e\u003cbr\u003eRubin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e4:20 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e4:50 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eSex Tech, Chatbots, and the Future of Intimacy\u003c\/strong\u003e\u003cbr\u003eBrandon\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"time\"\u003e4:50 PM\u003c\/td\u003e\n\u003ctd class=\"time\"\u003e5:30 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eQuestion-and-Answer Session\u003c\/strong\u003e\u003cbr\u003ePanel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539510089,"sku":"MED-AMB05585","price":120.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/ChatGPT-Image-2-_D9_81_D8_A8_D8_B1_D8_A7_D9_8A_D8_B1-2026_D8_8C-12_04_40-_D8_B5.png?v=1781873806"},{"product_id":"advances-in-anesthesia-2025-original-pdf-from-publisher","title":"Advances in Anesthesia, 2025 (Original PDF from Publisher)","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"bbb44b8\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cstrong\u003eby Laurence Torsher MD (ed.), Ralf E. Gebhard MD (ed.), Arna Banerjee MD (ed.), Evan G. Pivalizza MD (ed.)\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv\u003e\n\u003cdiv\u003eAdvances in Anesthesia reviews the year’s most important findings and updates within the field in order to provide anesthesiologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Laurence Torsher, identifies key areas of major progress and controversy and invites preeminent clinicians to contribute original articles devoted to these topics. These insightful overviews in anesthesia inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care. \u003cbr\u003e\u003cul\u003e\n\u003cli\u003eContains 11 articles on such topics as acupuncture and anesthesia; perioperative management of the breast-feeding woman; extending the duration and improving the efficacy of peripheral nerve blocks; cryoablation as a tool for acute pain management; psychedelics and the perioperative period (recreational, therapeutic, microdosing); highlights of POCUS for the anesthesiologist; and more\u003c\/li\u003e\n\u003cli\u003eProvides in-depth, clinical reviews in anesthesia, providing actionable insights for clinical practice\u003c\/li\u003e\n\u003cli\u003ePresents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539805001,"sku":"MED-AMB05411","price":20.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Advances-in-Anesthesia-2025-Original-PDF-from-Publisher-2.jpg?v=1781873805"},{"product_id":"scripps-san-diego-genitourinary-annual-course-in-oncology-guaco-2025","title":"Scripps San Diego Genitourinary Annual Course in Oncology (GUACO) 2025","description":"\u003cdiv id=\"panel-70-0-0-1\" class=\"so-panel widget widget_sow-editor\" data-index=\"1\"\u003e\r\n\u003cdiv class=\"native default panel-widget-style panel-widget-style-for-70-0-0-1\"\u003e\r\n\u003cdiv class=\"so-widget-sow-editor so-widget-sow-editor-base\"\u003e\r\n\u003cdiv class=\"siteorigin-widget-tinymce textwidget\"\u003e\r\n\u003ch1 class=\"product_title entry-title\"\u003eScripps San Diego Genitourinary Annual Course in Oncology (GUACO) 2025\u003c\/h1\u003e\r\n\u003cstrong\u003e+ Include: 15 videos + 16 pdfs, size: 2.35 GB\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Target Audience: oncologists, urologists, radiation oncologists, advanced practice providers\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\r\nSAN DIEGO GU Annual Course in Oncology (GUACO) Presented by Scripps Cancer Center\r\n\r\nSeptember 12-13, 2025 Coronado Island Marriott • Coronado, California\r\n\r\nThe San Diego Genitourinary Annual Course in Oncology (GUACO) promises to be a premier event for clinicians and practitioners who care for patients suffering from genitourinary malignancies. The focus of this course will be on prostate, bladder, and kidney cancer. This dynamic course features expert-led sessions designed to provide attendees with an overview of standard-of-care treatment algorithms and options, as well as innovative strategies for patient care. Through interactive case-based discussions and engaging panel sessions, participants will have the opportunity to deepen their understanding of complex\r\nclinical scenarios and to translate knowledge into practice. Attendees will leave empowered with actionable tools and strategies to optimize patient outcomes, improve quality of life, and to elevate the standard of care for individuals suffering from GU malignancy.\r\n\r\n\u003cstrong\u003eEducational Objectives\u003c\/strong\u003e\r\n\r\nAfter attending this live activity, participants should be able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eSummarize the current landscape of prostate, bladder, and kidney cancer, highlighting epidemiological trends, advancements in diagnosis, treatment strategies, and ongoing challenges in patient management.\u003c\/li\u003e\r\n \t\u003cli\u003eExplore current best practices and emerging approaches in the management of localized and advanced genitourinary malignancies, focusing on evidence-based standards and innovative strategies shaping the future of GU cancer care.\u003c\/li\u003e\r\n \t\u003cli\u003eDevelop a comprehensive outline of optimal clinical approaches for utilizing available treatment modalities in the management of GU malignancy.\u003c\/li\u003e\r\n \t\u003cli\u003eIntegrate multidisciplinary collaboration and shared decision-making into the management of complex patient cases, emphasizing coordinated care and proactive strategies to mitigate unfavorable clinical outcomes.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe Scripps San Diego \u003cem\u003eGenitourinary Annual Course in Oncology (GUACO) 2025\u003c\/em\u003e is best for oncologists, urologists, radiation oncologists, advanced practice providers, and trainees who want CME‑accredited, expert‑led updates on the latest therapies, clinical trials, and multidisciplinary management of genitourinary cancers.\r\n\u003ch3\u003e Who Should Attend\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eMedical oncologists and hematologists treating prostate, bladder, kidney, and testicular cancers.\u003c\/li\u003e\r\n \t\u003cli\u003eUrologists and surgical oncologists involved in surgical management of GU malignancies.\u003c\/li\u003e\r\n \t\u003cli\u003eRadiation oncologists integrating systemic and local therapies for GU cancers.\u003c\/li\u003e\r\n \t\u003cli\u003eAdvanced practice providers (NPs, PAs, CNSs) working in oncology or urology clinics.\u003c\/li\u003e\r\n \t\u003cli\u003eResidents and fellows in oncology, urology, or radiation oncology preparing for subspecialty practice.\u003c\/li\u003e\r\n \t\u003cli\u003eOncology nurses and pharmacists supporting GU cancer treatment and survivorship care.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch3\u003e What You’ll Learn\u003c\/h3\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eLatest clinical trial data and FDA approvals in GU oncology.\u003c\/li\u003e\r\n \t\u003cli\u003eUpdates in systemic therapies: immunotherapy, targeted therapy, and hormonal therapy for prostate and bladder cancer.\u003c\/li\u003e\r\n \t\u003cli\u003eSurgical and radiation advances: minimally invasive techniques, focal therapy, and integration with systemic treatment.\u003c\/li\u003e\r\n \t\u003cli\u003eMultidisciplinary case discussions: real‑world scenarios highlighting diagnostic and therapeutic challenges.\u003c\/li\u003e\r\n \t\u003cli\u003eSurvivorship and supportive care strategies tailored to GU cancer patients.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n \r\n\r\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003eFriday, September 12, 2025\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e4 p.m. Registration \u0026amp; Welcome Reception\u003c\/li\u003e\r\n \t\u003cli\u003e5 p.m. Keynote Presentation New Frontiers in Molecular Imaging of Kidney Cancer Brian Shuch, MD\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eSaturday, September 13, 2025\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e7:30 a.m. Breakfast \u0026amp; View Exhibits\u003c\/li\u003e\r\n \t\u003cli\u003e8:25 a.m. Welcome \u0026amp; Educational Overview Ramdev Konijeti, MD\u003c\/li\u003e\r\n \t\u003cli\u003eSession I: Prostate Cancer 8:30 a.m. Prostate Cancer Screening and Detection in 2025 Ramdev Konijeti, MD\u003c\/li\u003e\r\n \t\u003cli\u003e8:45 a.m. Role of Primary Therapy in Oligometastatic Prostate Cancer Shane Mesko, MD\u003c\/li\u003e\r\n \t\u003cli\u003e9 a.m. Prostate Cancer Theranostics: Current and Future Nik Patel, MD\u003c\/li\u003e\r\n \t\u003cli\u003e9:15 a.m. Castrate Resistant Prostate Cancer in 2025 Mohammad Jaloudi, MD\u003c\/li\u003e\r\n \t\u003cli\u003e9:30 a.m. Case Presentations\/Panel Discussion 10 a.m. Break \u0026amp; View Exhibits\u003c\/li\u003e\r\n \t\u003cli\u003eSession II: Bladder Cancer 10:30 a.m. Intravesical Therapy and Management of Non-Muscle Invasive Bladder Cancer Ramdev Konijeti, MD\u003c\/li\u003e\r\n \t\u003cli\u003e10:45 a.m. Radiotherapy for Invasive Bladder Cancer: Review of Current Data Shane Mesko, MD\u003c\/li\u003e\r\n \t\u003cli\u003e11 a.m. Role of Lymphadenectomy in 2025 Phil Kim, MD\u003c\/li\u003e\r\n \t\u003cli\u003e11:15 a.m. Immunotherapy and Antibody Drug Conjugates—Future of Systemic Therapy in Bladder Cancer Munveer Bhangoo, MD\u003c\/li\u003e\r\n \t\u003cli\u003e11:30 a.m. Case Presentations\/Panel Discussion Noon Lunch\u003c\/li\u003e\r\n \t\u003cli\u003eSession III: Kidney Cancer 1:15 p.m. Radiotherapy for Small Renal Masses Patrick Linson, MD\u003c\/li\u003e\r\n \t\u003cli\u003e1:30 p.m. Cytoreductive Nephrectomy in 2025 Carol Salem, MD\u003c\/li\u003e\r\n \t\u003cli\u003e1:45 p.m. Subtyping Renal Cell Carcinoma Phataraporn Thorson, MD\u003c\/li\u003e\r\n \t\u003cli\u003e2 p.m. Hereditary Kidney Cancer Guidelines 2025 Brian Shuch, MD\u003c\/li\u003e\r\n \t\u003cli\u003e2:15 p.m. Case Presentations\/Panel Discussion\u003c\/li\u003e\r\n \t\u003cli\u003e2:45 p.m. Adjourn Topics, times and speakers are subject to change\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539837769,"sku":"MED-AMB05339","price":50.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Scripps-San-Diego-Genitourinary-Annual-Course-in-Oncology-GUACO-2025.jpg?v=1781873806"},{"product_id":"uchicago-medicine-2nd-annual-university","title":"UChicago Medicine 2nd Annual University of Chicago Multidisciplinary Breast Cancer Symposium 2025","description":"\u003ch1 class=\"product_title entry-title\"\u003eUChicago Medicine 2nd Annual University of Chicago Multidisciplinary Breast Cancer Symposium 2025\u003c\/h1\u003e\n\u003cstrong\u003e Include: 13 videos + 13 audios + 13 file sub vtts + 1 pdf, size: 2.12 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: physicians and other healthcare professionals caring for patients with breast cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"field-label\"\u003eEvent starts: 01\/31\/2025 – 10:00am – 5:00pm\u003c\/div\u003e\n\u003cdiv class=\"field field-name-field-course-summary field-type-text-with-summary field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cdiv\u003e\n\u003cdiv\u003e\n\u003cdiv\u003e\n\u003cdiv\u003eJoin us for a dynamic and comprehensive symposium where we will dive into the latest best practices and tackle key controversies across medical, surgical, reconstructive, and radiation oncology. You’ll also explore essential topics like survivorship and supportive care, gaining practical strategies you can immediately implement in your clinical practice. Stay ahead of the curve with insights into this year’s most significant advancements and a sneak peek at groundbreaking therapies on the horizon. This is your opportunity to enhance outcomes for all breast cancer subtypes and empower long-term survivors, as we navigate the future of breast cancer care together.\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eLearn more at the symposium website!\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003ch2\u003eTarget Audience\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-target-audience field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cdiv\u003e\n\u003cdiv\u003eThis activity is designed for physicians and other healthcare professionals caring for patients with breast cancer.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-learning-objectives field-group-div\"\u003e\n\u003ch2\u003eLearning Objectives\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-learning-objectives field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eAfter this activity, participants will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cdiv\u003eIdentify the principles of breast cancer survivorship;\u003c\/div\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003eDiscuss changes in surgical management of breast cancer including de-escalation of axillary surgery;\u003c\/div\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003eIllustrate how the latest key research findings can be applied to improve clinical care and treatment strategies for patients with breast cancer;\u003c\/div\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003eDescribe how to manage common toxicities of novel therapies for breast cancer, including antibody-drug conjugates and novel endocrine therapies;\u003c\/div\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cdiv\u003eEvaluate the scientific rationale and patient population of ongoing, relevant clinical trials in breast cancer.\u003c\/div\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"markdown-block sqs-block sqs-block-markdown\" data-block-type=\"44\" id=\"block-yui_3_17_2_1_1727871960836_2124\"\u003e\n\u003cdiv class=\"sqs-block-content\"\u003e\n\u003ctable class=\"custom-table-block custom-table-block-full-width\" data-auto-detect-links=\"false\" data-borders-color=\"rgba(203,203,203,1)\" data-def-classes=\"custom-table-block-full-width\" data-disable-markdown=\"true\" data-follow-gss-styles=\"false\" data-gss-sync=\"false\" data-header-back=\"rgba(224,224,224,1)\" data-header-color=\"rgba(0,0,0,1)\" data-mobile-styles=\"disabled\" data-table-back=\"rgba(255,255,255,1)\" data-table-color=\"rgba(0,0,0,1)\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth class=\"table-header-th table-label\"\u003eTime\u003c\/th\u003e\n\u003cth class=\"table-header-th table-header-not-label\"\u003eActivity\u003c\/th\u003e\n\u003cth class=\"table-header-th table-header-not-label\"\u003eSpeaker\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003cbr\u003e\u003ctbody\u003e\n\u003ctr class=\"table-row table-row-0\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e10:00 AM\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eREGISTRATION\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-1\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e10:45 AM\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eWELCOME\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-2\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e11:00 AM – 12:00 PM\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eBREAKOUT SESSIONS\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-3\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\n\u003cstrong\u003eProvider Track: Challenging Cases\u003c\/strong\u003e\u003cbr\u003eModerator: Rita Nanda, MD\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003eSteve Chmura, MD, PhD, Olwen Hahn, MD, Fred Howard, MD, Nora Jaskowiak, MD, Betty Fan, DO\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-4\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\n\u003cstrong\u003eSupportive Track: Survivorship, Lymphedema, Toxicities of New Therapies Toxicities\u003c\/strong\u003e\u003cbr\u003eModerator: Nan Chen, MD\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003e\n\u003cstrong\u003eSurvivorship: \u003c\/strong\u003eMaryam Lustberg, MD, MPH, Sudha Yarlagadda, MD, Donna Christian, APN\u003cbr\u003e\u003cstrong\u003eLymphedema:\u003c\/strong\u003e Summer Hanson, MD, PhD, Scott Grumeretz, PT, DPT, CLT\u003cbr\u003e\u003cstrong\u003eToxicities:\u003c\/strong\u003e Heng Yang, PharmD, MS, BCOP, Joly Raju, MS, NP-C, Amanda Krug, PA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-5\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e12:00 PM\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eLUNCH\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-6\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e1:00 PM\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eKeynote Speaker: Survivorship in Breast Cancer: Managing Long-Term Toxicities and Recurrence Risk\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003eMaryam Lustberg, MD, MPH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-7\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e2:00 PM – 3:15 PM\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eMEDICAL ONCOLOGY\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-8\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eUpdates in ER+\/Her2- Breast Cancer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003eNan Chen, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-9\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eUpdates in HER2+ Breast Cancer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003eSudha Yarlagadda, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-10\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eUpdates in TNBC\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003eFrederick Howard, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-11\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eQ \u0026amp; A\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003eModerator: Rita Nanda, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-12\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eBREAK\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-13\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e3:30 PM – 4:45 PM\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eSURGICAL ONCOLOGY\/RADIATION ONCOLOGY\/PLASTICS\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-14\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eDe-Escalation of Axillary Breast Surgery\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003eSarah P. Shubeck, MD, MS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-15\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eUpdates in Reconstructive Breast Surgery and Lymphedema Surgery\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003eMaureen Beederman, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-16\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eUpdates in Radiation Oncology\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003eRohan Katipally, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-17\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eQ \u0026amp; A\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-3\"\u003eModerator: Nora Jaskowiak, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"table-row table-row-18\"\u003e\n\u003ctd class=\"first-cell table-cell table-cell-1\"\u003e5:00 PM\u003c\/td\u003e\n\u003ctd class=\"next-cell table-cell table-cell-2\"\u003e\u003cstrong\u003eADJOURN\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539870537,"sku":"MED-AMB05357","price":10.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/05dac7de-5e3e-420c-9d02-e324f7a5f7d1.png?v=1781873806"},{"product_id":"atlas-of-genitourinary-pathology","title":"Atlas of Genitourinary Pathology: A Pattern Based Approach (ePub)","description":"\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003ch1 class=\"product-title product_title entry-title\"\u003eAtlas of Genitourinary Pathology: A Pattern Based Approach (ePub)\u003c\/h1\u003e\n\u003ch4 class=\"product-title product_title entry-title\"\u003eClosely mirroring the daily sign-out process, Atlas of Genitourinary Pathology: A Pattern Based Approach is a highly illustrated, efficient guide to accurate diagnosis. This practical reference uses a proven, pattern-based approach to clearly explain how to interpret challenging cases by highlighting red flags in the clinical presentation and locating hidden clues in the slides. Useful as a daily “scope-side guide,” it features numerous clinical and educational features that help you find pertinent information, reach a correct diagnosis, and assemble a thorough and streamlined pathology report.\u003cbr\u003eMore than 1,200 high-quality photomicrographs capture the subtle morphologic spectrum of both biopsy and resection specimens of the prostate, bladder, kidney, testis, and the male genital tract. Each image is captioned with key diagnostic considerations and includes call-outs showing subtle features and diagnostic clues.\u003cbr\u003ePractical tools throughout the text include:\u003cbr\u003eTables that emphasize salient clinicopathologic features, management implications, and therapeutic options\u003cbr\u003eDiscussions of how and when to incorporate immunohistochemical, and if necessary, molecular tools\u003cbr\u003eChecklists for key elements of the diagnostic approach and sample notes for inclusion in pathology reports.\u003cbr\u003ePhotographs of select gross specimens, and numerous histologic correlates\u003cbr\u003eBrief reviews of normal histology that provide contrast to succeeding patterns\u003cbr\u003e“Pearls and Pitfalls” and “Near Misses” sections with lessons from real life sign-out experience\u003cbr\u003e“Frequently Asked Questions” sections that discuss common diagnostic dilemmas\u003cbr\u003e“Sample Note” sections that offer a template of how to synthesize complicated or especially challenging topics\u003cbr\u003eComprehensive quiz provides experience with high-yield, board-style teaching topics\u003cbr\u003eEnrich Your eBook Reading Experience\u003cbr\u003eRead directly on your preferred device(s), such as computer, tablet, or smartphone.\u003cbr\u003eEasily convert to audiobook, powering your content with natural language text-to-speech.\u003c\/h4\u003e\n\u003ch3 class=\"product-title product_title entry-title\"\u003e\n\u003cbr\u003eProduct details\u003c\/h3\u003e\n\u003ch4 class=\"product-title product_title entry-title\"\u003e\n\u003cbr\u003eHardcover : 496 pages\u003cbr\u003eISBN-10 : 1496397665\u003cbr\u003eISBN-13 : 978-1496397669\u003cbr\u003ePublisher : LWW; First Edition (December 11, 2020)\u003cbr\u003eLanguage: : English\u003c\/h4\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539903305,"sku":"MED-AMB05005","price":18.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Atlas-of-Genitourinary-Pathology-A-Pattern-Based-Approach-ePub.webp?v=1781873806"},{"product_id":"arrs-imaging-of-pathologies-of-male","title":"ARRS Imaging of Pathologies of Male External Genitalia 2025","description":"\u003cdiv class=\"woocommerce-tabs wc-tabs-wrapper container tabbed-content\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv aria-labelledby=\"tab-title-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" id=\"tab-description\" role=\"tabpanel\"\u003e\n\u003cdiv class=\"woocommerce-tabs wc-tabs-wrapper container tabbed-content\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv aria-labelledby=\"tab-title-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" id=\"tab-description\" role=\"tabpanel\"\u003e\n\u003ch3\u003eARRS Imaging of Pathologies of Male External Genitalia 2025\u003c\/h3\u003e\n\u003ch3\u003e\n\u003cstrong\u003eDate of Original Release:\u003c\/strong\u003e October 2024\u003c\/h3\u003e\n\u003ch4\u003eThis Online Course provides comprehensive review of various pathologies affecting the male external genitalia. Topics include acute non-traumatic pathologies of inguino-scrotal region, traumatic injuries of penis and scrotum, neoplasms affecting penis and testis and normal anatomy and complications of penile prosthesis.\u003c\/h4\u003e\n\u003cbr\u003e \u003cbr\u003e\u003ch2\u003eLearning Outcomes and Modules\u003c\/h2\u003e\n\u003cbr\u003eAfter completing this course, the learner should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDiscuss differential diagnoses for acute non-traumatic inguino-scrotal pathologies.\u003c\/li\u003e\n\u003cli\u003eIdentify and differentiate types of traumatic injuries to both penis and scrotum to triage further management.\u003c\/li\u003e\n\u003cli\u003eRecognize imaging findings of neoplasms affecting penis and testis.\u003c\/li\u003e\n\u003cli\u003eAssess penile anatomy after prosthesis placement and evaluate associated complications.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSpeakers and Lectures\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eNontraumatic Acute Scrotum and Extratesticular and Inguinal Pathology: Part 1—\u003cem\u003ePaul Nikolaidis\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNontraumatic Acute Scrotum and Extratesticular and Inguinal Pathology: Part 2—\u003cem\u003eHelena Gabriel\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003ePenile Prosthesis: Complications of Cylinders—\u003cem\u003eYashant Aswani\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eNeoplasms of the Male External Genitalia—\u003cem\u003eMark Sugi\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003eTraumatic Abnormalities of Male External Genitalia—\u003cem\u003eSadhna Verma\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539936073,"sku":"MED-AMB04945","price":45.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/ARRS-Imaging-of-Pathologies-of-Male-External-Genitalia-2025.webp?v=1781873805"},{"product_id":"icahn-school-of-medicine-advances-in-peritoneal-dialysis-2024","title":"Icahn School of Medicine Advances in Peritoneal Dialysis 2024","description":"\u003ch3\u003eIcahn School of Medicine Advances in Peritoneal Dialysis 2024\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 12 videos + 1 pdf, size: 5 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: nephrologists, dialysis nurses, clinician-scientists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e \u003c\/strong\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location: Friday, September 27, 2024, 7:45 AM – 5:00 PM, 1425 Madison Avenue, Goldwurm Auditorium, New York, NY\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eTarget Audience \u003cem\u003eSpecialties\u003c\/em\u003e – Nephrology, Nurse Practitioner, Nursing, Nutrition, Primary Care Physician\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eCourse Overview\u003c\/strong\u003e\u003c\/div\u003e\u003cbr\u003eThis is a one day conference on home dialysis sponsored by the Icahn School of Medicine at Mount Sinai. Practitioners, researchers, clinician-scientists and RNs who are experts in the field of kidney disease will discuss current developments in the field of Peritoneal Dialysis and related dialysis modalities. There will be a variety of topics, including roundtable discussion with patients on increasing the utilization and retention of home dialysis.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eSummarize the practices in peritoneal dialysis in the UK and explore what we can learn from it in the USA.\u003c\/li\u003e\n\u003cli\u003eReview the management of diabetes in patients on peritoneal dialysis.\u003c\/li\u003e\n\u003cli\u003eDiscuss the strategies to improve the outreach of dialysis modalities education in CKD population.\u003c\/li\u003e\n\u003cli\u003eDiscuss the importance and role of resilience in managing chronic dialysis.\u003c\/li\u003e\n\u003cli\u003eExamine and discuss the current administrative barriers to growing PD.\u003c\/li\u003e\n\u003c\/ol\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003ch3 class=\"boxAgendaTitle\"\u003eFriday, September 27, 2024\u003c\/h3\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"12u\"\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e7:45AM – 8:15AM Registration and Breakfast\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e8:15AM – 8:20AM Welcome John Ci-Jiang He, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e8:20AM – 8:30AM Introduction and Welcome Jaime Uribarri, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e8:30AM – 9:00AM The UK Experience on Peritoneal Dialysis Andrew Davenport, MD, FRCP, Head CKD \u0026amp; Dialysis\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e9:00AM – 9:30AM Glycemic Management in Diabetic Patients Undergoing Peritoneal Dialysis Adam M. Segal, MD\u003c\/li\u003e\n\u003cli\u003e9:30AM – 10:00AM Roundtable: CKD Education for Dialysis Modalities Odessa A. Gaspar-Salamanca, MSN Tarah Paul , MSN, ANP, AGPCNP-BC Wai Yin Leung, DNP, Nurse Practitioner\u003c\/li\u003e\n\u003cli\u003e10:00AM – 10:30AM Coffee Break\u003c\/li\u003e\n\u003cli\u003e10:30AM – 11:00AM Home Dialysis Fellowship: Report and Future Directions Shuchita Sharma, MD\u003c\/li\u003e\n\u003cli\u003e11:00AM – 11:30AM Placement of PD Catheters Stephen Haggerty, MD, FACS, Clinical Professor\u003c\/li\u003e\n\u003cli\u003e11:30AM – 12:00PM Resilience in Managing Chronic Disease, Namely Peritoneal Dialysis Patients Lauren A. Peccoralo, MD, MPH\u003c\/li\u003e\n\u003cli\u003e12:00PM – 12:30PM AI Applications in PD Lili Chan, MD\u003c\/li\u003e\n\u003cli\u003e12:30PM – 1:30PM Lunch\u003c\/li\u003e\n\u003cli\u003e1:30PM – 2:00PM Administrative Barriers to Growing PD in 2024 Thomas A. Golper, MD, FACP, FASN, Professor of Medicine\u003c\/li\u003e\n\u003cli\u003e2:00PM – 2:30PM Future of Peritoneal Dialysis Osama El Shamy, MD\u003c\/li\u003e\n\u003cli\u003e2:30PM – 3:00PM Health Policies Promoting Access to Home Dialysis Lauren Drew, JD\u003c\/li\u003e\n\u003cli\u003e3:00PM – 4:00PM Asking the Expert Session Round Table Andrew Davenport, MD, FRCP, Head CKD \u0026amp; Dialysis Osama El Shamy, MD Thomas A. Golper, MD, FACP, FASN, Professor of Medicine Adam M. Segal, MD\u003c\/li\u003e\n\u003cli\u003e4:00PM – 4:05PM Closing Remarks Shuchita Sharma, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662539968841,"sku":"MED-AMB04865","price":20.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Icahn-School-of-Medicine-Advances-in-Peritoneal-Dialysis-2024.png?v=1781873806"},{"product_id":"hackensack-meridian-urogyn-symposium-2024","title":"Hackensack Meridian UroGyn Symposium 2024","description":"\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003ch3\u003eHackensack Meridian UroGyn Symposium 2024\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 1 videos, size: 1.92 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: urogynecologists, general OB-GYNs, urologists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp data-end=\"337\" data-start=\"48\"\u003eA practical, case-based update on female pelvic medicine and reconstructive surgery. Sessions translate guideline changes and new evidence into clear pathways for evaluation, conservative therapy, office procedures, and operative management of pelvic floor disorders.\u003c\/p\u003e\n\u003cp data-end=\"364\" data-start=\"339\"\u003e\u003cstrong data-end=\"362\" data-start=\"339\"\u003eWhat You Will Learn\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1039\" data-start=\"365\"\u003e\n\u003cli data-end=\"452\" data-start=\"365\"\u003e\n\u003cp data-end=\"452\" data-start=\"367\"\u003eStepwise workups for stress\/urge\/mixed incontinence, OAB, and pelvic organ prolapse\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"554\" data-start=\"453\"\u003e\n\u003cp data-end=\"554\" data-start=\"455\"\u003ePelvic floor rehabilitation: behavioral therapy, pessaries, vaginal devices, and when to escalate\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"674\" data-start=\"555\"\u003e\n\u003cp data-end=\"674\" data-start=\"557\"\u003eProcedural updates: midurethral slings, autologous fascial slings, bulking agents, apical suspensions, colpocleisis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"762\" data-start=\"675\"\u003e\n\u003cp data-end=\"762\" data-start=\"677\"\u003eNeuromodulation \u0026amp; chemodenervation: patient selection, programming, troubleshooting\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"856\" data-start=\"763\"\u003e\n\u003cp data-end=\"856\" data-start=\"765\"\u003eMesh \u0026amp; complication management: pain, exposure, erosion—diagnosis and surgical strategies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"942\" data-start=\"857\"\u003e\n\u003cp data-end=\"942\" data-start=\"859\"\u003eUTI prevention in the urogyne patient, GSM management, sexual function counseling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1039\" data-start=\"943\"\u003e\n\u003cp data-end=\"1039\" data-start=\"945\"\u003ePerioperative optimization, ERAS, imaging\/urodynamics pearls, and shared decision-making tools\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1060\" data-start=\"1041\"\u003e\u003cstrong data-end=\"1058\" data-start=\"1041\"\u003eEvent Details\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1270\" data-start=\"1061\"\u003e\n\u003cli data-end=\"1148\" data-start=\"1061\"\u003e\n\u003cp data-end=\"1148\" data-start=\"1063\"\u003eFormat: Live lectures, case panels, and “how-I-do-it” sessions with interactive Q\u0026amp;A\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1270\" data-start=\"1149\"\u003e\n\u003cp data-end=\"1270\" data-start=\"1151\"\u003eStructure: Conservative → Office procedures → OR strategies → Complications → Long-term care, with take-home checklists\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1466\" data-start=\"1272\"\u003e\u003cstrong data-end=\"1293\" data-start=\"1272\"\u003eWho Should Attend\u003c\/strong\u003e\u003cbr\u003eUrogynecologists, general OB-GYNs, urologists, pelvic floor PTs, nurse practitioners\/PAs, pelvic health nurses, and trainees seeking a clinic-ready urogynecology refresh.\u003c\/p\u003e\n\u003cp data-end=\"1484\" data-start=\"1468\"\u003e\u003cstrong data-end=\"1482\" data-start=\"1468\"\u003eWhy Attend\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1753\" data-start=\"1485\"\u003e\n\u003cli data-end=\"1571\" data-start=\"1485\"\u003e\n\u003cp data-end=\"1571\" data-start=\"1487\"\u003eTurn guidelines into reproducible care pathways for common pelvic floor conditions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1655\" data-start=\"1572\"\u003e\n\u003cp data-end=\"1655\" data-start=\"1574\"\u003eImprove outcomes with disciplined patient selection and complication prevention\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1753\" data-start=\"1656\"\u003e\n\u003cp data-end=\"1753\" data-start=\"1658\"\u003eLeave with algorithms, counseling scripts, and perioperative checklists you can use immediately\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eTopics:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the section below\u003cbr\u003e\u003cul data-end=\"2570\" data-start=\"1768\"\u003e\n\u003cli data-end=\"1869\" data-start=\"1768\"\u003e\n\u003cp data-end=\"1869\" data-start=\"1770\"\u003eIncontinence \u0026amp; OAB: diagnostics, first-line therapies, meds, tibial\/sacral neuromodulation, Botox\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1973\" data-start=\"1870\"\u003e\n\u003cp data-end=\"1973\" data-start=\"1872\"\u003ePelvic organ prolapse: staging, pessaries, native tissue vs. mesh-augmented options, apical support\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2068\" data-start=\"1974\"\u003e\n\u003cp data-end=\"2068\" data-start=\"1976\"\u003eMesh issues \u0026amp; pain: evaluation, imaging, partial\/complete excision, multidisciplinary care\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2179\" data-start=\"2069\"\u003e\n\u003cp data-end=\"2179\" data-start=\"2071\"\u003eUTI \u0026amp; GSM: prophylaxis strategies, non-antibiotic options, vaginal estrogen use, microbiome considerations\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2267\" data-start=\"2180\"\u003e\n\u003cp data-end=\"2267\" data-start=\"2182\"\u003eUrodynamics \u0026amp; imaging: when it changes management and how to interpret key tracings\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2353\" data-start=\"2268\"\u003e\n\u003cp data-end=\"2353\" data-start=\"2270\"\u003eSexual function \u0026amp; pelvic pain: counseling, dyspareunia algorithms, PT integration\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2460\" data-start=\"2354\"\u003e\n\u003cp data-end=\"2460\" data-start=\"2356\"\u003ePeriop \u0026amp; ERAS: risk stratification, anesthesia\/analgesia, VTE prevention, return-to-activity timelines\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2570\" data-start=\"2461\"\u003e\n\u003cp data-end=\"2570\" data-start=\"2463\"\u003eQuality, equity \u0026amp; safety: informed consent, documentation, outcomes tracking, and patient-reported measures\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662540132681,"sku":"MED-AMB04853","price":10.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Hackensack-Meridian-UroGyn-Symposium-2024.jpg?v=1781873807"},{"product_id":"dos-and-donts-best-practice","title":"Do’s and Dont’s Best Practice in Neonatology 1st joint Congress of UENPS and EFCNI 2024","description":"\u003cdiv class=\"col-md-8 col-sm-8 col-xs-12 bottom-detail-product\"\u003e\n\u003cdiv class=\"tab-content\"\u003e\n\u003cdiv class=\"tab-pane fade in active\" id=\"content\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003cdiv class=\"a-section a-spacing-micro bylineHidden feature\" id=\"bylineInfo\"\u003e\n\u003cdiv class=\"a-section a-spacing-micro bylineHidden feature\" id=\"bylineInfo\"\u003e\n\u003ch1 class=\"product_title entry-title\"\u003eDo’s and Dont’s Best Practice in Neonatology 1st joint Congress of UENPS and EFCNI 2024\u003c\/h1\u003e\n\u003cstrong\u003e+ Include: 12 videos, size: 24.7 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: physicians, fellows, resident and any other healthcare professional interested in neonatal care\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003eThe “Do’s and Dont’s Best Practice in Neonatology” 1st joint Congress of UENPS and EFCNI will take place from July 3-5, 2024, in Ljubljana, Slovenia. This inaugural event will focus on best practices in neonatal care and will feature workshops and presentations on topics such as immediate skin-to-skin contact, mother-newborn couplet care, parenteral nutrition, and RSV prevention\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbr\u003eThe “Do’s and Dont’s Best Practice in Neonatology” 1st joint Congress of UENPS and EFCNI 2024 is designed for a diverse group of professionals and stakeholders involved in neonatal care. The target audience includes:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDoctors\u003c\/li\u003e\n\u003cli\u003eNurses\u003c\/li\u003e\n\u003cli\u003eMidwives\u003c\/li\u003e\n\u003cli\u003ePatient and parent representatives\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThis congress aims to provide a platform for these professionals to share knowledge, discuss best practices, and improve neonatal care.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eJuly 3 Do’s and Don’ts Interactive session 1.mp4\u003c\/li\u003e\n\u003cli\u003eJuly 3 Do’s and Don’ts Interactive session 2.mp4\u003c\/li\u003e\n\u003cli\u003eJuly 3 PLENARY SESSION – State-of-the-art.mp4\u003c\/li\u003e\n\u003cli\u003eJuly 3 PLENARY SESSION.mp4\u003c\/li\u003e\n\u003cli\u003eJuly 4 Do’s and Don’ts Interactive session (BRAINNEUROLOGY).mp4\u003c\/li\u003e\n\u003cli\u003eJuly 4 Do’s and Don’ts Interactive session (FOLLOW – UP).mp4\u003c\/li\u003e\n\u003cli\u003eJuly 4 PLENARY SESSION – Follow up.mp4\u003c\/li\u003e\n\u003cli\u003eJuly 4 PLENARY SESSION – State-of-the-art (BRAIN).mp4\u003c\/li\u003e\n\u003cli\u003eJuly 5th Do’s and Don’ts Interactive session (NUTRITION).mp4\u003c\/li\u003e\n\u003cli\u003eJuly 5th Do’s and Don’ts Interactive session.mp4\u003c\/li\u003e\n\u003cli\u003eJuly 5th PLENARY SESSION – Infections.mp4\u003c\/li\u003e\n\u003cli\u003eJuly 5th PLENARY SESSION – State-of-the-art Nutrition.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662540165449,"sku":"MED-AMB04834","price":40.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Dos-and-Donts-Best-Practice-in-Neonatology-1st-joint-Congress-of-UENPS-and-EFCNI-2024.jpg?v=1781873806"},{"product_id":"ut-health-san-antonio-4th-annual","title":"UT Health San Antonio 4th Annual Cardio Renal Connection 2021","description":"\u003cdiv class=\"col-md-8 col-sm-8 col-xs-12 bottom-detail-product\"\u003e\n\u003cdiv class=\"tab-content\"\u003e\n\u003cdiv class=\"tab-pane fade in active\" id=\"content\"\u003e\n\u003ch1 class=\"product_title entry-title\"\u003eUT Health San Antonio 4th Annual Cardio Renal Connection 2021\u003c\/h1\u003e\n\u003cstrong\u003e+ Include: 13 videos + 1 pdf, size: 7.59 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: cardiologists, nephrologists, hospitalists, primary-care clinicians, endocrinologists, advanced practice providers\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp data-end=\"363\" data-start=\"68\"\u003eA practical, case-based meeting at the intersection of cardiovascular and kidney disease. Faculty translate current evidence into coordinated care pathways that improve outcomes for patients with CKD, HF, diabetes, and hypertension across inpatient and ambulatory settings.\u003c\/p\u003e\n\u003cp data-end=\"390\" data-start=\"365\"\u003e\u003cstrong data-end=\"388\" data-start=\"365\"\u003eWhat You Will Learn\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1264\" data-start=\"391\"\u003e\n\u003cli data-end=\"517\" data-start=\"391\"\u003e\n\u003cp data-end=\"517\" data-start=\"393\"\u003eIntegrated risk stratification for CKD, ASCVD, and heart failure—including how to stage, phenotype, and prioritize therapy\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"647\" data-start=\"518\"\u003e\n\u003cp data-end=\"647\" data-start=\"520\"\u003eGuideline-aligned use of SGLT2 inhibitors, GLP-1 RAs, MRAs (finerenone), RAAS blockade, diuretics, and lipid-lowering therapy\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"754\" data-start=\"648\"\u003e\n\u003cp data-end=\"754\" data-start=\"650\"\u003eBlood pressure in CKD\/HF: targets, combinations, hyperkalemia mitigation, and resistant HTN algorithms\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"861\" data-start=\"755\"\u003e\n\u003cp data-end=\"861\" data-start=\"757\"\u003eHF in CKD: congestion assessment, diuretic strategies, GDMT initiation\/titration with renal monitoring\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"985\" data-start=\"862\"\u003e\n\u003cp data-end=\"985\" data-start=\"864\"\u003eDiabetes and CKD: glycemic goals, medication selection by eGFR, hypoglycemia prevention, and kidney-protective pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1072\" data-start=\"986\"\u003e\n\u003cp data-end=\"1072\" data-start=\"988\"\u003eAKI and contrast strategies in cardiac patients; peri-procedural kidney protection\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1154\" data-start=\"1073\"\u003e\n\u003cp data-end=\"1154\" data-start=\"1075\"\u003eAnemia, bone-mineral disease, and metabolic complications that impact CV risk\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1264\" data-start=\"1155\"\u003e\n\u003cp data-end=\"1264\" data-start=\"1157\"\u003eTeam-based coordination: cardiology–nephrology co-management, pharmacy support, and patient education tools\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1285\" data-start=\"1266\"\u003e\u003cstrong data-end=\"1283\" data-start=\"1266\"\u003eEvent Details\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1541\" data-start=\"1286\"\u003e\n\u003cli data-end=\"1389\" data-start=\"1286\"\u003e\n\u003cp data-end=\"1389\" data-start=\"1288\"\u003eFormat: Live lectures with case panels, multidisciplinary debates, and concise take-home checklists\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1541\" data-start=\"1390\"\u003e\n\u003cp data-end=\"1541\" data-start=\"1392\"\u003eStructure: Thematic blocks (risk\/prevention, therapeutics, HF\/CKD, diabetes\/CKD, complications, systems of care) designed for next-day implementation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1785\" data-start=\"1543\"\u003e\u003cstrong data-end=\"1564\" data-start=\"1543\"\u003eWho Should Attend\u003c\/strong\u003e\u003cbr\u003eCardiologists, nephrologists, hospitalists, primary-care clinicians, endocrinologists, advanced practice providers, pharmacists, nurses, and trainees caring for patients with overlapping cardio-renal-metabolic disease.\u003c\/p\u003e\n\u003cp data-end=\"1803\" data-start=\"1787\"\u003e\u003cstrong data-end=\"1801\" data-start=\"1787\"\u003eWhy Attend\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"2072\" data-start=\"1804\"\u003e\n\u003cli data-end=\"1879\" data-start=\"1804\"\u003e\n\u003cp data-end=\"1879\" data-start=\"1806\"\u003eConvert complex, cross-specialty guidance into simple, shared workflows\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1969\" data-start=\"1880\"\u003e\n\u003cp data-end=\"1969\" data-start=\"1882\"\u003eImprove safety and outcomes by aligning medications, labs, and follow-up across teams\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2072\" data-start=\"1970\"\u003e\n\u003cp data-end=\"2072\" data-start=\"1972\"\u003eBring back algorithms, order-set prompts, and counseling scripts that work in busy clinics and wards\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541017417,"sku":"MED-AMB04829","price":10.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/UT-Health-San-Antonio-4th-Annual-Cardio-Renal-Connection-2021.jpg?v=1781873807"},{"product_id":"aua-annual-review-course-webcast-2025","title":"AUA Annual Review Course Webcast 2025 (Videos with subtitles + Slides)","description":"\u003ch3\u003eOverview\u003c\/h3\u003e\u003cbr\u003eSpecifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast Only option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.\u003cbr\u003e\u003cbr\u003eFor the ABU Qualifying (Part 1) Examination, residents need to possess basic working urologic knowledge and an understanding of how to utilize current American Urological Association practice guidelines. There exists variability in how prepared residents are for the Exam, indicating a need for further education. To fulfill this need, the AUA developed this course to disseminate current urologic knowledge and best practices to successfully prepare residents for the ABU examination. This course is also of interest to practicing urologists as well as others, including allied health professionals, looking for a thorough review of basic urologic topics.\u003cbr\u003e\u003ch3\u003eTarget Audience\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eResidents\u003c\/li\u003e\n\u003cli\u003eUrologists\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003cdiv class=\"group-learning-objectives field-group-div\"\u003e\n\u003cdiv class=\"field field-name-field-learning-objectives field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eAfter participation in this CME activity, participants will be able to:\u003cbr\u003e\u003col\u003e\n\u003cli\u003eDemonstrate core knowledge of urology necessary for American Board of Urology (ABU) Qualifying (Part 1).\u003c\/li\u003e\n\u003cli\u003eEmploy basic, generally accepted urological practices for effective, high-quality patient care.\u003c\/li\u003e\n\u003cli\u003eUtilize AUA Guidelines for appropriate patient evaluation and management.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eCourse\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Anatomy and Embryology\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Pediatric Urology\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Renal Medicine\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Adrenal\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Urolithiasis\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Laparoscopy\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Bladder Cancer\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Renal and Ureteral Tumors\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Testicular Tumors\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Penile and Urethral Cancer\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Trauma and Reconstruction\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Prostate Cancer\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Erectile Dysfunction\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): GU Radiology\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Female Urology\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Female Sexual Dysfunction, Urodynamics, and Neurourology\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Urinary Tract Infection\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Interstitial Cystitis and Sexually Transmitted Diseases\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): BPH\u003c\/li\u003e\n\u003cli\u003eAnnual Review Course Webcast (2025): Infertility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541050185,"sku":"MED-AMB04557","price":120.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/AUA-Annual-Review-Course-Webcast-2025.webp?v=1781873807"},{"product_id":"harvard-intensive-review-of-nephrology-2025","title":"Harvard Intensive Review of Nephrology 2025","description":"\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003ch3\u003eHarvard Intensive Review of Nephrology 2025\u003c\/h3\u003e\n\u003cstrong\u003e Include: 96 videos + 77 pdfs, size: 24.4 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: nephrologists, internists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003ch4\u003e\n\u003cstrong\u003eIntensive Review of Nephrology \u003c\/strong\u003e\u003cstrong\u003eThe Comprehensive Clinical Update and Board Review\u003c\/strong\u003e\n\u003c\/h4\u003e\n\u003cem\u003eIntensive Review of Nephrology is an online course, using live streaming, electronic Q\u0026amp;A, and other remote learning technologies. \u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eOVERVIEW\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eWith over 70 interactive lectures, case discussions, board preparation sessions, and supplementary lectures, this program provides a comprehensive review of state-of-the-art nephrology practices offered by the clinical faculty of Harvard Medical School.\u003cbr\u003e\u003cbr\u003eIt offers accelerated learning for:\u003cbr\u003e\u003cbr\u003e► \u003cstrong\u003eClinicians seeking a practical and comprehensive review that ensures they are up to date across all major areas of nephrology: \u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThe latest options for diagnosis: what to choose, when, and why\u003c\/li\u003e\n\u003cli\u003eCurrent evidence-based treatment and care management strategies to optimize patient outcomes\u003c\/li\u003e\n\u003cli\u003eImproved approaches to common and complex clinical challenges\u003c\/li\u003e\n\u003cli\u003eNavigating clinical controversies\u003c\/li\u003e\n\u003cli\u003eHow to avoid medical mistakes\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e►\u003cstrong\u003e Physicians preparing to certify or recertify who seek a thorough, proven preparatory course in advance of their taking the Nephrology ABIM board examination:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDaily board review questions and sessions\u003c\/li\u003e\n\u003cli\u003eSessions to guide efficient preparation and study\u003c\/li\u003e\n\u003cli\u003eComprehensive syllabus and home study guide\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eOUTCOMES-DRIVEN EDUCATION\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eIncorporating recent advances in renal medicine into day-to-day practice enables PHYSICIANS, NPs and PAs to deliver optimal patient care and improve patient outcomes. The challenge for most clinicians is that the amount of new information can be overwhelming, and determining what is relevant and important cannot always be readily ascertained.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eIntensive Review of Nephrology\u003c\/strong\u003e synthesizes this information and presents it efficiently and effectively to ensure you are current with state-of-the-art practices and the best ways to apply them to the diagnosis and treatment of your patients.\u003cbr\u003e\u003cbr\u003e► For those who are preparing to certify or recertify, we complement this education with board examination preparation.\u003cbr\u003e\u003cbr\u003eThis special course spans all areas of nephrology. Sessions are led by nationally renowned speakers who are experts in their respective fields of nephrology. Coverage includes:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eELECTROLYTES and ACID-BASE\u003c\/li\u003e\n\u003cli\u003eGLOMERULONEPHRITIS\u003c\/li\u003e\n\u003cli\u003eACUTE KIDNEY INJURY\u003c\/li\u003e\n\u003cli\u003eCHRONIC KIDNEY DISEASE\u003c\/li\u003e\n\u003cli\u003eGENETIC KIDNEY DISEASE\u003c\/li\u003e\n\u003cli\u003eVASCULAR DISEASE\u003c\/li\u003e\n\u003cli\u003eHYPERTENSION\u003c\/li\u003e\n\u003cli\u003eEND-STAGE RENAL DISEASE\u003c\/li\u003e\n\u003cli\u003eTRANSPLANTATION\u003c\/li\u003e\n\u003cli\u003eONCONEPHROLOGY: CANCER and the KIDNEY\u003c\/li\u003e\n\u003cli\u003ePREGNANCY and RENAL DISEASE\u003c\/li\u003e\n\u003cli\u003ePOINT-of-CARE RENAL ULTRASOUND\u003c\/li\u003e\n\u003cli\u003eAI in NEPHROLOGY\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eIn the course of a week, you get an accelerated learning experience that is impactful and inspiring.\u003cbr\u003e\u003cbr\u003eHighlights of the 2025 program include:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eGenetic testing for improved diagnosis, prognosis, and selection of therapy\u003c\/li\u003e\n\u003cli\u003eIntroduction to point-of-care ultrasound: fundamentals for optimal image acquisition and accurate interpretation\u003c\/li\u003e\n\u003cli\u003ePhysical exam of the dialysis access\u003c\/li\u003e\n\u003cli\u003eFurther expansion of the roles of SGLT2i and finerenone in diabetic and non-diabetic kidney disease\u003c\/li\u003e\n\u003cli\u003eNew insights in immunology and the pathogenesis of glomerulonephritis\u003c\/li\u003e\n\u003cli\u003eNovel immunosuppressive agents for glomerulonephritis\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003ch4\u003eWho Should Attend\u003c\/h4\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-text-area field--type-text-long field--label-hidden field__item\"\u003e\n\u003cul\u003e\n\u003cli\u003ePHYSICIANS, NPs, PAs seeking a comprehensive update of the state of the art in nephrology\u003c\/li\u003e\n\u003cli\u003ePHYSICIANS preparing to certify\/recertify\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAugust 11 Anemia Management Update and Best Practices Dr. Brona Moloney.mp4\u003cbr\u003eAugust 11 Anemia Management Update and Best Practices Dr. Brona Moloney.pdf\u003cbr\u003eAugust 11 Basic Concepts of Immunology in Autoimmune Kidney Disease Dr. Ramon Bonegio.mp4\u003cbr\u003eAugust 11 Basic Concepts of Immunology in Autoimmune Kidney Disease Dr. Ramon Bonegio.pdf\u003cbr\u003eAugust 11 Current Approaches to Urine Sediment Analysis Dr. Martina McGrath.mp4\u003cbr\u003eAugust 11 Current Approaches to Urine Sediment Analysis Dr. Martina McGrath.pdf\u003cbr\u003eAugust 11 Faculty Q\u0026amp;A 1.mp4\u003cbr\u003eAugust 11 Faculty Q\u0026amp;A 2.mp4\u003cbr\u003eAugust 11 Faculty Q\u0026amp;A 3.mp4\u003cbr\u003eAugust 11 Faculty Q\u0026amp;A 4.mp4\u003cbr\u003eAugust 11 IgA Nephropathy Dr. Gerald Appel.mp4\u003cbr\u003eAugust 11 IgA Nephropathy Dr. Gerald Appel.pdf\u003cbr\u003eAugust 11 Keynote AI in Nephrology Dr. Girish Nadkarni.mp4\u003cbr\u003eAugust 11 Keynote AI in Nephrology Dr. Girish Nadkarni.pdf\u003cbr\u003eAugust 11 Membranous Nephropathy Dr. Laurence Beck.mp4\u003cbr\u003eAugust 11 Membranous Nephropathy Dr. Laurence Beck.pdf\u003cbr\u003eAugust 11 Metabolic Management of Kidney Stones Dr. Gary Curhan.mp4\u003cbr\u003eAugust 11 Metabolic Management of Kidney Stones Dr. Gary Curhan.pdf\u003cbr\u003eAugust 11 Renal Pathology in 2025 Part 1 Dr. Helmut Rennke.mp4\u003cbr\u003eAugust 11 Renal Pathology in 2025 Part 1 Dr. Helmut Rennke.pdf\u003cbr\u003eAugust 11 Renal Pathology in 2025 Part 2 Dr. Astrid Weins.mp4\u003cbr\u003eAugust 11 Renal Pathology in 2025 Part 2 Dr. Astrid Weins.pdf\u003cbr\u003eAugust 11 Renal Physiology for the Boards Dr. Melanie Hoenig.mp4\u003cbr\u003eAugust 11 Renal Physiology for the Boards Dr. Melanie Hoenig.pdf\u003cbr\u003eAugust 11 Update on Lupus Nephritis Dr. Gerald Appel.mp4\u003cbr\u003eAugust 11 Update on Lupus Nephritis Dr. Gerald Appel.pdf\u003cbr\u003eAugust 11 Welcome Remarks Announcements.mp4\u003cbr\u003eAugust 12 Acid-Base Disorders I Anion Gap Metabolic Acidosis Dr. Alan Yu.mp4\u003cbr\u003eAugust 12 Acid-Base Disorders I Anion Gap Metabolic Acidosis Dr. Alan Yu.pdf\u003cbr\u003eAugust 12 Acid-Base Disorders II Non Gap Acidosis and Metabolic Alkalosis Dr. Alan Yu.mp4\u003cbr\u003eAugust 12 Acid-Base Disorders II Non Gap Acidosis and Metabolic Alkalosis Dr. Alan Yu.pdf\u003cbr\u003eAugust 12 Faculty Q\u0026amp;A 1.mp4\u003cbr\u003eAugust 12 Faculty Q\u0026amp;A 2.mp4\u003cbr\u003eAugust 12 Faculty Q\u0026amp;A 4.mp4\u003cbr\u003eAugust 12 Genetics and Kidney Disease Dr. Friedhelm Hildebrandt.mp4\u003cbr\u003eAugust 12 Genetics and Kidney Disease Dr. Friedhelm Hildebrandt.pdf\u003cbr\u003eAugust 12 Genetics How to Integrate It into Practice Dr. Ana Onuchic-Whitford.mp4\u003cbr\u003eAugust 12 Genetics How to Integrate It into Practice Dr. Ana Onuchic-Whitford.pdf\u003cbr\u003eAugust 12 Hypokalemia and Hyperkalemia Dr. David Mount.mp4\u003cbr\u003eAugust 12 Hypokalemia and Hyperkalemia Dr. David Mount.pdf\u003cbr\u003eAugust 12 Hyponatremia and Hypernatremia Dr. David Mount.mp4\u003cbr\u003eAugust 12 Hyponatremia and Hypernatremia Dr. David Mount.pdf\u003cbr\u003eAugust 12 Important New Trials in GN Dr. David Mount.mp4\u003cbr\u003eAugust 12 Important New Trials in GN Dr. David Mount.pdf\u003cbr\u003eAugust 12 Pediatric Nephrology Dr. Michael Somers.mp4\u003cbr\u003eAugust 12 Pediatric Nephrology Dr. Michael Somers.pdf\u003cbr\u003eAugust 12 Rapidly Progressive Glomerulonephritis Dr. John Niles.mp4\u003cbr\u003eAugust 12 Rapidly Progressive Glomerulonephritis Dr. John Niles.pdf\u003cbr\u003eAugust 12 Update on Polycystic Kidney Disease Dr. Fouad Chebib and Faculty Q \u0026amp; A – 577HMSIRN2025.pdf\u003cbr\u003eAugust 12 Update on Polycystic Kidney Disease Dr. Fouad Chebib and Faculty Q\u0026amp;A 3.mp4\u003cbr\u003eAugust 13 Donor Evaluation Dr. Kassem Safa.mp4\u003cbr\u003eAugust 13 Donor Evaluation Dr. Kassem Safa.pdf\u003cbr\u003eAugust 13 Early Post-Transplant Management Dr. Anil Chandraker.mp4\u003cbr\u003eAugust 13 Early Post-Transplant Management Dr. Anil Chandraker.pdf\u003cbr\u003eAugust 13 Faculty Q\u0026amp;A 1.mp4\u003cbr\u003eAugust 13 Faculty Q\u0026amp;A 2.mp4\u003cbr\u003eAugust 13 Faculty Q\u0026amp;A 3.mp4\u003cbr\u003eAugust 13 Geriatric Nephrology Dr. Ernest Mandel and Faculty Q\u0026amp;A 4.mp4\u003cbr\u003eAugust 13 Geriatric Nephrology Dr. Ernest Mandel.pdf\u003cbr\u003eAugust 13 Immunological Assessment Pre- and Post-Transplant Drs. Indira Guleria.pdf\u003cbr\u003eAugust 13 Immunological Assessment Pre- and Post-Transplant Drs. Melissa Yeung and Indira Guleria.mp4\u003cbr\u003eAugust 13 Immunological Assessment Pre- and Post-Transplant Drs. Melissa Yeung.pdf\u003cbr\u003eAugust 13 Infections in Transplant Recipients Dr. Barbra Blair.mp4\u003cbr\u003eAugust 13 Infections in Transplant Recipients Dr. Barbra Blair.pdf\u003cbr\u003eAugust 13 Late Loss of the Kidney Transplant Dr. Rania Khedher El Fekih.mp4\u003cbr\u003eAugust 13 Late Loss of the Kidney Transplant Dr. Rania Khedher El Fekih.pdf\u003cbr\u003eAugust 13 Late Post-Transplant Medical Complications Dr. Leonardo Riella.mp4\u003cbr\u003eAugust 13 Late Post-Transplant Medical Complications Dr. Leonardo Riella.pdf\u003cbr\u003eAugust 13 Monitoring Kidney Transplant Patients Beyond Creatinine Dr. Jamil Azzi.mp4\u003cbr\u003eAugust 13 Monitoring Kidney Transplant Patients Beyond Creatinine Dr. Jamil Azzi.pdf\u003cbr\u003eAugust 13 Poisonings and Intoxications What a Nephrologist Needs to Know Dr. Charlotte Goldfine.mp4\u003cbr\u003eAugust 13 Poisonings and Intoxications What a Nephrologist Needs to Know Dr. Charlotte Goldfine.pdf\u003cbr\u003eAugust 13 Pre-Transplant Evaluation of Recipients Dr. Rania Khedher El Fekih.mp4\u003cbr\u003eAugust 13 Pre-Transplant Evaluation of Recipients Dr. Rania Khedher El Fekih.pdf\u003cbr\u003eAugust 13 Thrombotic Microangiopathies Dr. Jean Francis.mp4\u003cbr\u003eAugust 13 Thrombotic Microangiopathies Dr. Jean Francis.pdf\u003cbr\u003eAugust 13 Transplant Immunosuppression for the Boards Dr. Brittany Schreiber.mp4\u003cbr\u003eAugust 13 Transplant Immunosuppression for the Boards Dr. Brittany Schreiber.pdf\u003cbr\u003eAugust 13 Why Do We Reject a Transplant Dr. Jamil Azzi.mp4\u003cbr\u003eAugust 13 Why Do We Reject a Transplant Dr. Jamil Azzi.pdf\u003cbr\u003eAugust 14 Acute Kidney Injury Syndromes Dr. Alice Sheridan.mp4\u003cbr\u003eAugust 14 Acute Kidney Injury Syndromes Dr. Alice Sheridan.pdf\u003cbr\u003eAugust 14 APOL1 and Kidney Disease Dr. Opeyemi Olabisi.mp4\u003cbr\u003eAugust 14 APOL1 and Kidney Disease Dr. Opeyemi Olabisi.pdf\u003cbr\u003eAugust 14 Cancer and Acute Kidney Injury Dr. Raad Chowdhury.mp4\u003cbr\u003eAugust 14 Cancer and Acute Kidney Injury Dr. Raad Chowdhury.pdf\u003cbr\u003eAugust 14 Cardio-Renal Syndrome Dr. Finnian McCausland.mp4\u003cbr\u003eAugust 14 Cardio-Renal Syndrome Dr. Finnian McCausland.pdf\u003cbr\u003eAugust 14 Faculty Q\u0026amp;A 1.mp4\u003cbr\u003eAugust 14 Faculty Q\u0026amp;A 2.mp4\u003cbr\u003eAugust 14 Faculty Q\u0026amp;A 3.mp4\u003cbr\u003eAugust 14 Faculty Q\u0026amp;A 4.mp4\u003cbr\u003eAugust 14 ICU Nephrology and Continuous Renal Replacement Therapies Dr. David Steele.mp4\u003cbr\u003eAugust 14 ICU Nephrology and Continuous Renal Replacement Therapies Dr. David Steele.pdf\u003cbr\u003eAugust 14 Keynote Climate Change, Global Inequities, and the Kidney Valerie A. Luyckx, MBBCh, MSc, PhD.mp4\u003cbr\u003eAugust 14 Keynote Climate Change, Global Inequities, and the Kidney Valerie A. Luyckx, MBBCh, MSc, PhD.pdf\u003cbr\u003eAugust 14 Liver and the Kidney Dr. Andrew Allegretti.mp4\u003cbr\u003eAugust 14 Liver and the Kidney Dr. Andrew Allegretti.pdf\u003cbr\u003eAugust 14 Management of Hypertension in CKD-Intensive or Standard Regimens Dr. Richard Glassock.mp4\u003cbr\u003eAugust 14 Management of Hypertension in CKD-Intensive or Standard Regimens Dr. Richard Glassock.pdf\u003cbr\u003eAugust 14 Paraprotein-Induced Kidney Injury Dr. Raad Chowdhury.mp4\u003cbr\u003eAugust 14 Paraprotein-Induced Kidney Injury Dr. Raad Chowdhury.pdf\u003cbr\u003eAugust 14 Pathophysiology and Treatment of Diabetic Kidney Disease Dr. Gearoid McMahon.mp4\u003cbr\u003eAugust 14 Pathophysiology and Treatment of Diabetic Kidney Disease Dr. Gearoid McMahon.pdf\u003cbr\u003eAugust 14 Pathophysiology of Acute Kidney Injury Dr. Joseph Bonventre.mp4\u003cbr\u003eAugust 14 Pathophysiology of Acute Kidney Injury Dr. Joseph Bonventre.pdf\u003cbr\u003eAugust 14 Primary Aldosteronism Dr. Anand Vaidya.mp4\u003cbr\u003eAugust 14 Primary Aldosteronism Dr. Anand Vaidya.pdf\u003cbr\u003eAugust 14 Therapy of FSGS Lesions in 2025 Dr. Richard Glassock.mp4\u003cbr\u003eAugust 14 Therapy of FSGS Lesions in 2025 Dr. Richard Glassock.pdf\u003cbr\u003eAugust 15 Acute Kidney Injury Related to Immune Checkpoint Inhibitors Dr. Shruti Gupta.mp4\u003cbr\u003eAugust 15 Acute Kidney Injury Related to Immune Checkpoint Inhibitors Dr. Shruti Gupta.pdf\u003cbr\u003eAugust 15 Chronic Kidney Disease Epidemiology A 2025 Update Dr. Gearoid McMahon.mp4\u003cbr\u003eAugust 15 Chronic Kidney Disease Epidemiology A 2025 Update Dr. Gearoid McMahon.pdf\u003cbr\u003eAugust 15 Dialysis A Case-Based Clinical Review and Update Dr. J. Kevin Tucker.mp4\u003cbr\u003eAugust 15 Dialysis A Case-Based Clinical Review and Update Dr. J. Kevin Tucker.pdf\u003cbr\u003eAugust 15 Dialysis Vascular Access Assessment and Complications Dr. Dirk Hentschel.mp4\u003cbr\u003eAugust 15 Dialysis Vascular Access Assessment and Complications Dr. Dirk Hentschel.pdf\u003cbr\u003eAugust 15 Faculty Q\u0026amp;A 1.mp4\u003cbr\u003eAugust 15 Faculty Q\u0026amp;A 2.mp4\u003cbr\u003eAugust 15 Faculty Q\u0026amp;A 3.mp4\u003cbr\u003eAugust 15 Faculty Q\u0026amp;A 4.mp4\u003cbr\u003eAugust 15 Mesoamerican Nephropathy Dr. David Friedman.mp4\u003cbr\u003eAugust 15 Mesoamerican Nephropathy Dr. David Friedman.pdf\u003cbr\u003eAugust 15 Mineral and Bone Disease Dr. David Bushinsky.mp4\u003cbr\u003eAugust 15 Mineral and Bone Disease Dr. David Bushinsky.pdf\u003cbr\u003eAugust 15 Patient Perspective Dialysis Dosing J. Kevin Tucker, MD (Slides Not Available).mp4\u003cbr\u003eAugust 15 Pearls in Mineral and Bone Disease Dr. David Bushinsky.mp4\u003cbr\u003eAugust 15 Pearls in Mineral and Bone Disease Dr. David Bushinsky.pdf\u003cbr\u003eAugust 15 Peritoneal Dialysis Complications Dr. Joanne Bargman.mp4\u003cbr\u003eAugust 15 Peritoneal Dialysis Complications Dr. Joanne Bargman.pdf\u003cbr\u003eAugust 15 Peritoneal Dialysis Dr. Joanne Bargman.mp4\u003cbr\u003eAugust 15 Peritoneal Dialysis Dr. Joanne Bargman.pdf\u003cbr\u003eAugust 15 Ultrasound for the Clinical Nephrologist Dr. Adina Voiculescu.mp4\u003cbr\u003eAugust 15 Ultrasound for the Clinical Nephrologist Dr. Adina Voiculescu.pdf\u003cbr\u003eBONUS LECTURE- Fundamentals of Point of Care Ultrasound with a Focus on Image Acquisition A Tutorial for the Nephrologist.mp4\u003cbr\u003eHarvard CME _ Intensive Review of Nephrology.pdf\u003cbr\u003eStudy Hall Chronic Kidney Disease in the Community Meeting Them Where They Are Dr. Li-Li Hsiao.mp4\u003cbr\u003eStudy Hall Chronic Kidney Disease in the Community Meeting Them Where They Are Dr. Li-Li Hsiao.pdf\u003cbr\u003eStudy Hall COVID-19 Vaccination in Immunocompromised Patients Dr. Ann Woolley.mp4\u003cbr\u003eStudy Hall COVID-19 Vaccination in Immunocompromised Patients Dr. Ann Woolley.pdf\u003cbr\u003eStudy Hall Electrolyte and Acid-Base Disorders Questions \u0026amp; Answers Session – Part 1 Dr. Alan Yu.mp4\u003cbr\u003eStudy Hall Electrolyte and Acid-Base Disorders Questions \u0026amp; Answers Session – Part 1 Dr. Alan Yu.pdf\u003cbr\u003eStudy Hall Electrolyte and Acid-Base Disorders Questions \u0026amp; Answers Session – Part 2 Dr. Alan Yu.mp4\u003cbr\u003eStudy Hall Electrolyte and Acid-Base Disorders Questions \u0026amp; Answers Session – Part 2 Dr. Alan Yu.pdf\u003cbr\u003eStudy Hall Ethics ISN Dr. Valerie Luyckx.mp4\u003cbr\u003eStudy Hall Ethics ISN Dr. Valerie Luyckx.pdf\u003cbr\u003eStudy Hall Glomerulonephritis Questions \u0026amp; Answers Session Dr. Gerald Appel.mp4\u003cbr\u003eStudy Hall Glomerulonephritis Questions \u0026amp; Answers Session Dr. Gerald Appel.pdf\u003cbr\u003eStudy Hall Must-Know Board Zebras Dr. Emily Robinson.mp4\u003cbr\u003eStudy Hall Must-Know Board Zebras Dr. Emily Robinson.pdf\u003cbr\u003eStudy Hall Must-Know Clinical Images in Nephrology Dr. Annie Liu.mp4\u003cbr\u003eStudy Hall Must-Know Clinical Images in Nephrology Dr. Annie Liu.pdf\u003cbr\u003eStudy Hall Nephrology Board Review Practice 1 Dr. Finnian McCausland.mp4\u003cbr\u003eStudy Hall Nephrology Board Review Practice 1 Dr. Finnian McCausland.pdf\u003cbr\u003eStudy Hall Nephrology Board Review Practice 2 Dr. Gearoid McMahon.mp4\u003cbr\u003eStudy Hall Nephrology Board Review Practice 2 Dr. Gearoid McMahon.pdf\u003cbr\u003eStudy Hall Pregnancy and Renal Disease Dr. Jessica Tangren.mp4\u003cbr\u003eStudy Hall Pregnancy and Renal Disease Dr. Jessica Tangren.pdf\u003cbr\u003eStudy Hall Transplant Board Review Dr. Anil Chandraker.mp4\u003cbr\u003eStudy Hall Transplant Board Review Dr. Anil Chandraker.pdf\u003cbr\u003eStudy Hall Transplant Cases Board Review Practice Dr. Melissa Yeung and Dr. Edgar Milford.mp4\u003cbr\u003eStudy Hall Transplant Cases Board Review Practice Dr. Melissa Yeung and Dr. Edgar Milford.pdf\u003cbr\u003eStudy Hall Update on Renovascular Disease Dr. Joseph Garasic.mp4\u003cbr\u003eStudy Hall Update on Renovascular Disease Dr. Joseph Garasic.pdf\u003cbr\u003eStudy Hall ?Immunologic Basis of Kidney Disease Dr. Vivek Kasinath.mp4\u003cbr\u003eStudy Hall ?Immunologic Basis of Kidney Disease Dr. Vivek Kasinath.pdf\u003cbr\u003eStudy Hall ?Interstitial Nephritis Dr. Julie Paik.mp4\u003cbr\u003eStudy Hall ?Interstitial Nephritis Dr. Julie Paik.pdf\u003cbr\u003eStudy Hall ?Pre-Transplant Surgical Evaluation of Recipients Dr. Sayeed Malek.mp4\u003cbr\u003eStudy Hall ?Pre-Transplant Surgical Evaluation of Recipients Dr. Sayeed Malek.pdf\u003cbr\u003eStudy Hall ?Use of Checkpoint Inhibitors in Kidney Transplant Recipients Dr. Naoka Murakami.mp4\u003cbr\u003eStudy Hall ?Use of Checkpoint Inhibitors in Kidney Transplant Recipients Dr. Naoka Murakami.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541279561,"sku":"MED-AMB04424","price":90.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Harvard-Intensive-Review-of-Nephrology-2025-768x265-1.jpg?v=1781873807"},{"product_id":"astro-practical-radiation-oncology-program-2023","title":"ASTRO Practical Radiation Oncology Program 2023","description":"\u003ch3\u003eASTRO Practical Radiation Oncology Program 2023\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 10 videos, size: 3.5 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: radiation oncologists, radiation oncology residents, radiation therapists, radiation dosimetrists, medical oncologists, surgeons, physicists, nurses, pathologists, and urologists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"field field-name-field-course-summary field-type-text-with-summary field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eThis program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a coding update and a scientific overview.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003ch2\u003eTARGET AUDIENCE\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-target-audience field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eThe activity is designed to meet the interests of radiation oncologists, radiation oncology residents, radiation therapists, radiation dosimetrists, medical oncologists, surgeons, physicists, nurses, pathologists, and urologists.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-learning-objectives field-group-div\"\u003e\n\u003ch2\u003eLEARNING OBJECTIVES\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-learning-objectives field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eUpon completion of this activity, participants should be able to do the following:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDiscuss various techniques for breast cancer patient set-up and motion management.\u003c\/li\u003e\n\u003cli\u003eDiscuss hypofractionation and ultra-hypofractionation techniques.\u003c\/li\u003e\n\u003cli\u003eIdentify the different treatment strategies for sarcoma based on clinical presentation.\u003c\/li\u003e\n\u003cli\u003eImplement different treatment techniques for sarcoma based on clinical scenario.\u003c\/li\u003e\n\u003cli\u003eDiscuss treatment of larynx cancers for different stages of disease.\u003c\/li\u003e\n\u003cli\u003eManage care of long-term survivors of larynx cancer.\u003c\/li\u003e\n\u003cli\u003eContour planning volumes to the current standard of care in lung cancer management.\u003c\/li\u003e\n\u003cli\u003eSelect appropriate dose\/fractionation schedule for common palliative scenarios in lung cancer management.\u003c\/li\u003e\n\u003cli\u003eKnow appropriate fractionation schemes for retreatment in the central nervous system, head and neck, and prostate.\u003c\/li\u003e\n\u003cli\u003eUnderstand the risk\/benefit ration of retreatment in the central nervous system, head and neck, and prostate and be able to communicate this to patients.\u003c\/li\u003e\n\u003cli\u003eAssess their existing brachytherapy capabilities for treatment of gynecologic cancers and evaluate ways to enhance access and capabilities in a community setting.\u003c\/li\u003e\n\u003cli\u003eSelect patients for appropriate treatment of recurrent or inoperable endometrial cancer and navigate anatomic or technical challenges to provide quality radiation care.\u003c\/li\u003e\n\u003cli\u003eIncorporate information to improve the management of primary and metastatic brain tumors.\u003c\/li\u003e\n\u003cli\u003eReturn to their teams with techniques to improve their radiosurgery programs in the treatment of primary brain tumors.\u003c\/li\u003e\n\u003cli\u003eComfortably differentiate patients with oligometastatic disease that may benefit from radiation therapy in the context of recent supportive studies.\u003c\/li\u003e\n\u003cli\u003eAssess their available resources and apply safe, effective radiation when indicated with greater comfort of dose, technique, timing, and prognostication principles specific to metastasis-directed radiation.\u003c\/li\u003e\n\u003cli\u003eDiscuss the multidisciplinary management of esophagogastric, borderline resectable pancreatic and rectal cancer.\u003c\/li\u003e\n\u003cli\u003eOptimize radiation techniques and plans for esophagogastric, borderline resectable pancreatic and rectal cancer.\u003c\/li\u003e\n\u003cli\u003eAssess updated dose limits to critical structures to minimize long term morbidity.\u003c\/li\u003e\n\u003cli\u003eDetermine what data and testing is available to tailor the use of androgen deprivation therapy in intermediate risk and post prostatectomy patients.\u003c\/li\u003e\n\u003cli\u003eExplain the combinations and sequencing of systemic therapies for high risk, node positive, and metastatic prostate cancer patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003col\u003e\n\u003cli\u003e Updates in Breast Cancer: Hypofractionation, Treatment Techniques, and Systemic Therapy\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eHypofractionation for Breast Cancer—Nicolas Prionas, MD, PhD\u003c\/li\u003e\n\u003cli\u003eBreast Radiation Techniques and Motion Management—Jolinta Lin, MD\u003c\/li\u003e\n\u003cli\u003eAdvances in Systemic Therapy for Breast Cancer—Cathie Chung, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe Who, What and How of Sarcoma\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eOverview of Sarcoma—Manpreet Bedi, MD, MS\u003c\/li\u003e\n\u003cli\u003eMultidisciplinary Management of Sarcoma—Andrew Bishop, MD\u003c\/li\u003e\n\u003cli\u003eUnresectable and Metastatic Disease—Anusha Kalbasi, MD\u003c\/li\u003e\n\u003cli\u003eRadiation Technique and Case Presentation—Shauna Campbell, MD, DO\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eTreatment and Management of Larynx Cancer\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eEarly Stage Larynx Cancer—David Sher, MD, MPH\u003c\/li\u003e\n\u003cli\u003eLocally Advanced Larynx Cancer—Zain Husain, MD\u003c\/li\u003e\n\u003cli\u003eTreatment Strategies in Post Operative and Recurrent Larynx Cancer—Gary Walker, MD, MS, MPH\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eUpdates in Lung Cancer Management\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCurrent Management of Stage III Non Small Cell Lung Cancer—Saumil Gandhi, MD, PhD\u003c\/li\u003e\n\u003cli\u003eNon Definitive Lung Options: Palliation and XRT Alone—Uzoma Iheagwara, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSmall Cell Lung Cancer Treatment Volumes—Sara Zakem, MD, BS\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eReirradiation for Prostate, CNS and Head and Neck Cancers\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eReirradiation for Local Recurrence of Prostatic Carcinoma—Abhishek Solanki, MD, MS\u003c\/li\u003e\n\u003cli\u003eReirradiation in Primary and Metastatic CNS Malignancy—Susan McGovern, MD, PhD\u003c\/li\u003e\n\u003cli\u003ePro Retreatment: Head and Neck—James Caudell, MD, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eInoperable\/Recurrent Endometrial Cancer and Building a Brachytherapy Practice in a Community Setting\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eInoperable Endometrial Cancer—J. Spencer Thompson, MD\u003c\/li\u003e\n\u003cli\u003eRecurrent Endometrial Cancer—Emma Fields, MD\u003c\/li\u003e\n\u003cli\u003eImplementing a Successful Brachytherapy Program in the Community—Malolan Rajagopalan, MD, MBA\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eManagement of Primary Brain Tumors in the Molecular Era and Building and Refining a Radiosurgery Program\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eManagement of Gliomas in the Molecular Era—Sara Hardy, MD, MS\u003c\/li\u003e\n\u003cli\u003eManagement of Large and Multiple Brain Metastases—Raju Raval, MD, DPhil\u003c\/li\u003e\n\u003cli\u003eStarting and Refining a Radiosurgery Program—Roshan Prabhu, MD, MS\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eOligometastatic Disease: Practical Aspects of Metastasis-Directed Therapy in a Community Practice\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eData and Dose Selection: To Ablate or Not to Ablate?—Beant Gill, MD\u003c\/li\u003e\n\u003cli\u003ePrognostication, Timing, and Patient Selection—David Palma, MD, PhD\u003c\/li\u003e\n\u003cli\u003eSetting Up for Success—Melissa O’Neil, MRT(T)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003eMaximizing Patient Outcomes and Minimizing Morbidity in Gastrointestinal Cancer\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eOptimizing Multimodality Management of Gastroesophageal Junction Cancer—Edward Kim, MD\u003c\/li\u003e\n\u003cli\u003eTNT, W\u0026amp;W, and Beyond: Applying the Explosion of Data to Rectal Cancer Practice—Krishan Jethwa, MD\u003c\/li\u003e\n\u003cli\u003eAdvances in Radiation for Pancreatic Cancer—Erqi Pollom, MD, MS\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003ePersonalization of Systemic Therapy for Localized to Metastatic Prostate Cancer\u003cbr\u003e\u003cul\u003e\n\u003cli\u003ePersonalizing ADT Use in the Definitive Treatment of Intermediate Risk Prostate Cancer—Angela Jia, MD, PhD\u003c\/li\u003e\n\u003cli\u003eDuration and Combination of Systemic Therapies for Patients with High Risk, Node Positive, and Oligometastatic Prostate Cancer—Anne Rajkumar, MD\u003c\/li\u003e\n\u003cli\u003eOverview of Systemic Therapies in Metastatic Prostate Cancer—Rana Mckay, MD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541312329,"sku":"MED-AMB04337","price":45.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/American-Society-for-Radiation-Oncology.jpg?v=1781873808"},{"product_id":"tumors-of-the-prostate-gland","title":"Tumors of the Prostate Gland, Seminal Vesicles, Penis, and Scrotum (AFIP Atlas of Tumor and Non-Tumor Pathology","description":"\u003cdiv class=\"top-nav-bar feature_text_colour feature_background_menu_colour_bg\"\u003e\n\u003ch1\u003eTumors of the Prostate Gland, Seminal Vesicles, Penis, and Scrotum (AFIP Atlas of Tumor and Non-Tumor Pathology, Series 5, Fascicle 2) (Original PDF from Publisher)\u003c\/h1\u003e\n\u003cbr\u003eBy Jonathan I. Epstein, Cristina Magi-Galluzzi, Ming Zhou, Antonio L. Cubilla\u003cbr\u003eSince the last edition of the Tumors of Prostate Gland, Seminal Vesicles, , and Scrotum, there have been numerous significant developments in the diagnosis and treatment of prostate and penile cancers. The new Fifth Series Fascicle of the AFIP Atlas of Tumor and Non-tumor Pathology includes these developments as well as abundant images and diagrams to depict the morphological spectrum of disease entities. In this richly illustrated atlas, the authors emphasize the gross and light microscopic diagnosis and differential diagnosis, present immunohistochemistry and molecular pathology studies that are of current value in diagnosis, and discuss pathological diagnosis in terms of prognosis and treatment.\u003ci class=\"a-icon a-icon-extender-expand\"\u003e\u003c\/i\u003e\n\u003cbr\u003e\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePublisher ‏ : ‎ American Registry of Pathology (October 30, 2020)\u003c\/li\u003e\n\u003cli\u003eLanguage ‏ : ‎ English\u003c\/li\u003e\n\u003cli\u003eISBN-10 ‏ : ‎ 1933477903\u003c\/li\u003e\n\u003cli\u003eISBN-13 ‏ : ‎ 978-1933477909\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541345097,"sku":"MED-AMB04252","price":90.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Tumors-of-the-Prostate-Gland-Seminal-Vesicles-Penis-and-Scrotum-AFIP-Atlas-of-Tumor-and-Non-Tumor-Pathology-Series-5-Fascicle-2-Original-PDF-from-Publisher.webp?v=1781873808"},{"product_id":"tumors-and-tumor-like-lesions-2","title":"Tumors and Tumor-Like Lesions of the Testis and Adjacent Tissues (AFIP Atlas of Tumor and Non-Tumor Pathology","description":"\u003cdiv class=\"top-nav-bar feature_text_colour feature_background_menu_colour_bg\"\u003e\n\u003ch3\u003eTumors and Tumor-Like Lesions of the Testis and Adjacent Tissues (AFIP Atlas of Tumor and Non-Tumor Pathology, Series 5 Vol. 12) (Original PDF from Publisher)\u003c\/h3\u003e\n\u003cbr\u003eBy T. — Kao M. Ulbright\u003cbr\u003e\u003cbr\u003eHow does a pathologist become interested and develop expertise in testicular and paratesticular neoplasms, which are relatively uncommon? The truth is simple—the opportunity to see many cases. The authors of this 5th Series Fascicle have such expertise and share a remarkable range of cases from their institutions as well as from many pathologists throughout the world who have sent them cases in consultation over the years. This fascicle is rich source of material that will be a great resource for practicing pathologists and pathologists in training.\u003ci class=\"a-icon a-icon-extender-expand\"\u003e\u003c\/i\u003e\n\u003cbr\u003e\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePublisher ‏ : ‎ American Registry of Pathology (January 1, 2022)\u003c\/li\u003e\n\u003cli\u003eLanguage ‏ : ‎ English\u003c\/li\u003e\n\u003cli\u003eISBN-10 ‏ : ‎ 1933477229\u003c\/li\u003e\n\u003cli\u003eISBN-13 ‏ : ‎ 978-1933477220\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541377865,"sku":"MED-AMB04250","price":90.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Tumors-and-Tumor-Like-Lesions-of-the-Testis-and-Adjacent-Tissues-AFIP-Atlas-of-Tumor-and-Non-Tumor-Pathology-Series-5-Vol.-12-Original-PDF-from-Publisher-1.webp?v=1781873808"},{"product_id":"international-society-of-cosmetogynecology-world-congress-of-cosmetic-gyn-body-contouring-2023","title":"International Society of Cosmetogynecology World Congress of Cosmetic Gyn \u0026 Body Contouring 2023","description":"\u003ch3\u003eInternational Society of Cosmetogynecology World Congress of Cosmetic Gyn \u0026amp; Body Contouring 2023\u003c\/h3\u003e\n\u003cstrong\u003e Include: 87 videos \u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: plastic surgeons, gynecologists, urogynecologists\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp data-end=\"494\" data-start=\"300\"\u003e\u003cstrong data-end=\"402\" data-start=\"300\"\u003eInternational Society of Cosmetogynecology – World Congress of Cosmetic Gyn \u0026amp; Body Contouring 2023\u003c\/strong\u003e\u003cbr\u003e\u003cstrong data-end=\"494\" data-start=\"405\"\u003eThe Premier Gathering for Innovation in Cosmetic Gynecology \u0026amp; Body Aesthetic Practice\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"818\" data-start=\"496\"\u003eHeld on \u003cstrong data-end=\"524\" data-start=\"504\"\u003eMarch 9–11, 2023\u003c\/strong\u003e in \u003cstrong data-end=\"556\" data-start=\"528\"\u003eFort Lauderdale, Florida\u003c\/strong\u003e, this three-day World Congress attracted leading specialists in cosmetic gynecology, body contouring, and aesthetic medicine from around the globe. The program delivered cutting-edge clinical insights, hands-on surgical pearls, and practice-building strategies.\u003c\/p\u003e\n\u003chr data-end=\"823\" data-start=\"820\"\u003e\n\u003cp data-end=\"845\" data-start=\"825\"\u003e\u003cstrong data-end=\"845\" data-start=\"825\"\u003eWhat You’ll Gain\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1353\" data-start=\"847\"\u003e\n\u003cli data-end=\"1002\" data-start=\"847\"\u003e\n\u003cp data-end=\"1002\" data-start=\"849\"\u003eComprehensive exposure to the latest in \u003cstrong data-end=\"950\" data-start=\"889\"\u003ecosmetic gynecology procedures, body sculpting techniques\u003c\/strong\u003e, and \u003cstrong data-end=\"1000\" data-start=\"956\"\u003emarketing and business growth strategies\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1129\" data-start=\"1003\"\u003e\n\u003cp data-end=\"1129\" data-start=\"1005\"\u003eUninterrupted access to \u003cstrong data-end=\"1083\" data-start=\"1029\"\u003ethree full days of content with no parallel tracks\u003c\/strong\u003e, so you won’t miss any expert presentations\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1240\" data-start=\"1130\"\u003e\n\u003cp data-end=\"1240\" data-start=\"1132\"\u003eSpecialty sessions including a \u003cstrong data-end=\"1180\" data-start=\"1163\"\u003eSpanish track\u003c\/strong\u003e, interactive live demos, and \u003cstrong data-end=\"1238\" data-start=\"1210\"\u003eThe Dr. Miami Experience\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1353\" data-start=\"1241\"\u003e\n\u003cp data-end=\"1353\" data-start=\"1243\"\u003eCommunity highlights like the \u003cstrong data-end=\"1299\" data-start=\"1273\"\u003ePresident’s VIP Dinner\u003c\/strong\u003e, ISCG Awards, and opportunities for global networking\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"1358\" data-start=\"1355\"\u003e\n\u003cp data-end=\"1381\" data-start=\"1360\"\u003e\u003cstrong data-end=\"1381\" data-start=\"1360\"\u003eWho Should Attend\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1871\" data-start=\"1383\"\u003e\n\u003cli data-end=\"1542\" data-start=\"1383\"\u003e\n\u003cp data-end=\"1542\" data-start=\"1385\"\u003e\u003cstrong data-end=\"1447\" data-start=\"1385\"\u003ePlastic surgeons, gynecology and urogynecology specialists\u003c\/strong\u003e, and aesthetic medicine providers performing cosmetic genital and body contouring procedures\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1657\" data-start=\"1543\"\u003e\n\u003cp data-end=\"1657\" data-start=\"1545\"\u003e\u003cstrong data-end=\"1591\" data-start=\"1545\"\u003ePractice owners, surgical center directors\u003c\/strong\u003e, and clinic leaders seeking growth strategies and peer insights\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1763\" data-start=\"1658\"\u003e\n\u003cp data-end=\"1763\" data-start=\"1660\"\u003e\u003cstrong data-end=\"1727\" data-start=\"1660\"\u003eSurgical nurses, physician assistants, techs, and support staff\u003c\/strong\u003e working in aesthetic environments\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1871\" data-start=\"1764\"\u003e\n\u003cp data-end=\"1871\" data-start=\"1766\"\u003e\u003cstrong data-end=\"1814\" data-start=\"1766\"\u003eInternational trainees and global clinicians\u003c\/strong\u003e aiming to refine skills and expand professional networks\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"1876\" data-start=\"1873\"\u003e\n\u003cp data-end=\"1907\" data-start=\"1878\"\u003e\u003cstrong data-end=\"1907\" data-start=\"1878\"\u003eWhy This Event Stands Out\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"2374\" data-start=\"1909\"\u003e\n\u003cli data-end=\"2041\" data-start=\"1909\"\u003e\n\u003cp data-end=\"2041\" data-start=\"1911\"\u003eThe \u003cem data-end=\"1921\" data-start=\"1915\"\u003eonly\u003c\/em\u003e North American congress entirely dedicated to cosmetic gynecology and body contouring, run without overlapping tracks\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2156\" data-start=\"2042\"\u003e\n\u003cp data-end=\"2156\" data-start=\"2044\"\u003eWorld-renowned experts deliver \u003cstrong data-end=\"2134\" data-start=\"2075\"\u003eclinical pearls, live demos, and procedural innovations\u003c\/strong\u003e in over 70 sessions\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2270\" data-start=\"2157\"\u003e\n\u003cp data-end=\"2270\" data-start=\"2159\"\u003eA unique combination of \u003cstrong data-end=\"2268\" data-start=\"2183\"\u003eclinical science, aesthetic surgery, marketing strategy, and business development\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2374\" data-start=\"2271\"\u003e\n\u003cp data-end=\"2374\" data-start=\"2273\"\u003eSpecial sessions for international attendees and Spanish speakers to enhance inclusivity and learning\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2379\" data-start=\"2376\"\u003e\n\u003cp data-end=\"2442\" data-start=\"2381\"\u003e\u003cstrong data-end=\"2442\" data-start=\"2381\"\u003eElevate Your Cosmetic Practice with Expert-Led Innovation\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"2623\" data-start=\"2444\"\u003eParticipate in the \u003cstrong data-end=\"2491\" data-start=\"2463\"\u003eISCG 2023 World Congress\u003c\/strong\u003e to gain technique mastery, expand your professional network, and elevate your expertise in cosmetic gynecology and body contouring.\u003c\/p\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003ctable class=\"ep-list\"\u003e\n\u003ctbody\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e1.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 101\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e2:00:08\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e2.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 102\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:55:06\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e3.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 103\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:59:24\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e4.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 104 Spanish\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e2:18:51\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e5.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 105\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:55:18\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e6.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 106\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e2:05:19\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e7.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 107\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:58:06\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e8.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 108\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:52:48\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e9.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 109\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:59:52\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e10.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 110\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e2:01:11\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e11.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 111\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e2:00:17\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e12.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 112\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e2:01:58\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e13.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eForewarned is Forearmed: The Evolution of Women’s Wellness Best Practice\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:29\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e14.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSurgical Reduction of Clitoral Hypertrophy\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:31\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e15.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCombined Clitoral Hood and Labia Minora Surgical Approach\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:05\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e16.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Angel-Wing Combined Labia Minora\/Majoraplasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e26:26\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e17.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSUI vs EBD: What to do When My Equipment Fails\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e24:39\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e18.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eUnified Approach to Perineoplasty, Majoraplasty, Minoraplasty, and Clitoral Hood Reduction\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:55\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e19.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCombined Labiaplasty-Clitoral Prepuce Plasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e39:12\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e20.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eClitoral Hood Inverted Y-Plasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:03\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e21.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eFat Graft Applications in Gynecology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:22\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e22.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eExcimer Laser Combined with Exosomes for Lichen Sclerosus\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e12:15\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e23.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003ePelvic Floor Neuro-Muscular Evaluation Before and After Surgery\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e09:32\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e24.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003ePerineal Surgery: Sexual and Aesthetic Elements\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e16:14\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e25.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eProlotherapy Gyno: A New Regenerative Protocol\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e11:37\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e26.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eMonsplasty: How to Make it Beautiful\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:43\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e27.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eNonsurgical Endolaser Vulvar Lift\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e11:45\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e28.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLabia Majora Lifting\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:00\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e29.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLefort Colpocleisis in Office Under Local Anesthesia\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:36\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e30.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eAP Repair and TOT Sling in Office Under Local Anesthesia\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:38\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e31.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eAplicaciones del Tejido Adiposo en Ginecologia\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:14\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e32.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eExcimer Laser 308nm y Exosomes en el Manejo de Liquen Escleroso y Atrofico\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e09:21\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e33.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSubcision para el Cirujano Estético\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:53\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e34.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eEndolifting Vulvar Laser en Español\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:22\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e35.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eRejuvenecimiento de Los Labios Mayores\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e16:23\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e36.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSistema 3D Para el Tratamiento del SUI de Grado 3\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:14\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e37.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eTratamiento Quirurgico de Lipodistrofia Genital\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e16:20\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e38.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eProlotherapy Gyno en Español\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:32\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e39.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSPONSORED: Vaginal Restoration with CO2 Lift V\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:44\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e40.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSPONSORED: How to Market with Webinars and Podcasts\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:20\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e41.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eExosomes in Feminine Health\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:36\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e42.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eUpdate on Botox for Sexual Dysfunction\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e23:16\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e43.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eAn Expedited Approach to Post-Op Healing\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e11:17\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e44.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eBioidentical Hormone Therapy\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:49\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e45.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eStewards of the Penis\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e25:03\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e46.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003ePenuma Update 2023\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e23:16\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e47.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eA Toolbox for Overcoming the Challenge of Effective Practice Branding\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:55\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e48.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCellulite Subcision for the Cosmetic Surgeon\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:02\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e49.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eMedspa Mastery\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e45:04\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e50.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Dr. Miami Experience\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e54:46\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e51.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Brazilian Butt Lift: How I Do It\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e26:09\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e52.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003ePearls in High Definition Liposculpting and Postop Care\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:52\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e53.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eBody Contouring in a Urology Practice\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:31\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e54.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eStapleShape Mastopexy Augmentation\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e21:57\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e55.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eNipple Sparing Transgender Mastectomy under Local Anesthesia\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e12:28\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e56.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLaser Treatment of Recurrent Vulvovaginal Infections.mp4\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e12:40\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e57.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCombined Abdominoplasty and Gyn Surgery\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:32\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e58.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHyaluronic Acid for GSM\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e10:33\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e59.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHymenoplasty Pillar Technique\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:50\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e60.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLabia Majora Rejuvenation\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e16:16\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e61.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSad Umbilicus: Prevention and Correction Technique\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:27\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e62.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eAdvanced Menopause Management and Sexual Health\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e40:13\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e63.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eGenital Hair: Epilation or Transplant?\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:37\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e64.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eInnovative Treatment Options for Pelvic Pain\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e24:44\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e65.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eGenital Pathologies in Women and Men: Unsolved Etiologies, Working Hypotheses\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:51\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e66.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Role of PRP-HA in Aesthetic Gynecology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e16:20\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e67.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003e5 Step Blueprint to Exit and Sell Your Practice\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:21\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e68.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eProactive Risk Management Saving You $1 Million.mp4\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:47\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e69.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLidocaine TLA with\/without Ropivacaine in Chin Liposuction\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e25:58\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e70.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eNonsurgical Labiaplasty and Vulvar Remodeling\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e21:09\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e71.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eAvoiding Professional Liability Actions in Cosmetic Gynecology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:57\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e72.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eBioidentical Hormones and Peptides\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:02\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e73.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Circles of the Vulva: The Integrative Anatomy Applied to Cosmetic Gynecology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:16\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e74.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003e3D System for the Treatment and Cure of SUI, Outpatient, In Office\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:44\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e75.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eVaginoplasty: How to Achieve the Best Results Consistently\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:41\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e76.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eVaginoperineoplasty as Office Procedure\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e10:01\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e77.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Use of Threads for Various Indications in Cosmetic Gynecology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:39\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e78.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHymenoplasty Vestibulo-Introital Tightening Technique\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:31\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e79.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eManagement of the Protruberant Clitoris\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:59\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e80.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCombined HIFU \u0026amp; Monopolar RF for Symptomatic Vaginal Laxity\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e08:01\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e81.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eReoperation After Labia Minora Hypercorrection. Guidelines for Surgical Treatment\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e38:03\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e82.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSingle Thread Vagino-Perineoplasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:00\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e83.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eVulvar Whitening and Tightening with Lasers\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e23:03\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e84.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSurgical Treatment of Genital Lipodystrophy\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:19\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541410633,"sku":"MED-AMB04348","price":80.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/image_1447-02-08_00-27-54.jpg?v=1781873808"},{"product_id":"aua-2025-annual-meeting-las-vegas","title":"AUA 2025 Annual Meeting – Las Vegas","description":"\u003ch3 class=\"title\"\u003eAmerican Urological Association Annual meeting 2025\u003c\/h3\u003e\n\u003cstrong\u003eWHEN:\u003c\/strong\u003e Sunday, April 27, 202\u003cbr\u003e\u003ch4 class=\"subhead2\"\u003eOther AUA2025 Program Highlights Include:\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli class=\"listorder\"\u003eCase-based guidelines panel presentations in the Plenary: Review new and existing AUA guidelines with a real-life clinical case application.\u003c\/li\u003e\n\u003cli class=\"listorder\"\u003eNEW, Interactive Poster Sessions focused on conversations between moderators, authors, and attendees.\u003c\/li\u003e\n\u003cli class=\"listorder\"\u003eP2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: Showcase the exceptional, groundbreaking studies that are expected to change the day-to-day practice of urology. Reserved for the most impactful studies, P2s will be presented on the Plenary stage, providing the greatest exposure and profile for the research.\u003c\/li\u003e\n\u003cli class=\"listorder\"\u003eAUA2025 Learning Lab including:\u003cbr\u003e\u003cul\u003e\n\u003cli class=\"listorder\"\u003eClinical Trials in Progress: important clinical trials expected to influence practice when published\u003c\/li\u003e\n\u003cli class=\"listorder\"\u003eFlip the Script Case Presentations: an entertaining review of interesting urology scenarios with content experts.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli class=\"listorder\"\u003eFor the first time in Annual Meeting history, the AUA is hosting the National Residency Abstract Olympics! This spirited competition gives U.S. Residency Programs the opportunity to go for the gold by having the most accepted resident abstracts at AUA2025.\u003c\/li\u003e\n\u003cli class=\"listorder\"\u003e70+ Instructional Courses: 2-hour courses presented by experts in a specific field of urology. These courses take a deep dive into specific techniques, AUA guidelines, and surgical skills and span the spectrum of urology. (Available with the Platinum and Silver Packages)\u003c\/li\u003e\n\u003cli class=\"listorder\"\u003e Stay for the Key Takeaways: Thought-provoking discussions with the experts on the top science presented at this year’s meeting\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541443401,"sku":"MED-AMB04239","price":155.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/AUA-2025-Annual-Meeting-_E2_80_93-Las-Vegas.png?v=1781873809"},{"product_id":"2025-arrs-annual-meeting-on-demand","title":"2025 ARRS Annual Meeting On demand","description":"\u003csection background_background class=\"elementor-section elementor-top-section elementor-element elementor-element-7226a46 elementor-section-full_width elementor-section-height-min-height elementor-section-content-middle elementor-section-height-default elementor-section-items-middle elementskit-parallax-multi-container\" data-element_type=\"section\" data-id=\"7226a46\" data-settings=\"{\"\u003e\n\u003cdiv class=\"elementor-container elementor-column-gap-default\"\u003e\n\u003cdiv class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6d02dbd\" data-element_type=\"column\" data-id=\"6d02dbd\"\u003e\n\u003cdiv class=\"elementor-widget-wrap elementor-element-populated\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-27966e7 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"27966e7\" data-settings=\"{\" data-widget_type=\"heading.default\" ekit_we_effect_on\u003e\n\u003cdiv class=\"elementor-widget-container\"\u003e\n\u003cdiv class=\"Section\"\u003e\n\u003ch2 class=\"panel-title FloatLeft\"\u003e\u003cspan id=\"ctl01_TemplateBody_WebPartManager1_gwpciEventDisplay_ciEventDisplay_TitleText\"\u003e2025 ARRS Annual Meeting in San Diego\u003c\/span\u003e\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"EventDisplay\" id=\"ctl01_TemplateBody_WebPartManager1_gwpciEventDisplay_ciEventDisplay_DataDiv\"\u003e\n\u003cdiv class=\"EventSummary row\" id=\"ctl01_TemplateBody_WebPartManager1_gwpciEventDisplay_ciEventDisplay_EventSummaryDiv\"\u003e\n\u003cdiv class=\"col\"\u003e\n\u003cdiv class=\"PhotoArea\" id=\"ctl01_TemplateBody_WebPartManager1_gwpciEventDisplay_ciEventDisplay_ImageDiv\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"Description\"\u003e\n\u003cdiv class=\"PanelField\" id=\"ctl01_TemplateBody_WebPartManager1_gwpciEventDisplay_ciEventDisplay_DescriptionDiv\"\u003e\u003cspan id=\"ctl01_TemplateBody_WebPartManager1_gwpciEventDisplay_ciEventDisplay_DescriptionData\"\u003eThe general Annual Meeting registration provides registrants with access to more than 136 educational sessions\u003c\/span\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003ch2\u003e\u003c\/h2\u003e\n\u003ch2 class=\"elementor-heading-title elementor-size-default\"\u003eSessions For Every Subspecialty\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003csection class=\"elementor-section elementor-top-section elementor-element elementor-element-c610ee8 elementor-section-boxed elementor-section-height-default elementor-section-height-default elementskit-parallax-multi-container\" data-element_type=\"section\" data-id=\"c610ee8\"\u003e\n\u003cdiv class=\"elementor-container elementor-column-gap-default\"\u003e\n\u003cdiv class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-d263d55\" data-element_type=\"column\" data-id=\"d263d55\"\u003e\n\u003cdiv class=\"elementor-widget-wrap elementor-element-populated\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-786f791 elementor-widget elementor-widget-text-editor\" data-element_type=\"widget\" data-id=\"786f791\" data-settings=\"{\" data-widget_type=\"text-editor.default\" ekit_we_effect_on\u003e\n\u003cdiv class=\"elementor-widget-container\"\u003e\n\u003cul\u003e\n\u003cli\u003eAbdominal Imaging\u003c\/li\u003e\n\u003cli\u003eArtificial Intelligence\u003c\/li\u003e\n\u003cli\u003eBreast Imaging\u003c\/li\u003e\n\u003cli\u003eCardiac\u003c\/li\u003e\n\u003cli\u003eChest\u003c\/li\u003e\n\u003cli\u003eEmergency Radiology\u003c\/li\u003e\n\u003cli\u003eGastrointestinal\u003c\/li\u003e\n\u003cli\u003eGeneral Radiology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-e1ac583\" data-element_type=\"column\" data-id=\"e1ac583\"\u003e\n\u003cdiv class=\"elementor-widget-wrap elementor-element-populated\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-77b945d elementor-widget elementor-widget-text-editor\" data-element_type=\"widget\" data-id=\"77b945d\" data-settings=\"{\" data-widget_type=\"text-editor.default\" ekit_we_effect_on\u003e\n\u003cdiv class=\"elementor-widget-container\"\u003e\n\u003cul\u003e\n\u003cli\u003eGenitourinary\u003c\/li\u003e\n\u003cli\u003eMusculoskeletal\u003c\/li\u003e\n\u003cli\u003eNeuroradiology\u003c\/li\u003e\n\u003cli\u003eNuclear Medicine\u003c\/li\u003e\n\u003cli\u003ePediatric\u003c\/li\u003e\n\u003cli\u003eQuality in Practice\u003c\/li\u003e\n\u003cli\u003eUltrasound\u003c\/li\u003e\n\u003cli\u003eVascular\/Interventional\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541607241,"sku":"MED-AMB04225","price":275.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Screenshot-2025-05-09-160341-1.png?v=1781873809"},{"product_id":"2025-pathology-review-practical-updates-in-breast-gastrointestinal-and-genitourinary-pathology-for-the-general-pathologist","title":"2025 Pathology Review: Practical Updates in Breast, Gastrointestinal and Genitourinary Pathology for the General Pathologist","description":"\u003cdiv class=\"field__item\"\u003e\n\u003cdiv class=\"paragraph paragraph--type--basic-text paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"clearfix text-formatted field field--name-field-text-area field--type-text-long field--label-hidden field__item\"\u003e\n\u003cbr\u003e\u003cbr\u003eAbout This CME Teaching Activity\u003cbr\u003e\u003cbr\u003e\u003chr\u003e\n\u003cdiv\u003eThis CME teaching activity has been designed to provide an extensive overview of some of the most common areas of diagnostic difficulty encountered by practicing surgical pathologists in the areas of breast, gastrointestinal, and genitourinary pathology. This course provides details of some of the most important diagnostic features which allow pathologists to make accurate diagnoses in each of these subspecialized areas, as well as how to assess essential diagnostic clues and avoid the most common misdiagnoses. In each lecture, there is a thorough discussion on the use of ancillary diagnostic techniques, including immunohistochemistry and molecular diagnostics.\u003c\/div\u003e\n\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\n\u003cbr\u003e\u003chr\u003e\n\u003cbr\u003e\u003cbr\u003eThis CME activity is primarily intended and designed to educate practicing pathologists.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEducational Objectives\u003c\/strong\u003e\n\u003cbr\u003e\u003chr\u003e\n\u003cbr\u003e\u003cbr\u003eAt the completion of this CME teaching activity, you should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eRecognize the most common and more recently described renal cell tumors.\u003c\/li\u003e\n\u003cli\u003eIdentify some of the most common pitfalls in the diagnosis of biopsies of the urinary bladder and prostate.\u003c\/li\u003e\n\u003cli\u003eList the most common tumors encountered in the male genitourinary tract.\u003c\/li\u003e\n\u003cli\u003eExplain the most appropriate handling and staging of renal tumors.\u003c\/li\u003e\n\u003cli\u003eDescribe some of the newest forms of esophagitis.\u003c\/li\u003e\n\u003cli\u003eIdentify the various patterns of gastritis and gastropathy.\u003c\/li\u003e\n\u003cli\u003eList the most common pitfalls in duodenal biopsy interpretation.\u003c\/li\u003e\n\u003cli\u003eDefine the most common inflammatory patterns in colorectal biopsy specimens.\u003c\/li\u003e\n\u003cli\u003eRecognize the most common diagnostic pitfalls in breast core biopsies.\u003c\/li\u003e\n\u003cli\u003eReview the essential features of triple-negative breast cancer.\u003c\/li\u003e\n\u003cli\u003eDescribe the most common changes in post neoadjuvant treatment breast specimens.\u003c\/li\u003e\n\u003cli\u003eExplain biomarker testing in breast cancer.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003ePROGRAM\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eInterpretations of Breast Core Biopsies: An Assortment of Common Diagnostic Challenges\u003cbr\u003e\u003cem\u003eHannah Wen, M.D., Ph.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eWhat’s New in Esophagitis?\u003cbr\u003e\u003cem\u003eRhonda K. Yantiss, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe Spectrum of Triple Negative Breast Cancer\u003cbr\u003e\u003cem\u003eHannah Wen, M.D., Ph.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eGastritis and Gastropathy\u003cbr\u003e\u003cem\u003eRhonda K. Yantiss, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003ePattern-Based Approach to Renal Cell Tumors\u003cbr\u003e\u003cem\u003eSean R. Williamson, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003ePathologic Evaluation of Breast Specimens Post Neoadjuvant Treatment\u003cbr\u003e\u003cem\u003eHannah Wen, M.D., Ph.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eBladder Cancer Pathology Updates\u003cbr\u003e\u003cem\u003eSean R. Williamson, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eSlide Seminar: Special Subtypes of Triple Negative Breast Cancer\u003cbr\u003e\u003cem\u003eHannah Wen, M.D., Ph.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eProstate Cancer Pathology Updates\u003cbr\u003e\u003cem\u003eSean R. Williamson, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003ePractical Approach to Duodenal Biopsy Interpretation\u003cbr\u003e\u003cem\u003eRhonda K. Yantiss, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eSlide Seminar: Interesting Cases in Genitourinary Pathology\u003cbr\u003e\u003cem\u003eSean R. Williamson, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eInflammatory Patterns in Colonic Biopsy Samples\u003cbr\u003e\u003cem\u003eRhonda K. Yantiss, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eSlide Seminar: Spindle Cell Lesions of the Breast\u003cbr\u003e\u003cem\u003eHannah Wen, M.D., Ph.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eRecognizing Sneaky Cancers in Gastric Biopsies and How to Work Them Up\u003cbr\u003e\u003cem\u003eRhonda K. Yantiss, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eCommon Issues in Male Genital Pathology\u003cbr\u003e\u003cem\u003eSean R. Williamson, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eBreast Pathology in the Era of Genomics\u003cbr\u003e\u003cem\u003eHannah Wen, M.D., Ph.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe Differential Diagnosis of Ischemic Colitis\u003cbr\u003e\u003cem\u003eRhonda K. Yantiss, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eBiomarker Testing in Breast Cancer\u003cbr\u003e\u003cem\u003eHannah Wen, M.D., Ph.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eAnal Pathology 101: HPV-Related Lesions and Other Important Findings\u003cbr\u003e\u003cem\u003eRhonda K. Yantiss, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eStaging and Handling of Renal Tumors\u003cbr\u003e\u003cem\u003eSean R. Williamson, M.D.\u003c\/em\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541705545,"sku":"MED-AMB04174","price":55.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/2025-Pathology-Review-Practical-Updates-in-Breast-Gastrointestinal-and-Genitourinary-Pathology-for-the-General-Pathologist.png?v=1781873810"},{"product_id":"asco-genitourinary-cancers-symposium","title":"ASCO Genitourinary Cancers Symposium 2025 (Videos + Slides + Posters)","description":"\u003ch3\u003eProgram\u003c\/h3\u003e\u003cbr\u003eThe 2025 ASCO Genitourinary Cancers Symposium will provide expert, multidisciplinary perspectives on the latest clinical and scientific advances in the field. View the official \u003cstrong\u003eMeeting Announcement\u003c\/strong\u003e for a message from the Chair, Program Highlights, Featured Sessions information, and how to register.\u003cbr\u003e\u003ch3\u003eProgram At A Glance\u003c\/h3\u003e\n\u003ch3\u003eThursday, February 13, 2025\u003c\/h3\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:00 AM-\u003cbr\u003e8:00 AM\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eComplimentary Continental Breakfast\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:00 AM-\u003cbr\u003e6:45 AM\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eExhibits Open\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:00 AM-\u003cbr\u003e9:40 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eOral Abstract Session A: Prostate Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eKosj Yamoah, MD, PhD—Chair\u003c\/strong\u003e\u003cbr\u003eH. Lee Moffitt Cancer Center and Research Institute\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eChanning Judith Paller, MD—Chair\u003c\/strong\u003e\u003cbr\u003eThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003ePeter Hoskin, MD, FRCP, FRCR\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWelcome of the Day\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 308:\u003c\/strong\u003e Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials.\u003cbr\u003eFirst Author: \u003cstrong\u003eShuang Zhao, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 309:\u003c\/strong\u003e Radical prostatectomy (RP) versus radiotherapy (RT) in high-risk prostate cancer (HR-PCa): Emulated randomized comparison with individual patient data (IPD) from two phase III randomized trials (RCTs).\u003cbr\u003eFirst Author: \u003cstrong\u003eSoumyajit Roy, MBBS\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eEdwin Posadas, MD, FACP\u003c\/strong\u003e\u003cbr\u003eCedars-Sinai Medical Center\u003cbr\u003e\u003cem\u003eDiscussion\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT LBA18\u003c\/strong\u003e: Final overall survival (OS) with talazoparib (TALA) + enzalutamide (ENZA) as first-line treatment in unselected patients with metastatic castration-resistant prostate cancer (mCRPC) in the phase 3 TALAPRO-2 trial.\u003cbr\u003eFirst Author: \u003cstrong\u003eNeeraj Agarwal, MD, FASCO\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 20:\u003c\/strong\u003e Which patients with metastatic hormone-sensitive prostate cancer (mHSPC) benefit more from androgen receptor pathway inhibitors (ARPIs)? STOPCAP meta-analyses of individual participant data (IPD).\u003cbr\u003eFirst Author: \u003cstrong\u003eDavid John Fisher, MSc\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTanya B. Dorff, MD\u003c\/strong\u003e\u003cbr\u003eCity of Hope Comprehensive Cancer Center\u003cbr\u003e\u003cem\u003eDiscussion\u003c\/em\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:40 AM-10:10 AM\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:10 AM-11:25 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eUnderstanding Radioligand Therapies for Advanced Prostate Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eAngela Y Jia, MD, PhD—Chair\u003c\/strong\u003e\u003cbr\u003eUniversity Hospitals Seidman Cancer Center and Case Western Reserve University\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eDevaki Shilpa Surasi, MBBS—Chair\u003c\/strong\u003e\u003cbr\u003eUniversity of Texas at MD Anderson Cancer Center\u003cbr\u003e\u003cem\u003ePSMA-Based Therapy in Advanced Disease: Touching on Combination Sequencing\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eWilliam Kevin Kelly, DO\u003c\/strong\u003e\u003cbr\u003eThomas Jefferson University Hospital\u003cbr\u003e\u003cem\u003eBeyond PSMA-Targeted Agents for Advanced Disease\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eDanny Mena Cortes\u003c\/strong\u003e\u003cbr\u003eNuclear Medicine World\u003cbr\u003e\u003cem\u003eSeeing Is Believing: Radiographic Criteria to Assess Response\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 17:\u003c\/strong\u003e Overall survival and quality of life with [\u003csup\u003e177\u003c\/sup\u003eLu] Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in poor-risk, metastatic, castration-resistant prostate cancer in ENZA-p (ANZUP 1901).\u003cbr\u003eFirst Author: \u003cstrong\u003eLouise Emmett, MD, FRACP, MBChB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 16: \u003c\/strong\u003eAssociation of baseline and on-treatment ctDNA fraction with clinical outcomes in patients with mCRPC in the PSMAfore study of \u003csup\u003e177\u003c\/sup\u003eLu-PSMA-617.\u003cbr\u003eFirst Author: \u003cstrong\u003eJohann S. De Bono, MD, PhD, MB, FRCP\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:25 AM-12:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePoster Session A: Prostate Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWith Complimentary Boxed Lunch\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:25 AM-12:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eTrials in Progress Poster Session A: Prostate Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWith Complimentary Boxed Lunch\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:35 AM-12:35 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eTrainee and Early-Career Networking Luncheon\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eView the networking faculty list\u003cstrong\u003e \u003cem\u003e\u003ca data-entity-substitution=\"canonical\" data-entity-type=\"node\" data-entity-uuid=\"86e3556e-09bd-46aa-ac12-97b30b57a775\" href=\"https:\/\/conferences.asco.org\/gu\/onsite-connections\" title=\"Onsite Connections\"\u003ehere\u003c\/a\u003e\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:45 PM-2:00 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eCase-Based Session: Management of Biochemical Recurrence After Radiation Therapy for Localized Prostate Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eMichael Cookson, MD, MMHC, FACS—Chair\u003c\/strong\u003e\u003cbr\u003eUniversity of Oklahoma College of Medicine\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eBarbara Jereczek-Fossa, MD—Chair\u003c\/strong\u003e\u003cbr\u003eIEO European Institute of Oncology IRCCS\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eMichael Cookson, MD, MMHC, FACS\u003c\/strong\u003e\u003cbr\u003eUniversity of Oklahoma College of Medicine\u003cbr\u003e\u003cem\u003eRecurrence After Radiation Therapy: Evaluation, Management, and Outcomes\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eHeather H. Cheng, MD, PhD\u003c\/strong\u003e\u003cbr\u003eUniversity of Washington\u003cbr\u003e\u003cem\u003eMedical Oncology\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eJuanita Crook, FRCPC\u003c\/strong\u003e\u003cbr\u003eThe University of British Columbia\u003cbr\u003e\u003cem\u003eRadiation Oncology\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eThomas Polascik, MD\u003c\/strong\u003e\u003cbr\u003eDuke University Division of Urologic Surgery\u003cbr\u003e\u003cem\u003eUrology (Ablative Focal)\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eAshley Ross, MD, PhD\u003c\/strong\u003e\u003cbr\u003eNorthwestern University Feinberg School of Medicine\u003cbr\u003e\u003cem\u003eUrology (Salvage Surgery)\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eAlicia K. Morgans, MD, MPH, FASCO\u003c\/strong\u003e\u003cbr\u003eDana-Farber Cancer Institute\u003cbr\u003e\u003cem\u003eThe Impact of Salvage Therapies: Functional Outcomes and Quality of Life\u003c\/em\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2:15 PM-3:05 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eKeynote\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003ePeter Hoskin, MD, FRCP, FRCR - Chair\u003c\/strong\u003e\u003cbr\u003eMount Vernon Cancer Centre, University College London, and University of Manchester\u003cbr\u003e\u003cem\u003eIntroduction of Dr. Dahut\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eWilliam L. Dahut, MD\u003c\/strong\u003e\u003cbr\u003eAmerican Cancer Society\u003cbr\u003e\u003cem\u003eCreative Innovation: Driving Science to Improve Patient-Centered Care\u003c\/em\u003e\n\u003cbr\u003e\u003cem\u003eQuestion and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:05 PM-\u003cbr\u003e3:30 PM\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3:30 PM-\u003cbr\u003e4:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eCase-Based Session: Evolving Landscape of the Management of Oligometastatic Disease\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eKaren E. Hoffman, MD, MHSc, MPH—Chair\u003c\/strong\u003e\u003cbr\u003eThe University of Texas MD Anderson Cancer Center\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eNicholas David James—Chair\u003c\/strong\u003e\u003cbr\u003eInstitute of Cancer Research, The Royal Marsden Hospital NHS Foundation Trust\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eABSTRACT 15:\u003c\/strong\u003e World-wide oligometastatic prostate cancer (omPC) meta-analysis leveraging individual patient data (IPD) from randomized trials (WOLVERINE): An analysis from the X-MET collaboration.\u003cbr\u003eFirst Author: \u003cstrong\u003eChad Tang, MD, BS, MS\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eKenneth L. Gage, MD, PhD\u003c\/strong\u003e\u003cbr\u003eH. Lee Moffitt Cancer Center and Research Institute\u003cbr\u003e\u003cem\u003eRadiology\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eBrandon A. Mahal, MD\u003c\/strong\u003e\u003cbr\u003eUniversity of Miami\u003cbr\u003e\u003cem\u003eRadiation Oncology\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eKasmintan A. Schrader, PhD, MBBS\u003c\/strong\u003e\u003cbr\u003eBC Cancer\u003cbr\u003e\u003cem\u003eGenetics\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eSandy Srinivas, MD\u003c\/strong\u003e\u003cbr\u003eStanford School of Medicine\u003cbr\u003e\u003cem\u003eMedical Oncology\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003ePanel Question and Answer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5:00 PM-\u003cbr\u003e5:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eRapid Oral Abstract Session A: Prostate Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eMarjory Jolicoeur, MD, PhD, FRCPC—Chair\u003c\/strong\u003e\u003cbr\u003eHôpital Charles-LeMoyne\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eABSTRACT 310:\u003c\/strong\u003e Impact of testosterone recovery after androgen deprivation therapy on overall survival in patients with high-risk prostate cancer: Long-term data from a phase III trial. - 5 minutes\u003cbr\u003eFirst Author: \u003cstrong\u003eAbdenour Nabid, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 311:\u003c\/strong\u003e Gut health and prostate cancer: The influence of a specific phytochemical-rich food capsule plus or minus a probiotic\/prebiotic blend on symptoms and progression—A randomised, double-blind placebo-controlled trial. - 5 minutes\u003cbr\u003eFirst Author: \u003cstrong\u003eRobert J. Thomas, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 312:\u003c\/strong\u003e A high omega-3, low omega-6 diet with fish oil for men with prostate cancer on active surveillance: The CAPFISH-3 randomized clinical trial. - 5 minutes\u003cbr\u003eFirst Author: \u003cstrong\u003eWilliam Aronson, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 21:\u003c\/strong\u003e Transdermal oestradiol (tE2) patches as androgen deprivation therapy (ADT): Efficacy and safety of combining with androgen receptor pathway inhibitors (ARPIs) in metastatic (M1) prostate cancer—Randomised comparison from the STAMPEDE trial platform. - 5 minutes\u003cbr\u003eFirst Author: \u003cstrong\u003eNicholas David James, PhD, FRCP, MBBS\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 22:\u003c\/strong\u003e Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration resistant prostate cancer: A randomized phase II trial (GROUQ-PCS 9). - 5 minutes\u003cbr\u003eFirst Author: \u003cstrong\u003eTamim Niazi, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT LBA138:\u003c\/strong\u003e Mevrometostat (PF-06821497), an enhancer of zeste homolog 2 (EZH2) inhibitor, in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC): A randomized dose-expansion study. - 5 minutes\u003cbr\u003eFirst Author: \u003cstrong\u003eMichael Thomas Schweizer, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5:45 PM-6:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePoster Session A (Continued)\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWith Complimentary Wine and Cheese Reception\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5:45 PM-6:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eTrials in Progress Poster Session A (Continued)\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWith Complimentary Wine and Cheese Reception\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6:00 PM-6:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePoster Walks: Prostate Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eMarjory Jolicoeur, MD, PhD, FRCPC\u003c\/strong\u003e\u003cbr\u003eHôpital Charles-LeMoyne\u003cbr\u003e\u003cem\u003ePoster Walk Leader\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eChanning Judith Paller, MD\u003c\/strong\u003e\u003cbr\u003eThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\u003cbr\u003e\u003cem\u003ePoster Walk Leader\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6:00 PM-\u003cbr\u003e6:45 PM\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eWomen's Networking Reception\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003ch3\u003eFriday, February 14, 2025\u003c\/h3\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:00 AM-8:10 AM\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eComplimentary Continental Breakfast\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:00 AM-5:45 PM\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eExhibits Open\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:10 AM-9:45 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eOral Abstract Session B: Urothelial Carcinoma\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eElizabeth A. Guancial, MD—Chair\u003c\/strong\u003e\u003cbr\u003eFlorida Cancer Specialists \u0026amp; Research Institute\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eNicholas I. Simon, MD, MSc—Chair\u003c\/strong\u003e\u003cbr\u003eNational Cancer Institute\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eAndrea B Apolo, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWelcome of the Day\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 658: \u003c\/strong\u003eAdjuvant nivolumab (NIVO) vs placebo (PBO) for high-risk muscle-invasive urothelial carcinoma (MIUC): Additional efficacy outcomes including overall survival (OS) in patients (pts) with muscle-invasive bladder cancer (MIBC) from CheckMate 274.\u003cbr\u003eFirst Author: \u003cstrong\u003eMatthew I. Milowsky, MD, FASCO\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 659:\u003c\/strong\u003e Additional efficacy and safety outcomes and an exploratory analysis of the impact of pathological complete response (pCR) on long-term outcomes from NIAGARA. - 10 minutes\u003cbr\u003eFirst Author: \u003cstrong\u003eMatthew D. Galsky, MD, FASCO\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eElizabeth R. Plimack, MD, FASCO, MS\u003c\/strong\u003e\u003cbr\u003eFox Chase Cancer Center, Temple Health\u003cbr\u003e\u003cem\u003eDiscussion\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 661:\u003c\/strong\u003e Safety and efficacy of neoadjuvant immunotherapy with durvalumab (MEDI 4736) in combination with neoadjuvant chemotherapy (gemcitabine\/cisplatin or carboplatin) in patients with operable high-risk upper tract urothelial carcinoma. - 10 minutes\u003cbr\u003eFirst Author: \u003cstrong\u003eNadine Houede, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 665:\u003c\/strong\u003e Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with muscle-invasive bladder cancer (MIBC) with HER2 expression: Updated efficacy and safety results from the phase II RC48-C017 trial. - 10 minutes\u003cbr\u003eFirst Author: \u003cstrong\u003eXinan Sheng, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eScot Anthony Niglio, MD, MS\u003c\/strong\u003e\u003cbr\u003eNational Institutes of Health Division of Occupational Health and Safety\u003cbr\u003e\u003cem\u003eDiscussion\u003c\/em\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:45 AM-10:15 AM\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:15 AM-11:30 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eCase-Based Session: Non-Muscle Invasive Bladder Cancer: Exploring Therapies Beyond Bacillus Calmette-Guérin\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eBrian Christopher Baumann, MD—Chair\u003c\/strong\u003e\u003cbr\u003eSpringfield Clinic\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eBogdana Schmidt, MD, MPH—Chair\u003c\/strong\u003e\u003cbr\u003eUniversity of Utah\u003cbr\u003e\u003cem\u003eThe Changing World of Non-Muscle Invasive Bladder Cancer\u003c\/em\u003e\n\u003cbr\u003e\u003cem\u003eCase Presentation\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eGirish S. Kulkarni, MD, PhD\u003c\/strong\u003e\u003cbr\u003eDepartment of Surgical Oncology, Princess Margaret Cancer Center, University Health Network\u003cbr\u003e\u003cem\u003eUrology\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eMark Tyson, MPH\u003c\/strong\u003e\u003cbr\u003eMayo Clinic Arizona\u003cbr\u003e\u003cem\u003eUrology\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eTracy L Rose, MD\u003c\/strong\u003e\u003cbr\u003eUniversity of North Carolina at Chapel Hill\u003cbr\u003e\u003cem\u003eMedical Oncology\u003c\/em\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:30 AM-12:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePoster Session B: Urothelial Carcinoma\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWith Complimentary Boxed Lunch\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:30 AM-12:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eTrials in Progress Poster Session B: Urothelial Carcinoma\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWith Complimentary Boxed Lunch\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:40 AM-12:35 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eBreakout Session: Emerging Trends and Advances in Germ Cell Tumors\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eAditya Bagrodia, MD—Chair\u003c\/strong\u003e\u003cbr\u003eUniversity of California, San Diego Health\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eAnja Lorch, MD—Chair\u003c\/strong\u003e\u003cbr\u003eUniversitätsspital Zürich\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eNabil Adra, MD\u003c\/strong\u003e\u003cbr\u003eIndiana University Health Melvin and Bren Simon Comprehensive Cancer Center\u003cbr\u003e\u003cem\u003eHigh-Dose Chemotherapy in Testicular Cancer: Current Evidence and Clinical Indications \u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eAxel Heidenreich, MD\u003c\/strong\u003e\u003cbr\u003eUniversity Hospital of Cologne\u003cbr\u003e\u003cem\u003ePrimary Retroperitoneal Lymph Node Dissection in Stage II Seminoma: Management Strategies and Current Controversies\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eDarren R. Feldman, MD\u003c\/strong\u003e\u003cbr\u003eMemorial Sloan Kettering Cancer Center\u003cbr\u003e\u003cem\u003eLandscape of New Trials and Targets in Refractory Germ Cell Tumors \u003c\/em\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer \u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:45 PM-2:00 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eThe ABCs of ADCs: Unleashing the Power of Antibody-Drug Conjugates in Advanced Bladder Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eKent William Mouw, MD, PhD—Chair\u003c\/strong\u003e\u003cbr\u003eDana-Farber Cancer Institute, Brigham and Women’s Hospital\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eBenjamin Garmezy, MD—Chair\u003c\/strong\u003e\u003cbr\u003eSarah Cannon Research Institute\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eDi Maria Jiang, MD, MSc, FRCPC\u003c\/strong\u003e\u003cbr\u003ePrincess Margaret Hospital, University Health Network\u003cbr\u003e\u003cem\u003eTargeting Bladder Cancer With Antibody Drug Conjugates\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eFunda Meric-Bernstam, MD, FASCO\u003c\/strong\u003e\u003cbr\u003eUniversity of Texas MD Anderson Cancer Center\u003cbr\u003e\u003cem\u003eHER2 Antibody-Drug Conjugate Therapy: A New Frontier in Bladder Cancer\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eDaniel Castellano, MD\u003c\/strong\u003e\u003cbr\u003eServicio de Oncología Médica, Hospital Universitario 12 de Octubre\u003cbr\u003e\u003cem\u003eOvercoming Challenges of Antibody-Drug Conjugate Toxicity in Bladder Cancer\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eTerence W. Friedlander, MD\u003c\/strong\u003e\u003cbr\u003eUniversity of California, San Francisco Medical Center\u003cbr\u003e\u003cem\u003eBetter Together? Exploring Novel Drug Combinations With Antibody-Drug Conjugates\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 657:\u003c\/strong\u003e Nectin-4 targeted ADC, SHR-A2102, in patients with advanced or metastatic urothelial carcinoma: A phase 1 study.\u003cbr\u003eFirst Author: \u003cstrong\u003eBixia Tang, MD, PhD\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2:00 PM-2:30 PM\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2:30 PM-3:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePanning for Gold: The Role of ctDNA as a Biomarker for Bladder Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eBernadett Szabados, MBBS—Chair\u003c\/strong\u003e\u003cbr\u003eBarts Cancer Centre\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eJoaquim Bellmunt, MD—Chair\u003c\/strong\u003e\u003cbr\u003eDana-Farber Cancer Institute\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eRoger Li, MD\u003c\/strong\u003e\u003cbr\u003eH. Lee Moffitt Cancer Center and Research Institute\u003cbr\u003e\u003cem\u003eCapturing What You Cannot See: How Can ctDNA Be Used to Improve Clinical Staging for Upper Tract Disease?\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eAlexander William Wyatt, PhD\u003c\/strong\u003e\u003cbr\u003eVancouver Prostate Centre, University of British Columbia\u003cbr\u003e\u003cem\u003eEvolution of Ctdna Detection with Next Generation Technology\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eNimira S. Alimohamed, FRCPC\u003c\/strong\u003e\n\u003cbr\u003e\u003cspan lang=\"en-AS\" xml:lang=\"en-AS\"\u003eArthur Child Comprehensive Cancer Centre, University of Calgary\u003c\/span\u003e\n\u003cbr\u003e\u003cem\u003ePotential Impact of ctDNA on Perioperative Management of Muscle-Invasive Bladder Cancer\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eGillian Vandekerkhove, PhD, MSc\u003c\/strong\u003e\u003cbr\u003eVancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia\u003cbr\u003e\u003cem\u003eBeneath the Surface: Unleashing the Potential of Ctdna across the Spectrum of Urothelial Carcinoma\u003c\/em\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4:00 PM-4:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eRapid Oral Abstract Session B: Urothelial Carcinoma\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eKatie S. Murray, DO, FACS, MS—Chair\u003c\/strong\u003e\u003cbr\u003eDepartment of Urology, NYU Langone Health\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eABSTRACT 662:\u003c\/strong\u003e A first-in-human phase 1 study of LY3866288 (LOXO-435), a potent, highly isoform-selective FGFR3 inhibitor (FGFR3i) in advanced solid tumors with \u003cem\u003eFGFR3 \u003c\/em\u003ealterations: Initial results from FORAGER-1.\u003cbr\u003eFirst Author: \u003cstrong\u003eGopa Iyer, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 663:\u003c\/strong\u003e Datopotamab deruxtecan (Dato-DXd) in locally advanced\/metastatic urothelial cancer: Updated results from the phase 1 TROPIONPanTumor01 study.\u003cbr\u003eFirst Author: \u003cstrong\u003eFunda Meric-Bernstam, MD, FASCO\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 664\u003c\/strong\u003e: EV-302: Updated analysis from the phase 3 global study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally advanced or metastatic urothelial carcinoma (la\/mUC).\u003cbr\u003eFirst Author: \u003cstrong\u003eThomas Powles, MD, PhD, FCRP\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 666\u003c\/strong\u003e: Clinically advanced urothelial bladder cancer (CAUBC) in young onset bladder cancer (YOUC) patients: A genomic landscape study.\u003cbr\u003eFirst Author: \u003cstrong\u003eAlina Basnet, MD, MBBS\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 667: \u003c\/strong\u003eA phase 1\/2 trial of durvalumab plus intravesical gemcitabine and docetaxel in BCG-unresponsive non-muscle invasive bladder cancer patients (HCRN GU16-243: ADAPT-BLADDER Cohort 4).\u003cbr\u003eFirst Author: \u003cstrong\u003eNoah M. Hahn, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 815\u003c\/strong\u003e: A phase 2 trial of risk enabled therapy after neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer (RETAIN-2).\u003cbr\u003eFirst Author: \u003cstrong\u003ePooja Ghatalia, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4:45 PM-5:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePoster Session B (Continued)\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWith Complimentary Wine and Cheese Reception\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4:45 PM-5:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eTrials in Progress Poster Session B (Continued)\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWith Complimentary Wine and Cheese Reception\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5:00 PM-5:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePoster Walks: Urothelial Carcinoma\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eElias Chandran, FRACP, MBBS\u003c\/strong\u003e\u003cbr\u003eNational Cancer Institute\u003cbr\u003e\u003cem\u003ePoster Walk Leader\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eArmine Smith, MD\u003c\/strong\u003e\u003cbr\u003eJohns Hopkins University School of Medicine\u003cbr\u003e\u003cem\u003ePoster Walk Leader\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003ch3\u003eSaturday, February 15, 2025\u003c\/h3\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:00 AM-8:10 AM\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eComplimentary Continental Breakfast\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:10 AM-8:10 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePoster Session C: Renal Cell Cancer;\u003c\/strong\u003e \u003cstrong\u003eAdrenal, Penile, Testicular and Urethral Cancers\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:10 AM-8:10 AM\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eTrials in Progress Poster Session C: Renal Cell Cancer; Adrenal, Penile, Testicular and Urethral Cancers\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:10 AM-9:45 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eOral Abstract Session C: Renal Cell Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eArpita Desai, MD—Chair\u003c\/strong\u003e\u003cbr\u003eUniversity of California, San Francisco\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eDaniel Shapiro—Chair\u003c\/strong\u003e\u003cbr\u003eUniversity of Wisconsin-Madison\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTodd Matthew Morgan, MD\u003c\/strong\u003e\u003cbr\u003eWelcome of the Day\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eABSTRACT 438:\u003c\/strong\u003e Cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC): Final results of COSMIC-313.\u003cbr\u003eFirst Author: \u003cstrong\u003eLaurence Albiges, MD, PhD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 439: \u003c\/strong\u003eNivolumab plus cabozantinib (N+C) vs sunitinib (S) for previously untreated advanced renal cell carcinoma (aRCC): Final follow-up results from the CheckMate 9ER trial.\u003cbr\u003eFirst Author: \u003cstrong\u003eRobert J. Motzer, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 440:\u003c\/strong\u003e KEYMAKER-U03 Substudy 03B: Pembrolizumab (pembro) and targeted therapy combinations for advanced clear cell renal cell carcinoma (ccRCC).\u003cbr\u003eFirst Author: \u003cstrong\u003eKaty Beckermann, MD, PhD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTian Zhang, MD, MHS\u003c\/strong\u003e\u003cbr\u003eUT Southwestern University\u003cbr\u003e\u003cem\u003eDiscussion\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 618:\u003c\/strong\u003e Prospective COTRIMS (Cologne trial of retroperitoneal lymphadectomy in metastatic seminoma) trial: Final results.\u003cbr\u003eFirst Author: \u003cstrong\u003eAxel Heidenreich, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eClint Cary, MD, MBA, MPH\u003c\/strong\u003e\u003cbr\u003eIndiana University Simon Comprehensive Cancer Center\u003cbr\u003e\u003cem\u003eDiscussion\u003c\/em\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:45 AM-10:15 AM\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreak\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e10:15 AM-11:30 AM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eBiomarkers and Adjuvant Therapy for Renal Cell Carcinoma: Current State and Future Directions\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eShuchi Gulati, MD, MS, FACP—Chair\u003c\/strong\u003e\u003cbr\u003eUniversity of California, Davis Comprehensive Cancer Center\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eAxel Bex, MD, PhD—Chair\u003c\/strong\u003e\u003cbr\u003eRoyal Free London NHS Foundation Trust\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eABSTRACT 437:\u003c\/strong\u003e Evaluation of circulating kidney injury marker-1 (KIM-1) as a prognostic and predictive biomarker in advanced renal cell carcinoma (aRCC): Post-hoc analysis of CheckMate 214.\u003cbr\u003eFirst Author:\u003cstrong\u003e Wenxin Xu, MD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eSimpa Samuel Salami, MD, MPH\u003c\/strong\u003e\u003cbr\u003eUniversity of Michigan\u003cbr\u003e\u003cem\u003eBiomarkers in Renal Cell Carcinoma: Dead End or Turning Point?\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eSamra Turajlic, MD, PhD\u003c\/strong\u003e\u003cbr\u003eThe Francis Crick Institute\u003cbr\u003e\u003cem\u003eThe Future of Biomarkers in Renal Cell Carcinoma\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eLaurence Albiges, MD, PhD\u003c\/strong\u003e\u003cbr\u003eGustave Roussy, Université Paris Saclay\u003cbr\u003e\u003cem\u003eAdjuvant Therapy in Renal Cell Cancer: A Practical Guide\u003c\/em\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:30 AM-12:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePoster Session C (Continued)\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWith Complimentary Boxed Lunch\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:30 AM-12:45 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eTrials in Progress Poster Session C (Continued)\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003eWith Complimentary Boxed Lunch\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:40 AM-12:35 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eWomen in Genitourinary Cancers Networking Luncheon\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eView the networking faculty list\u003cstrong\u003e \u003cem\u003e\u003ca data-entity-substitution=\"canonical\" data-entity-type=\"node\" data-entity-uuid=\"86e3556e-09bd-46aa-ac12-97b30b57a775\" href=\"https:\/\/conferences.asco.org\/gu\/onsite-connections\" title=\"Onsite Connections\"\u003ehere\u003c\/a\u003e\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e11:45 AM-12:30 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003ePoster Walks: Renal Cell Cancer; Adrenal, Penile, Testicular and Urethral Cancers\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eBrittney Cotta, MD\u003c\/strong\u003e\u003cbr\u003eUniversity of Texas MD Anderson Cancer Center\u003cbr\u003e\u003cem\u003ePoster Walk Leader\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eShuchi Gulati, MD, FACP, MS\u003c\/strong\u003e\u003cbr\u003eUC Davis Comprehensive Cancer Center\u003cbr\u003e\u003cem\u003ePoster Walk Leader\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e12:45 PM-\u003cbr\u003e​​​​​​​1:30 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eRapid Oral Abstract Session C: Renal Cell Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eBrittney Cotta, MD—Chair\u003c\/strong\u003e\u003cbr\u003eUniversity of Texas MD Anderson Cancer Center\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eABSTRACT 441: \u003c\/strong\u003eCasdatifan (Cas) monotherapy in patients (pts) with previously treated clear cell renal cell carcinoma (ccRCC): Safety, efficacy and subgroup analysis across multiple doses from ARC-20, a phase 1 open-label study.\u003cbr\u003eFirst Author: T\u003cstrong\u003eoni K. Choueiri, MD, FASCO\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 442:\u003c\/strong\u003e Racial disparities in renal cell carcinoma histology and outcomes: Insights from the French Kidney Cancer Research Network (UroCCR-191).\u003cbr\u003eFirst Author: \u003cstrong\u003eXiaofan Lu, PhD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 443:\u003c\/strong\u003e Lenvatinib plus tislelizumab as first-line therapy for advanced fumarate hydratase-deficient renal cell carcinoma: A single-center, single-arm, phase II study.\u003cbr\u003eFirst Author: \u003cstrong\u003eWen Kong, PhD\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 444:\u003c\/strong\u003e Final overall survival and new ctDNA analysis in MET-driven advanced papillary renal cancer (CALYPSO).\u003cbr\u003eFirst Author: \u003cstrong\u003eFrancesca Jackson-Spence, MBChB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eABSTRACT 1:\u003c\/strong\u003e EPIC-A: Phase II trial of cemiplimab plus standard of care chemotherapy followed by maintenance cemiplimab in locally advanced or metastatic penile carcinoma.\u003cbr\u003eFirst Author: \u003cstrong\u003eAmit Bahl, MD, FRCP, FRCR\u003c\/strong\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1:45 PM-3:00 PM\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eCase-Based Session: Failure of Immunotherapy in Renal Cell Cancer: What’s Next?\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eLeslie K. Ballas, MD—Chair\u003c\/strong\u003e\u003cbr\u003eCedars-Sinai Medical Center\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eKathryn Hacker Gessner, MD, PhD—Chair\u003c\/strong\u003e\u003cbr\u003eUNC School of Medicine\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eMaria T. Bourlon, MD, MSc, FASCO\u003c\/strong\u003e\u003cbr\u003eInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán\u003cbr\u003e\u003cem\u003eMedical Oncology\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eMatthew T Campbell, MD, MS\u003c\/strong\u003e\u003cbr\u003eThe University of Texas MD Anderson Cancer Center\u003cbr\u003e\u003cem\u003eMedical Oncology\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eRaquibul Hannan, MD, PhD\u003c\/strong\u003e\u003cbr\u003eUniversity of Texas Southwestern Medical Center\u003cbr\u003e\u003cem\u003eRadiation Oncology\u003c\/em\u003e\n\u003cbr\u003e\u003cstrong\u003eViraj A. Master, MD, PhD\u003c\/strong\u003e\u003cbr\u003eEmory School of Medicine\u003cbr\u003e\u003cem\u003eUrology\u003c\/em\u003e\n\u003cbr\u003e\u003cem\u003ePanel Question and Answer\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541771081,"sku":"MED-AMB04123","price":160.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/ASCO-Genitourinary-Cancers-Symposium-2025-Videos-Slides-Posters.jpg?v=1781873809"},{"product_id":"tumors-and-tumor-like-lesions-of-the-testis-and-adjacent-tissues-afip-atlas-of-tumor-and-non-tumor-pathology-series-5-vol-12-2","title":"Tumors and Tumor-Like Lesions of the Testis and Adjacent Tissues (AFIP Atlas of Tumor and Non-Tumor Pathology, Series 5 Vol. 12) (Original PDF from Publisher)","description":"\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"prod-title\"\u003e\n\u003ch3\u003eTumors and Tumor-Like Lesions of the Testis and Adjacent Tissues (AFIP Atlas of Tumor and Non-Tumor Pathology, Series 5 Vol. 12) (Original PDF from Publisher)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cdiv class=\"prod-format-tab\"\u003e\n\u003cspan class=\"title\"\u003eFormat :\u003c\/span\u003ePublisher PDF \u003cspan class=\"title\"\u003eFile Size :\u003c\/span\u003e293.2 MB\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbr\u003eBy T. — Kao M. Ulbright\u003cbr\u003e\u003cbr\u003eHow does a pathologist become interested and develop expertise in testicular and paratesticular neoplasms, which are relatively uncommon? The truth is simple—the opportunity to see many cases. The authors of this 5th Series Fascicle have such expertise and share a remarkable range of cases from their institutions as well as from many pathologists throughout the world who have sent them cases in consultation over the years. This fascicle is rich source of material that will be a great resource for practicing pathologists and pathologists in training.\u003ci class=\"a-icon a-icon-extender-expand\"\u003e\u003c\/i\u003e\n\u003cbr\u003e\u003ch3\u003eProduct Details\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePublisher ‏ : ‎ American Registry of Pathology (January 1, 2022)\u003c\/li\u003e\n\u003cli\u003eLanguage ‏ : ‎ English\u003c\/li\u003e\n\u003cli\u003eISBN-10 ‏ : ‎ 1933477229\u003c\/li\u003e\n\u003cli\u003eISBN-13 ‏ : ‎ 978-1933477220\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541738313,"sku":"MED-AMB04088","price":90.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/image_1446-10-29_18-11-21.png?v=1781873810"},{"product_id":"iscg-2020-cosmetic-gyn-world-congress-fort-lauderdale","title":"ISCG 2020 Cosmetic Gyn World Congress Fort Lauderdale","description":"\u003cdiv class=\"meta-info\"\u003e\n\u003ch2 class=\"wsite-content-title\"\u003e​ISCG COSMETIC GYNECOLOGY WORLD CONGRESS\u003cbr\u003eMARCH 14-15, 2020 FORT LAUDERDALE, FLORIDA\u003c\/h2\u003e\n\u003cbr\u003ePage Link : https:\/\/vimeo.com\/ondemand\/iscg2020\u003cbr\u003e\u003cbr\u003etopics and Run time\u003cbr\u003e\u003ctable class=\"ep-list\"\u003e\n\u003ctbody\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e1.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003ePerformance Enhancement and Immunoboosting (Video)\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e12:49\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e2.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003ePerformance Enhancement and Immunoboosting (Podcast)\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:11:02\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e3.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eFractional CO2 Laser for Stress Urinary Incontinence\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:13\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e4.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eWe Can Make Functional What You Can Make Beautiful\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:16\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e5.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003ePerineal Rehabilitation: How to Increase Sexual Pleasure\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:39\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e6.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Crocobite Labiaplasty Technique for Wedge Revisions\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:28\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e7.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eRectocele Improvement by Laser Treatments by Anorectal Approach\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:41\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e8.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eMulti Modal Therapy for Genitourinary Syndrome of Menopause\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:28\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e9.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eErbium Laser Therapy for Recurrent Vaginal Candidiasis\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:29\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e10.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eDoes Vaginal Erbium Laser Affect Subsequent Vaginal Deliveries?\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e11:38\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e11.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLaser Genital Whitening\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:05\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e12.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eGenital Neuropathies \u0026amp; Treatment in Sexual Response \u0026amp; Orgasm\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:58\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e13.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCombined Tulua Abdominoplasty and Cesarean Section\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:02\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e14.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eA Proven Genital Plastics Recovery Protocol\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:29\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e15.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCreation of Vulva After Gigantic Tumor\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:12\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e16.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003e​Surgical Management of Severe Anatomical Surgical Distortion Post Thighplasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e29:00\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e17.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003ePhysicians, Patients and Prolapse: It’s Time for a Revolution\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:16\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e18.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eTreatment of Stress Urinary Incontinence with PRP and PDO Threads. The Luksenburg System\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:21\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e19.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLaser Colpoperineoplasty under Local Anesthesia\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:27\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e20.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eReactivation of Clitoral Sensitivity\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:23\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e21.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCommon Mistakes in Plastic Gynecology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e32:43\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e22.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eMini Abdominoplasty under Local Anesthesia\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:25\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e23.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eA Modified Wedge Labiaplasty That Does Not Open\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:39\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e24.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eEndovascular Laser for Vulvar Varicosities\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e12:35\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e25.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLabia Majora Laxity Classification and Treatment\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:37\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e26.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eA Superior System of Cellulite Ablation\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:08\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e27.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSurgical Management of Severe Mons Pubis Enlargement and Ptosis\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:21\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e28.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eTransvaginal Uterine Suspension and Pelvic Reconstruction with Dermis\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:44\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e29.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSocial Media Tips from Dr Miami\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e32:08\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e30.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eAmniotic Fluid for Gyn Conditions\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e22:42\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e31.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLaparoscopic Neovagina for Shortened Vagina\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e06:01\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e32.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHigh Intensity Focused Electromagnetic Field (HIFEM) Therapy for Prolapse\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:10\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e33.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eComplicated Labiaplasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e35:31\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e34.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eBariatric Surgery 2020\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e00:07\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e35.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003e​Comparative Study on GSM: Radiofrequency (RF) vs RF + Platelet Rich Plasma\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:43\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e36.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSurvey of 200 O-Shot Recipients\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:37\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e37.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eMale Genital Cosmetics: Past, Present and Future\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:51\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e38.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eRobo-Magnetic Vaginoplasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e12:49\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e39.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eIntraurethral Erbium:YAG Laser for Prostatodynia in Men\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:49\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e40.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCombined Vaginal and Urethral Laser Therapy for Genitourinary Syndrome of Menopause\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:40\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e41.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSimultaneous Vaginal Hysterectomy and Surgical Correction of Posterior and Anterior Walls of the Vagina\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e08:58\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e42.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eNonsurgical Labiaplasty with FemTite Radiofrequency Technology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:29\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e43.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHIFEM Therapy for Pelvic Floor Dysfunction\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e35:11\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e44.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eRejuvChip Testosterone Implant Experience\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:08\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e45.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eOptimizing Feminine Intimacy \u0026amp; Aesthetics\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e24:33\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e46.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCosmetic Gynecology 2020: The State of the Art\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e10:55\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e47.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eAdvanced In-Office Therapies for Pelvic Floor Dysfunction\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e38:24\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e48.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Penuma Penile Implant is Here…It Comes in L, XL, and XXL\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e27:10\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e49.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eDr Miami Extra (Podcast)\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e53:19\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e50.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe 2020 ISCG Awards in Cosmetic Gynecology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e06:19\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e51.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eAesthetic Genital Surgery: A 20-Year Experience\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:27\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541869385,"sku":"MED-AMB03932","price":55.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/E2_80_8BISCG-2020-_E2_80_8BCosmetic-Gyn-World-Congress-Fort-Lauderdale.png?v=1781873810"},{"product_id":"iscg-2021-cosmetic-gyn-world-congress","title":"ISCG 2021 Cosmetic Gyn World Congress","description":"\u003cdiv class=\"meta-info\"\u003e\n\u003cspan class=\"meta-info__label\"\u003eDuration: \u003c\/span\u003e\u003cspan class=\"meta-info__content\"\u003e22 hours 43 minutes\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"meta-info\"\u003e\n\u003cspan class=\"meta-info__label\"\u003eAvailability: \u003c\/span\u003e\u003cspan class=\"meta-info__content\"\u003eWorldwide\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"grid-row\"\u003e\n\u003cdiv\u003e\n\u003cdiv class=\"description-wrapper\"\u003e\n\u003cdiv class=\"description series\"\u003e\n\u003cp class=\"first\"\u003eWelcome to the first live cosmetic medical and surgical congress in the western world in over 1 year. Learn how to not get crushed in the greatest cosmetic surgery economy in the history of the world. Learn world class strategies and techniques to turn your practice into the only game in town. Brilliant presentations. The latest material. Unprecedented clinical experience. This is must-see TV for your survival.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ctable class=\"ep-list\" style=\"height: 1303px;\" width=\"932\"\u003e\n\u003ctbody\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e1.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 101 Day 1\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:59:13\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e2.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 102 Day 1\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:49:16\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e3.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 103 Day 1\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:58:33\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e4.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 104 Day 1\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:35:38\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e5.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 105 Day 2\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:03:56\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e6.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 106 Day 2\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:24:38\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e7.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSessions 107 and 108 Day 2\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:48:04\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e8.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHigh Intensity Focused Electromagnetic (HIFEM) Therapy: A Clinical Study\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:26\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e9.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eRF, HIFU, HIFEM: Which is Best for Pelvic Floor Rejuvenation?\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:49\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e10.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eReconstructive Labiaplasty after Hypercorrection of the Labia Minora\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e23:47\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e11.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eFunctional Evaluation of the Pelvic Floor: A New Approach\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e08:49\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e12.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eReview of 113,000 Cases of Vaginal Erbium Laser\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:08\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e13.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eRecurrent Vaginal Candidiasis: Its Management with Lasers\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:56\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e14.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eAesthetic Laser Procedures in the Gynecologist’s Office\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:05\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e15.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLaser Posterior Colpoperineorrhaphy under Local Anesthesia\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:59\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e16.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHapiFat Vulvovaginal Fat Grafting\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:58\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e17.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eRotation Flap Technique in Labia Minora Reconstruction\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:18\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e18.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eClassification and Surgical Management of the Cesarean Scar Apron\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e25:13\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e19.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eFinancial Considerations in Cosmetic Surgery\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:27\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e20.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eOutrage and Optimism: Patient Perspective Regarding Treatment Success\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:21\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e21.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eTreatment of Stress Urinary Incontinence with PRP and Polycaprolactone (PCL) Threads.\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e16:04\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e22.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eScarless Labiaplasty with Laser\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e11:28\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e23.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLabiaplasty: 23 Pearls for 23 Years of Female Genital Cosmetic Surgery\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e22:13\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e24.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eTransvaginal Uterine Suspension using Dermal Allograft under Local Anesthesia\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:53\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e25.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCG21: Cosmetic Gynecology 2021\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:33\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e26.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eVulvar Rejuvenation with Tensioning Threads and Fillers\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e12:11\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e27.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHistological and Clinical Correlations After Vaginal Laser\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:33\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e28.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eAbdominoplasty in an Aesthetic Gynecology Practice\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e08:29\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e29.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eApplication of the CO2 Laser in Gynecological Practice\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:56\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e30.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eClitoral Hood Reduction\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:42\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e31.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eComplex Labiaplasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:44\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e32.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eMonsplasty Strategies and Techniques\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:25\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e33.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eShockwave Therapy with Platelet Rich Plasma in Cosmetic Gynecology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:22\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e34.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eNonsurgical Labiaplasty with Radiofrequency Technology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:20\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e35.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eOffice Procedures with LightScalpel CO2 Laser\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e12:13\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e36.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eVaginoplasty: 23 Pearls for 23 Years of Female Genital Cosmetic Surgery\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e23:01\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e37.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eDouble Hockey StickTechnique (DHS ) – New Technique of Labia Majora Reduction\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:24\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e38.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eManagement of the Enlarged Ptotic Mons Pubis\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e25:23\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e39.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003ePerineal Band Release for Introital Dsypareunia\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:22\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e40.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eMale Genital Aesthetics\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:53\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e41.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eTreatment of Urinary Incontinence with PDO Threads in the Office\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:03\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e42.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eRobotic Vaginoplasty under Local Anesthesia with No Human Assistants\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:18\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e43.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eMale Aesthetic Penile Implants\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:26\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e44.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Vampire Wing Lift\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e10:19\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e45.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eTransgender FTM Mastectomy under Local Anesthesia\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e12:34\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e46.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCellulite Ablation Technique and Management of Complications\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e12:26\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e47.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eBONUS VIDEO: Simplified Vaginal Hysterectomy – The Ten Minute Vaginal Hysterectomy\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:13\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662541902153,"sku":"MED-AMB03933","price":65.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/ISCG-2021-Cosmetic-Gyn-World-Congress.jpg?v=1781873810"},{"product_id":"iscg-2022-cosmetic-gyn-body-contouring-3-day-world-congress","title":"ISCG 2022 Cosmetic Gyn \u0026 Body Contouring 3-Day World Congress","description":"\u003ch3 class=\"meta-info\"\u003eISCG 2022 Cosmetic Gyn \u0026amp; Body Contouring 3-Day World Congress\u003c\/h3\u003e\n\u003cdiv class=\"meta-info\"\u003eMINDBLOWING! The Best in the World of Cosmetic Gyn \u0026amp; Body Contouring, The World’s Top 3 Social Media Celebrity Docs shared how they do it and how you can do it, Dr Miami, Dr HiDef, Real Dr Feelgood, the latest techniques from Alinsod, Pelosi \u0026amp; Pelosi, Kuzlik, Serafin, Gaspar, Gaviria, Goodman…too many to list, business lectures from the mavericks of aesthetics and industry pros. Even a full-on Spanish session. They all said this was the best meeting they have ever attended. Now you can see every minute of this amazing meeting and relive the action over and over again.\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eHope Page : https:\/\/vimeo.com\/ondemand\/iscg2022\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003ctable class=\"ep-list\" style=\"height: 2132px;\" width=\"1146\"\u003e\n\u003ctbody\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e1.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 101\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:56:12\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e2.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 102\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:56:59\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e3.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 103\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:23:20\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e4.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 104 Spanish Session\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e2:18:24\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e5.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 105 Marketing, Hormones \u0026amp; The O-Shot\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:58:33\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e6.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 106 Business, Social Media, Cosmetic Urology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e2:07:58\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e7.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 107 Dr Miami, Real Dr Feelgood \u0026amp; Dr HiDef\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e2:03:12\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e8.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 108\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e2:29:29\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e9.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 109\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:55:30\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e10.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 110\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e1:45:43\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e11.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eSession 111 and 112\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e2:03:53\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e12.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eBody Dysmorphic Disorder\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e22:16\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e13.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCystorectocele Sling \u0026amp; TOT under Local\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:38\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e14.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLaser LeFort Colpocleisis under Local\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:36\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e15.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eAugmented Pelvic Floor Repair with Graft\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:28\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e16.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eMommy Makeover and the Pelosi Cesarean Apron\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e25:13\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e17.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThighplasty Refinements to Avoid Complications\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:14\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e18.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eInnovative Treatment Options for Pelvic Pain\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e10:49\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e19.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eComplex Labia Minora Reconstruction after Botched Labiaplasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e16:24\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e20.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eReconstruction of Complete Clitoral Absence after FGM\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e11:31\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e21.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003ePlatelet Growth Factors versus Hyaluronic Acid in Managing GSM\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:55\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e22.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eTrim Labiaplasty: What are the Limits?\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e11:08\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e23.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eA Novel Technique to Prevent Umbilical Sagging after Liposuction\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:36\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e24.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003ePerineal Rehabilitation: Why and How to Have it in Your Clinic\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e09:59\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e25.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eManagement of Recurrent Vulvar Fissures with Diode Laser and Injectable PRP\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e10:51\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e26.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLichen Sclerosus: Experience with Multimodal Management\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:34\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e27.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Vagina Enigma: Gaps in Women’s Wellness Screening\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:25\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e28.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eAusterlitz vs Armageddon: How to Win the War in Noninvasive Cosmetic Gynecology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e16:11\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e29.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLabiaplasty: Wedge vs Linear: Which Should You Choose\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e31:02\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e30.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eElectromagnetism in Cosmetic Gynecology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:37\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e31.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Buried Clitoris: Release and Maintenance\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:24\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e32.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Most Common Mistakes during Labiaplasty Requiring a Second Surgery\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e28:57\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e33.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eTranexamic Acid in Local Anesthesia for Female Genital Surgery\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e08:14\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e34.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCosmetic Gynecology 2022: The War\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:58\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e35.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eStewards of the Penis\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:23\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e36.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Penuma Implant: Clinical Update\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:22\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e37.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Adoption of an Aesthetic Practice Business Platform\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:29\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e38.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCellulite Surgical Therapy\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:22\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e39.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eRunning a Successful Aesthetic Business Practice\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:29\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e40.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eMedspa Mastery\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e40:21\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e41.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Dr Miami Experience\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e51:11\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e42.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHand Rejuvenation with Microfat and the Picosecond Laser\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:26\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e43.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Use of Autologous Fat in Urogynecology.mp4\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e14:01\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e44.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eGenital Bleaching Single Session Protocol.mp4\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:13\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e45.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHormones, Peptides, and Regenerative Medicine\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e10:52\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e46.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eVulvectomy and Simultaneous Reconstruction\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e08:36\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e47.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eClitoral Repositioning\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e10:20\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e48.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eVaginoplasty: How to Achieve the Best Results Consistently\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:17\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e49.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eFemtite Scarless Labiaplasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:15\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e50.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eIntimate Wellness Marketing\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e21:31\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e51.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eO-Shot Update and Variations\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e16:23\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e52.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003ePlasma Jet Therapy in Cosmetic Gyn\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e21:34\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e53.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHigh Contrast BBL\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e25:07\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e54.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHigh Def Liposuction Pearls and Post Op Care Review\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e27:25\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e55.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLaunching High Def Liposuction in a Urology Practice\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:53\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e56.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eCosmetic Breast Surgery in Aesthetic Gynecology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e11:41\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e57.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003e2000 Breast Augmentations under Local Anesthesia\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e24:54\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e58.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eIncontinence Therapy with Empower and Morpheus Radio Frequency\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e22:42\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e59.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eStaple Shape Breast Augmentation-Mastopexy\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e30:07\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e60.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLabiaplasty: The Stigma Persists\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e12:30\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e61.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eComplex Labiaplasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:04\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e62.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Nanofat O-Shot\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:34\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e63.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eUrogenital Pain in the Absence of Urogenital Pathology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e23:24\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e64.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eMenopause Management to the Max\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e20:22\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e65.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eVulvar Flap Reconstruction for Botched Labiaplasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e09:44\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e66.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eManagement of Prostatodynia with Intraurethral Laser\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e13:06\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e67.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Perfect Labiaplasty: Step by Step\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e26:43\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e68.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eDermal Allograft Pelvic Floor Repair\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e19:20\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e69.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eHyaluronic Acid for Labia Majora Deflation in Young Women\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e24:17\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e70.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eLabia Majoraplasty\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e21:37\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e71.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eThe Luksenburg System for Stress Urinary Incontinence\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:23\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e72.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eEN ESPANOL: Electromagnetismo en Cosmetogynecology\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e18:49\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e73.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eEN ESPANOL: Pigmentación Intima Abordaje Terapéutico\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e17:26\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e74.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eEN ESPANOL: Factores de Crecimiento Plaquetario vs Ácido Hialurónico\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e23:32\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e75.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eEN ESPANOL: Técnicas con Colgajo Vulvar para la Reconstrucción de Los Labios Menores\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e15:25\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e76.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eEN ESPANOL: Rejuvenecimiento de Las Manos\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e16:20\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e77.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eEN ESPANOL: El Sistema Luksenburg\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e23:35\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr class=\"\"\u003e\n\u003ctd class=\"ep-list__count\"\u003e78.\u003c\/td\u003e\n\u003ctd class=\"ep-list__title\"\u003eEN ESPANOL: Manejo de Fisura Vulvar Recidivante\u003c\/td\u003e\n\u003ctd class=\"ep-list__duration\" colspan=\"2\"\u003e11:55\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662542000457,"sku":"MED-AMB03931","price":80.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/ISCG-2022-Cosmetic-Gyn-Body-Contouring-3-Day-World-Congress.png?v=1781873811"},{"product_id":"2021-prostate-mri-program-1","title":"2021 Prostate MRI (Program 1) – John F. Feller, M.D(vedio)","description":"\u003ch3\u003eProstate  (MRIProgram 1) – John F. Feller, M.D. (Science) (Videos)\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eEdition : 2021\u003cbr\u003eFormat : 3 MP4\u003cbr\u003eFile Size : 586 MB\"\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eEducational Objectives\u003c\/h3\u003e\u003cbr\u003eAt the conclusion of this activity, participants should better be able to:\u003cbr\u003e\u003cbr\u003eDescribe recent advances and techniques in prostate imaging.-Describe the imaging anatomy and protocols that are necessary to arrive at a diagnosis of prostate diseases.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eJohn F. Feller, M.D.\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e• Medical Director \u0026amp; Founder – Desert Medical Imaging\u003cbr\u003e\u003ch4\u003e• Chief of Radiology – American Medical Center, Shanghai, China\u003c\/h4\u003e\u003cbr\u003eDr. John F. Feller is a founding partner of Desert Medical Imaging and currently the Chief Medical Officer for HALO Diagnostics. He is board-certified as a Diagnostic\u003cbr\u003eRadiologist with sub-specialties in Orthopedic \u0026amp; Sports Medicine Imaging, Body MRI, and holds a Level II Cardiac CT certification. Dr. Feller is also a partner in China’s\u003cbr\u003efirst American-owned multi-disciplinary outpatient healthcare facility, and serves as director of radiology.\u003cbr\u003eAfter completing a Bachelor’s degree in Metallurgical Engineering and Material Science at the University of Notre Dame, Dr. Feller graduated Summa Cum Laude from\u003cbr\u003eOhio State University School of Medicine, then an internship, residency, and fellowship training at Stanford University School of Medicine.\u003cbr\u003eServing as a United States Air Force (USAF) officer, Dr. Feller was the Chief of MRI at the David Grant USAF Medical Center for four years, while maintaining an academic\u003cbr\u003eaffiliation with Stanford as an Assistant Clinical Professor in the Department of Radiology, an affiliation that lasted 15 years. Currently, Dr. Feller is an Assistant Clinical Professor at Loma Linda University’s Department of Radiology.\u003cbr\u003e\u003ch3\u003e• Release date: May 28, 2021\u003c\/h3\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e• Estimated time to complete activity: 2 hours\u003c\/strong\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662542065993,"sku":"MED-AMB03918","price":55.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/2021-Prostate-MRI-Program-1-_E2_80_93-John-F.-Feller-M.D.jpg?v=1781873810"},{"product_id":"46th-annual-seminar-pathology","title":"46th Annual Seminar Pathology Review 2025 (Videos with subtitles + Slides)","description":"\u003cdiv class=\"custom-single-product product type-product post-425153 status-publish first instock product_cat-hot-books product_cat-gastroenterology-ebooks product_cat-general-internal-medicine product_cat-obstetrics-gynecology product_cat-urology product_cat-videos has-post-thumbnail sale downloadable virtual purchasable product-type-simple\" id=\"product-425153\"\u003e\n\u003cdiv class=\"single-product-desc\"\u003e\n\u003cdiv class=\"woo-tab-container\"\u003e\n\u003cdiv class=\"tabcontent\" id=\"descriptionTab\"\u003e\n\u003cdiv class=\"prod-desc\"\u003e\n\u003ch3\u003e46\u003csup\u003eth\u003c\/sup\u003e Annual Seminar, Pathology Review: Practical Updates in Breast, Gastrointestinal and Genitourinary Pathology for the General Pathologist\u003c\/h3\u003e\n\u003cstrong\u003eAbout the Meeting\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis seminar has been designed to provide an extensive overview of some of the most common areas of diagnostic difficulty encountered by practicing surgical pathologists in the areas of breast, gastrointestinal, and genitourinary pathology. This course will provide details of some of the most important diagnostic features which allow pathologists to make accurate diagnoses in each of these subspecialized areas, as well as how to assess essential diagnostic clues and avoid the most common misdiagnoses. In each lecture, there will also be a thorough discussion on the use of ancillary diagnostic techniques, including immunohistochemistry and molecular diagnostics. There will also be interactive case-based review sessions and sufficient time for interactive discussions between all of the faculty members and participants.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cbr\u003e46th Annual Seminar Pathology Review 2025\u003cbr\u003e\u003cdiv class=\"prod-desc\"\u003e\n\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis CME activity is primarily intended and designed to educate pathologists.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEducational Objectives\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eAttendees should, at the completion of this course, be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eRecognize the most common and more recently described renal cell tumors\u003c\/li\u003e\n\u003cli\u003eIdentify some of the most common pitfalls in the diagnosis of biopsies of the urinary bladder and prostate\u003c\/li\u003e\n\u003cli\u003eList the most common tumors encountered in the male genitourinary tract\u003c\/li\u003e\n\u003cli\u003eExplain the most appropriate handling and staging of renal tumors\u003c\/li\u003e\n\u003cli\u003eDescribe some of the newest forms of esophagitis\u003c\/li\u003e\n\u003cli\u003eIdentify the various patterns of gastritis and gastropathy\u003c\/li\u003e\n\u003cli\u003eList the most common pitfalls in duodenal biopsy interpretation\u003c\/li\u003e\n\u003cli\u003eDefine the most common inflammatory patterns in colorectal biopsy specimens\u003c\/li\u003e\n\u003cli\u003eRecognize the most common diagnostic pitfalls in breast core biopsies\u003c\/li\u003e\n\u003cli\u003eReview the essential features of triple-negative breast cancer\u003c\/li\u003e\n\u003cli\u003eDescribe the most common changes in post neoadjuvant treatment breast specimens\u003c\/li\u003e\n\u003cli\u003eExplain biomarker testing in breast cancer\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eCourse Organization\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis program is planned and organized by Educational Symposia, a leader in accredited continuing education since 1975.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cbr\u003e46th Annual Seminar Pathology Review 2025\u003cbr\u003e\u003cdiv class=\"prod-desc\"\u003e\n\u003ch3\u003eProgram\u003c\/h3\u003e\n\u003cstrong\u003eSUNDAY, FEBRUARY 9, 2025\u003c\/strong\u003e\n\u003cbr\u003e\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e3:00 - 4:00 PM\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eRegistration and Welcome Reception\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cstrong\u003eMONDAY, FEBRUARY 10, 2025\u003c\/strong\u003e\n\u003cbr\u003e\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e6:30 AM\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eRegistration \u0026amp; Breakfast for Registrants\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6:45–7:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eInterpretations of Breast Core Biopsies: An Assortment of Common Diagnostic Challenges\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eHannah Wen, M.D., Ph.D.\u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:45–8:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eWhat's New in Esophagitis?\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eRhonda K. Yantiss, M.D.\u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e8:45–8:50\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eCoffee Break \u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:50–9:50\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eThe Spectrum of Triple Negative Breast Cancer\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eHannah Wen, M.D., Ph.D. \u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:50–10:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eGastritis and Gastropathy\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eRhonda K. Yantiss, M.D. \u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10:45 AM\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eEnd of Session\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cstrong\u003eTUESDAY, FEBRUARY 11, 2025\u003c\/strong\u003e\n\u003cbr\u003e\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e6:30 AM\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreakfast for Registrants \u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6:45–7:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003ePattern-Based Approach to Renal Cell Tumors\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eSean R. Williamson, M.D.\u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:45–8:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003ePathologic Evaluation of Breast Specimens Post Neoadjuvant Treatment\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eHannah Wen, M.D., Ph.D.\u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e8:45–8:50\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eCoffee Break\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:50–9:50\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eBladder Cancer Pathology Updates\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eSean R. Williamson, M.D. \u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:50–10:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eSlide Seminar: Special Subtypes of Triple Negative Breast Cancer\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eHannah Wen, M.D., Ph.D.\u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10:45 AM\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eEnd of Session\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cstrong\u003eWEDNESDAY, FEBRUARY 12, 2025\u003c\/strong\u003e\n\u003cbr\u003e\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e6:30 AM\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreakfast for Registrants\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6:45–7:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eProstate Cancer Pathology Updates\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eSean R. Williamson, M.D.\u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:45–8:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003ePractical Approach to Duodenal Biopsy Interpretation\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eRhonda K. Yantiss, M.D.\u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e8:45–8:50\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eCoffee Break\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:50–9:50\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eSlide Seminar: Interesting Cases in Genitourinary Pathology\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eSean R. Williamson, M.D.\u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:50–10:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eInflammatory Patterns in Colonic Biopsy Samples\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eRhonda K. Yantiss, M.D.\u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10:45 AM\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eEnd of Session\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cstrong\u003eTHURSDAY, FEBRUARY 13, 2025\u003c\/strong\u003e\n\u003cbr\u003e\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e6:30 AM\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreakfast for Registrants\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6:45–7:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eSlide Seminar: Spindle Cell Lesions of the Breast\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eHannah Wen, M.D., Ph.D. \u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:45–8:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eRecognizing Sneaky Cancers in Gastric Biopsies and How to Work Them Up\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eRhonda K. Yantiss, M.D.\u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e8:45–8:50\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eCoffee Break\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:50–9:50\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eCommon Issues in Male Genital Pathology\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eSean R. Williamson, M.D.\u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:50–10:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eBreast Pathology in the Era of Genomics\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eHannah Wen, M.D., Ph.D. \u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10:45 AM\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eEnd of Session\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cstrong\u003eFRIDAY, FEBRUARY 14, 2025\u003c\/strong\u003e\n\u003cbr\u003e\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e6:30 AM\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBreakfast for Registrants\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6:45–7:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eThe Differential Diagnosis of Ischemic Colitis\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eRhonda K. Yantiss, M.D. \u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7:45–8:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eBiomarker Testing in Breast Cancer\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eHannah Wen, M.D., Ph.D. \u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e8:45–8:50\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eCoffee Break\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e8:50–9:50\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eAnal Pathology 101: HPV-Related Lesions and Other Important Findings\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eRhonda K. Yantiss, M.D. \u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e9:50–10:45\u003c\/td\u003e\n\u003ctd\u003e\n\u003cdiv\u003eStaging and Handling of Renal Tumors\u003c\/div\u003e\n\u003cdiv\u003e\u003cem\u003eSean R. Williamson, M.D.\u003c\/em\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003e10:45 AM\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eEnd of Program\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003caside class=\"section-product__sidebar\"\u003e\n\u003cdiv class=\"prods-widget\"\u003e\u003c\/div\u003e\n\u003c\/aside\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662552715593,"sku":"MED-AMB03880","price":160.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/46th-Annual-Seminar-Pathology-Review.jpg?v=1781873810"},{"product_id":"ucla-state-of-the-art-urology-2021","title":"UCLA State-of-the-Art Urology 2021","description":"\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003ch1\u003eUCLA State-of-the-Art Urology 2021\u003c\/h1\u003e\n\u003cbr\u003eUCLA Urology 2021\u003cbr\u003e\u003cdiv aria-labelledby=\"tab-title-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" id=\"tab-description\" role=\"tabpanel\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv class=\"panel entry-content active\" id=\"tab-description\"\u003e\n\u003ch4\u003eTOPICS \/ SPEAKERS\u003c\/h4\u003e\n\u003cp class=\"product-tab-content\"\u003eMale and Female Voiding Dysfunction, Reconstruction, Urethral Stricture Disease\u003c\/p\u003e\n\u003cbr\u003eUCLA State-of-the-Art Urology 2021\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEvaluation and Treatment of Mixed Urinary Incontinence in Women 2021\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eVictor W. Nitti, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTips on 3rd Line Therapies for Overactive Bladder – Videos Included\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eKathleen C. Kobashi, MD, FACS\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEvaluation and Management of Recurrent UTIs in Women\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eKathleen C. Kobashi, MD, FACS\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eValue of Genetic Testing and Next Generation Sequencing in Diagnosis of UTI\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eA. Lenore Ackerman, MD, PhD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePanel Discussion: Voiding Dysfunction and UTIs in Women\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eAudience Questions – Case Presentations\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eModerator: Dr. Ja-Hong Kim\u003cbr\u003ePanel: Drs. Ackerman, Baxter, Kobashi, and Nitti\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManagement of Urethral Stricture Disease in 2021: Dilation, Incision, Reconstruction\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eKurt A. McCammon, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnderactive Bladder and Bladder Outlet Obstruction in Men: Is Surgery Indicated?\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eVictor W. Nitti, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAre Male Slings a Good Option for Mild and Moderate Stress Incontinence in Men?\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eKurt A. McCammon, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eUCLA State-of-the-Art Urology 2021\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePanel Discussion: Male Voiding Dysfunction\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eAudience Questions – Case Presentations\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eModerator: Dr. Victor W. Nitti\u003cbr\u003ePanel: Drs. Baxter, Kim, Kobashi, and McCammon\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"product-tab-content\"\u003eUrolithiasis\/Endourology\u003c\/p\u003e\n\u003cbr\u003eUCLA State-of-the-Art Urology 2021\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic Evaluation and Medical Management of Urolithiasis: A Simplified Approach (Stone Tree)\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eRalph V. Clayman, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAntibiotic Use: Managing Pre and Post-Op Infections in Patients Undergoing Endoscopic Surgery\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eMatthew Dunn, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDeath of the PCNL – Increasing Utilization of Ureteroscopy Now and in the Future\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eRalph V. Clayman, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUreteral Stents – A Love\/Hate Relationship\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eKymora Scotland, MD, PhD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePanel Discussion – Audience Questions – Case Presentations\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eModerator: Dr. Matthew Dunn\u003cbr\u003ePanel: Drs. Clayman and Scotland\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eUCLA State-of-the-Art Urology 2021\u003cbr\u003e\u003cp class=\"product-tab-content\"\u003eMen’s Health – Penile Rehab, Priapism, Anorgasmia\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRehab of the Penis Post-Prostatectomy – The Hopkins Experience\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eArthur L. Burnett, MD, MBA\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHow and Why to Set Up a Men’s Health Clinic\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eJesse N. Mills, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMedical and Surgical Approaches to Priapism\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eArthur L. Burnett, MD, MBA\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnorgasmia: What, Why, and How to Treat\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eSriram Eleswarapu, MD, PhD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePanel Discussion – Audience Questions – Case Presentations\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eModerator: Dr. Jacob Rajfer\u003cbr\u003ePanel: Drs. Burnett, Eleswarapu, and Mills\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"product-tab-content\"\u003eVideo Sessions\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eUCLA State-of-the-Art Urology 2021\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSingle Port Robotic Surgery – Does This Advance Our Field?\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eArnold I. Chin, MD, PhD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRobotic Radical Prostatectomy – Techniques for Optimizing Continence, Potency, and Negative Margins\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eRobert E. Reiter, MD, MBA\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"product-tab-content\"\u003eProstate Cancer\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e10 Debunked Myths About Prostate Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eScott Eggener, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImproving the Quality of Decision Making in Prostate Cancer Using Shared Decision Making\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eChristopher S. Saigal, MD, MPH\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonalizing Adjuvant vs. Early Salvage Radiotherapy\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eDaniel E. Spratt, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFocal Therapy for Prostate Cancer – State of the Art\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eScott Eggener, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eActive Surveillance in 2021: Update on Intensity of Follow Up and Inclusion of 3+4 Disease\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eLeonard S. Marks, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePanel Discussion – Audience Questions – Case Presentations\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eModerator: Dr. Mark S. Litwin\u003cbr\u003ePanel: Drs. Eggener, Marks, Reiter, Saigal, and Spratt\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonalizing Hormone Therapy with Radiation Therapy Role for Biomarkers\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eDaniel E. Spratt, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManagement of Oligometastatic Disease in the World of PSMA Imaging\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eRobert E. Reiter, MD, MBA\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUpdate on Therapy for Advanced Prostate Cancer Integrating Genetic Testing\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eMatthew Rettig, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePanel Discussion – Audience Questions – Case Presentations\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eModerator: Dr. Mark S. Litwin\u003cbr\u003ePanel: Drs. Eggener, Marks, Rettig, Reiter, and Spratt\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"product-tab-content\"\u003eBladder Cancer\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNew Advances in Bladder Cancer in 2021\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eKarim Chamie, MD, MSHS\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUpdates for Non-Muscle Invasive Bladder Cancer During BCG Shortage\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eSam S. Chang, MD, MBA\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdvances in Upper Tract Urothelial Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eSam S. Chang, MD, MBA\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePanel Discussion and Case Presentations\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eModerator: Dr. Mark S. Litwin Panel: Drs. Chamie, Chang, Chin, Drakaki, and Kishan\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"product-tab-content\"\u003eTestis Cancer\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEverything a Urologist Needs to Know About Testis Cancer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eScott Eggener, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePanel Discussion – Audience Questions – Case Presentations\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eModerator: Dr. Stanley K. Frencher, Jr.\u003cbr\u003ePanel: Drs. Eggener, Drakaki, and Litwin\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"product-tab-content\"\u003eKidney Cancer\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRole for Elective Radical Nephrectomy for T1B\/T2A Renal Tumors\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eBrian Shuch, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManagement Considerations for Bilateral\/Multifocal Renal Tumors\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eBrian Shuch, MD\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePanel Discussion and Case Presentations\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e\u003cem\u003eModerator: Dr. Brian Shuch\u003cbr\u003ePanel: Drs. Chamie, Liu, Padia, Pantuck and Ye...\u003c\/em\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e ","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662552682825,"sku":"MED-AMB03530","price":50.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Capture-2-1.jpg?v=1781873811"},{"product_id":"new-vistas-in-prostate-cancer-imaging","title":"New Vistas in Prostate Cancer Imaging 2022","description":"\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003cbr\u003e\u003cbr\u003eAs the need to identify and treat prostate cancer increases, imaging is a critical tool in its diagnosis, staging and surveillance.  \u003cstrong\u003e\u003cem\u003eNew Vistas in Prostate Cancer Imaging\u003c\/em\u003e\u003c\/strong\u003e is designed to help radiologists, oncologists, radiation oncologists and urologists master this continually evolving technology.  This activity analyzes the two most promising imaging modalities for prostate cancer: multiparametric MRI and PSMA PET\/CT.  Essential concepts and multiple cases in both modalities are reviewed throughout the course, ensuring the audience a well rounded primer in the visualization and examination of this disease.\u003cbr\u003e\u003cdiv class=\"single-main-content\"\u003e\n\u003cstrong\u003eNew Vistas in Prostate Cancer Imaging\u003c\/strong\u003e\n\u003cbr\u003e\u003chr align=\"center\" width=\"95%\"\u003e\n\u003ctable border=\"0\" cellpadding=\"2\" cellspacing=\"2\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 1: Prostate MRI Intro, Protocols and Interpretation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntroduction: Continuing and Emerging Roles for  Prostate Imaging\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMastering Multiparametric MRI Prostate Protocols\u003c\/td\u003e\n\u003ctd\u003eAngabeen Khan, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnatomy of the Prostate With MRI: Pearls and Pitfalls\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGamuts of Prostate mpMRI Interpretation\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 2: PIRADSv2.1,  MRI-Targeted Biopsy \u0026amp; Extra Prostatic Findings\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePIRADSv2.1 Lexicon: Case Based Atlas and Structured Reporting\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCase Conference\u003c\/td\u003e\n\u003ctd\u003eMultiple Speakers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQuestions and Answers\u003c\/td\u003e\n\u003ctd\u003eMultiple Speakers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExtra Prostatic Findings on mpMRI\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMR\/TRUS Fusion Prostate Biopsy\u003c\/td\u003e\n\u003ctd\u003eJoseph Brito, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMR Directed Biopsy: Inbore Biopsy and Developing Inbore Applications\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 3: Prostate MRI Staging and Controversies\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProstate MRI for Staging of Prostate Cancer\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eControversies in Prostate Imaging: Biparamteric vs mpMRI and Beyond\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQuestions and Answers\u003c\/td\u003e\n\u003ctd\u003eMultiple Speakers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCase Conference 2\u003c\/td\u003e\n\u003ctd\u003eMultiple Speakers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 4: Multiparametric MRI Cases\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 1\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 2\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 3\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 4\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 5\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 6\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 7\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 8\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 9\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 10\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 11\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 12\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 5: Prostate Cancer PET\/CT Imaging Primer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eThe Basics of Prostate Cancer\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePET\/CT Applications With FDG and NAF\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eApproved Functional Imaging\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT- Ga68 PET\/CT\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT F-18 Pyl and F-18 1007\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA Therapy\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 6: Axumin, PET-C11 Choline and Best Practices\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eThe Changing Prostate Panorama: Axumin (18Fluciclovine) and Its Role in Biochemically Recurrent Prostate Cancer\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePET C-11 Choline Imaging and Other Radiotracers\u003c\/td\u003e\n\u003ctd\u003eMark Muscato, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAppropriate Patient Selection\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMaximizing Clinical Performance Case Review\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 7: PSMA PET\/CT Cases\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 1\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 2\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 3\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 4\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 5\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 6\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 7\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 8\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 9\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 10\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 11\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 12\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 13\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 8:  Community Challenges and Looking Ahead\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOvercoming Challenges to Prostate Imaging Within the Community Center\u003c\/td\u003e\n\u003ctd\u003eMark Muscato, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpace OAR and Beyond: What the Radiation Oncologists Need To Know\u003c\/td\u003e\n\u003ctd\u003eAngabeen Khan, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSeamless Integration of Fusion Biopsy Within the Community Practice: Case Based Approach\u003c\/td\u003e\n\u003ctd\u003eMultiple Speakers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFuture Horizons for Prostate Imaging: AI, Personalized Care and Prostate Radiogenomics\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cstrong\u003eRelease date: May 1, 2022\u003cbr\u003eExpiration date: April 30, 2025\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662552879433,"sku":"MED-AMB03529","price":28.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Pro001_lg-1.jpg?v=1781873811"},{"product_id":"harvard-21st-biennial-course-in-urologic","title":"Harvard 21st Biennial Course in Urologic Oncology 2022","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003ch2\u003eHarvard 21st Biennial Course in Urologic Oncology 2022\u003c\/h2\u003e\n\u003cbr\u003eBiennial Course in Urologic Oncology\u003cbr\u003e\u003cbr\u003e\u003cspan style=\"color: #1b1919; font-size: 24px;\"\u003e2022 Course Overview\u003c\/span\u003e\n\u003cbr\u003e\u003cdiv aria-labelledby=\"tab-title-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" id=\"tab-description\" role=\"tabpanel\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cbr\u003e\u003cbr\u003eBiennial Course in Urologic Oncology Beginning in 1982, the multidisciplinary Urologic Cancer Course was designed as a biennial course bringing together expertise from all the Harvard teaching hospitals in conjunction with invited world class experts in urologic oncology, medical oncology, and radiation oncology. Dr Marc B. Garnick led the course from 1982 to 1996 at which time Dr Jerome P. Richie assumed the leadership until 2014. Dr. Phillip W. Kantoff then led the course and subsequently in 2016 Dr Adam Kibel, Dr Toni Choueiri and Dr. Anthony V D’Amico co-led the course.\u003cbr\u003e\u003cbr\u003eBiennial Course in Urologic Oncology In 2022 our keynotes will be delivered by 2 internationally renowned scholars. Dr. George Daley Dean of Harvard Medical School and Dr. Lindsey Baden Principle Investigator of the Covid Moderna Trial.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003ch3 class=\"variant-1\"\u003eWho Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePrimary Care Physicians\u003c\/li\u003e\n\u003cli\u003eSpecialty Physicians\u003c\/li\u003e\n\u003cli\u003eNurses\u003c\/li\u003e\n\u003cli\u003eNurse Practitioners\u003c\/li\u003e\n\u003cli\u003ePharmacists\u003c\/li\u003e\n\u003cli\u003ePhysician Assistants\u003c\/li\u003e\n\u003cli\u003ePsychologists\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"variant-1\"\u003eLearning Objectives\u003c\/h3\u003e\n\u003cbr\u003eUpon completion of this activity, participants will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDemonstrate the optimal management of oligometastatic prostate, bladder, renal cancer\u003c\/li\u003e\n\u003cli\u003eExplain the role of immunotherapy in the management of bladder, prostate and renal cancer\u003c\/li\u003e\n\u003cli\u003eDetermine how to incorporate genomic classifiers, multiple parametric MRI, and clinical parameters into selecting optimal patients with prostate cancer for active surveillance or other definitive management approaches\u003c\/li\u003e\n\u003cli\u003eApply Level 1 evidence on the use of novel treatment paradigms and updated surveillance options for patients with prostate, renal, bladder, or testicular cancer\u003c\/li\u003e\n\u003cli\u003eApply novel minimally invasive treatments for GU malignancies including prostate, bladder and kidney cancer\u003c\/li\u003e\n\u003cli\u003eUse multiparametric MRI, fusion biopsy and novel markers in men at risk for prostate cancer\u003c\/li\u003e\n\u003cli\u003eBiennial Course in Urologic Oncology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003ch2 class=\"component-title field__item\"\u003e2022 Agenda\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003ch3 class=\"variant-1\"\u003eInformation for the 2023 course is not yet available.\u003c\/h3\u003e\n\u003cbr\u003eBiennial Course in Urologic Oncology\u003cbr\u003e\u003cbr\u003eAll agenda sessions are in Eastern Time.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"bundle--hms_program_details_list paragraph paragraph--type--hms-program-details-list paragraph--view-mode--default open\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12\"\u003e\n\u003cdiv class=\"hms-program-details-list--items field-wrapper field field--name-field-hms-pdl-item field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cstrong\u003eTHURSDAY, OCTOBER 13, 2022\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e7:15 – 8:00 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eRegistration\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:00 – 8:05 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eWelcome\u003cbr\u003eAnthony D’Amico\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:05 – 8:20 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eEpidemiology and Genetics\u003cbr\u003eLorelei Mucci\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:20 – 8:35 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eScreening in 2022: Role of PSA and Novel Biomakers\u003cbr\u003eAdam Kibel\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:35 – 8:50 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eAdvanced in Multiparametric MRI for Diagnosis and Staging\u003cbr\u003eClare Tempany\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:50 – 9:05 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eInterpreting Prostrate Biopsy Reports\u003cbr\u003eMichelle Hirsch\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e9:05 – 9:30 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eExpert Panel: Screening and Diagnosis\u003cbr\u003eModerator: Anthony D’Amico\u003cbr\u003eSpeakers: Michelle Hirsch, Adam Kibel, Lorelei Mucci and Clare Tempany\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e9:30 – 10:00 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eBreak\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:00 – 10:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eFocal Ablation and Active Surveillance in Intermediate Risk Disease\u003cbr\u003eAlexander Cole\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:15 – 10:30 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eRadical Prostatectomy in Intermediate Risk Disease\u003cbr\u003eQuoc-Dien Trin\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:30 AM – 10:45 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eHypofractionation and ADT use in Intermediate Risk Prostate Cancer\u003cbr\u003eNeil Martin\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:45 – 11:00 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eMRI Guided Radiation therapy\u003cbr\u003eJonathan Leeman\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:00 – 11:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eOptimizing Systemic Therapy in the Management of Intermediate and High-Risk Prostate Cancer\u003cbr\u003eAnthony D’Amico\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:15 – 11:30 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eNovel Approaches in the Preoperative Setting for the High-Risk Patient\u003cbr\u003eMary-Ellen Taplin\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:30 – 11:45 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eBiomarker Based Clinical Trials and Prostate Cancer\u003cbr\u003eMartin Gleave\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:45 AM – 12:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eExpert Panel: Patient Selection\u003cbr\u003eModerator: Anthony D’Amico\u003cbr\u003eSpeakers: Alexander Cole, Martin Gleave, Jonathan Leeman, Neil Martin, Mary-Ellen Taplin, Quoc-Dien Trinh\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:15 – 1:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eLunch\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:00 – 1:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003ePET Imaging in the PSA Recurrent Setting-Diagnostics\u003cbr\u003eHeather Jacene\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:15 – 1:30 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eTreatment of Oligo Metastatic Disease, Integration of Surgery\u003cbr\u003eSpeaker: Martin Gleave\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:30 – 1:45 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eTreatment of Oligo Metastatic Disease, Integration of Radiation\u003cbr\u003ePaul Nguyen\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:45 – 2:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003ePrecision Medicine in Prostate Cancer\u003cbr\u003eHimisha Beltran\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:00 – 2:30 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eExpert Panel: Updates in Diagnostics and Special Populations\u003cbr\u003eModerator: Adam Kibel\u003cbr\u003eSpeakers: Himisha Beltran, Martin Gleave, Heather Jacene and Paul Nguyen\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:30 – 2:45 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eBreak\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:45 – 3:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eAdjuvant versus Salvage Radiation\u003cbr\u003eAnthony D’Amico\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:00 – 3:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eManagement of the Rising PSA in the Patient with M0 Castrate Sensitive Prostate Cancer\u003cbr\u003eCharles Ryan\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:15 – 3:30 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eManagement of Advanced Prostate Cancer in the Elderly\u003cbr\u003eAlicia Morgans\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:30 – 3:45 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eSurvivorship and Side effects of ADT\u003cbr\u003ePhil Saylor\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:45 – 4:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eManagement of Side Effects of Radical Prostatectomy in the Denovo and Recurrent Settings\u003cbr\u003ePeter Chang\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e4:00 – 4:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eManagement of Side Effects of Radiation Therapy in the Denovo and Recurrent Settings\u003cbr\u003eDaniel Schmidt\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e4:15 – 4:30 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eManagement of the Side Effects of Non-ADT Systemic Treatment for Prostate Cancer\u003cbr\u003eMark Pomerantz\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e4:30 – 5:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eExpert Panel: Management of Treatment Related Toxicity and Recurrent Disease\u003cbr\u003eModerator: Adam Kibel\u003cbr\u003eSpeakers: Peter Chang, Anthony D’Amico, Alicia Morgans, Mark Pomerantz, Charles Ryan, Phil Saylor and Daniel Schmidt\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"bundle--hms_program_details_list paragraph paragraph--type--hms-program-details-list paragraph--view-mode--default open\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12\"\u003e\n\u003cdiv class=\"hms-program-details-list--items field-wrapper field field--name-field-hms-pdl-item field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 hms-program-details-list--term\"\u003e\u003cstrong\u003eFRIDAY, OCTOBER 14, 2022\u003c\/strong\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:00 AM – 8:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eManagement of the Rising PSA in the Patient with M0 Castrate Resistant Prostate Cancer\u003cbr\u003eAtish Choudhury\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:15 – 8:30 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003ePersonalizing Treatment Selection in Metastatic, Hormone-sensitive Prostate Cancer\u003cbr\u003eChristopher Sweeney\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:30 – 8:45 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eImmunotherapy for Prostate Cancer\u003cbr\u003eXiao Wei\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:45 – 9:00 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eNovel Androgen Receptor Targeted therapy of Castrate Resistant M1 PC\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e9:00 – 9:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003ePET Imaging in the PSA Recurrent Setting – Therapeutics\u003cbr\u003ePraful Ravi\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e9:15 – 9:45 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eExpert Panel: Management of Metastatic Prostate Cancer\u003cbr\u003eModerator: Glenn Bubley\u003cbr\u003eSpeakers: Atish Choudhury, Praful Ravi, Charles Ryan, Christopher Sweeney, and Xiao Wei\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e9:45 – 10:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eBreak\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:15 – 10:45 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eSpecial Lecture, Kidney Development and Wilms Tumor: Prospects for Regeneration\u003cbr\u003eGeorge Daley\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:45 – 11:00 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eRole of Biomarkers in Diagnosis and Follow-up\u003cbr\u003eAdam Feldman\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:00 – 11:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eManagement of Superficial Bladder Cancer\u003cbr\u003eAngela Smith\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:15 – 11:30 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eGenomics and its Role in the Management of Bladder Cancer\u003cbr\u003eJoaquim Bellmunt\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:30 – 11:45 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eManagement of Upper Tract Disease\u003cbr\u003eMatthew Mossanen\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:45 AM – 12:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eUrinary Diversion after Cystectomy, Choices and Outcomes\u003cbr\u003eAndrew Wagner\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:00 – 12:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eLymph Node Dissection and Approaches to Radical Cystectomy\u003cbr\u003eMark Preston\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e12:15 – 1:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eLunch\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e1:00 – 2:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eJudah Folkman Lecture: Emerging Strategies in the Fight Against Covid-19\u003cbr\u003eLindsey Baden\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:00 – 2:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eGenomic Predictors of Response to Chemotherapy\u003cbr\u003eKent Mouw\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:15 – 2:30 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003ePersonalizing Bladder Cancer Treatment in Variant Histology\u003cbr\u003eAngela Smith\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:30 – 2:45 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eNeoadjuvant and Adjuvant Chemotherapy\u003cbr\u003eRichard Lee\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e2:45 – 3:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eBladder Sparing Approaches\u003cbr\u003eJason Efstathiou\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:00 – 3:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eChemo and Immunotherapy for Advanced Urothelial Cancer\u003cbr\u003eJoaquim Bellmunt\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:15 – 3:45 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eExpert Panel: Bladder Cancer\u003cbr\u003eModerator: Adam Kibel\u003cbr\u003eSpeakers: Joaquim Bellmunt, Jason Efstathiou, Adam Feldman, Richard Lee,  Kent Mouw, Matthew Mossanen, Mark Preston, Angela Smith and Andrew Wagner\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e3:45 PM – 4:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eBreak\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e4:00 – 4:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eManagement of Seminoma\u003cbr\u003eAlok Tewari\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e4:15 – 4:30 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eManagement of Stage I non-seminoma\u003cbr\u003eTimothy Clinton\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e4:30 – 4:45 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eUpdates in Radiation Therapy in Testis Cancer\u003cbr\u003eSophia Kamran\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e4:45 – 5:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eManagement of Advanced Disease-Chemotherapy\u003cbr\u003eChristopher Sweeney\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e5:00 – 5:15 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eEmerging Role of Genomics in Testis Cancer\u003cbr\u003eEliezer Van Allen\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e5:15 – 5:45 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eExpert Panel: Testis Cancer\u003cbr\u003eModerator: Jerome Richie\u003cbr\u003eSpeakers: Timothy Clinton, Sophia Kamran, Christopher Sweeney, Alok Tewari and Eliezer Van Allen\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"bundle--hms_program_details_list paragraph paragraph--type--hms-program-details-list paragraph--view-mode--default open\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12\"\u003e\n\u003cdiv class=\"hms-program-details-list--items field-wrapper field field--name-field-hms-pdl-item field--type-entity-reference-revisions field--label-hidden field__items\"\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 hms-program-details-list--term\"\u003eSATURDAY, OCTOBER 15, 2022\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:00 – 8:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eTackling Tumor Metabolism in Renal Cell Carcinoma\u003cbr\u003eKimryn Rathmell\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:15 – 8:30 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eUpdated in the Pathology Classification of Renal Cell Cancer\u003cbr\u003eMichelle Hirsch\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:30 – 8:45 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eRole of Observation and Ablation for Small Renal Mass\u003cbr\u003eAria Olumi\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e8:45 – 9:00 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eRadical or Partial Nephrectomy: Techniques and Innovations\u003cbr\u003eSteven Chang\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e9:00 – 9:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eManaging the Primary when Metastatic and Metastatectomy\u003cbr\u003eKeyan Salari\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e9:15 – 9:30 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eAdjuvant Strategies in RCC\u003cbr\u003eToni Choueiri\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e9:30 – 10:00 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eBreak\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:00 – 10:15 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eAdvanced Disease: First Line Options\u003cbr\u003eVincent Xu\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:15 – 10:30 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eAdvanced Disease: Post IO Setting\u003cbr\u003eDavid McDermott\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:30 – 10:45 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eNon Clear Cell RCC\u003cbr\u003eBradley McGregor\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e10:45 – 11:00 AM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eNovel Targets Beyond Targeted Agents and IO Drugs\u003cbr\u003eXin Gao\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"hms-program-details-list--item field__item\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-4 hms-program-details-list--date\"\u003e11:00 AM – 12:00 PM\u003c\/div\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-8 hms-program-details-list--body\"\u003e\n\u003cbr\u003e\u003cbr\u003eExpert Panel: Renal Cell Carcinoma\u003cbr\u003eModerator: Tonu Choueiri\u003cbr\u003eSpeakers: Steven Chang, Xin Gao, Michelle Hirsch, David McDermott, Bradley McGregor, Aria Olumi, Kimryn Rathmell, Keyan Salari and Vincent Xu\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbr\u003eBiennial Course in Urologic Oncology\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662552846665,"sku":"MED-AMB03492","price":60.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/photo_2022-11-14_22-04-47-768x478-1.jpg?v=1781873810"},{"product_id":"practical-issues-in-urologic-pathology","title":"Practical Issues In Urologic Pathology – 40 New Cases! 2021 (Videos)","description":"\u003csection class=\"content\" tabindex=\"0\"\u003e\n\u003cdiv class=\"description\" data-role=\"course-description\"\u003e\n\u003ch2\u003ePractical Issues In Urologic Pathology – 40 New Cases! 2021 (Videos)\u003c\/h2\u003e\n\u003cbr\u003eSpecimens represented by prostate needle core biopsies, transurethral resection of prostate (TURP), radical prostatectomy, kidney biopsies, nephrectomy (radical or partial), bladder biopsies, cystectomy (radical or partial), cystoprostatectomy, testicular biopsies or orchiectomy are frequently handled by pathology residents\/fellows, general surgical pathologists and\/or urologic pathologists in academic institutions and private practices.\u003cbr\u003e\u003cbr\u003eThese specimens are associated with potential diagnostic challenges and risks in day-to-day practice. This experienced faculty has selected exemplary cases from their expert consultation files (and routine in-house cases) that illustrate recurrent professional practice gaps in urologic pathology. Through intimate mentoring, you will learn how to approach them, make accurate diagnoses, and avoid traps and pitfalls that could cause diagnostic error. The course is pragmatic, clinically-oriented and stimulating. It will focus on these issues:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e- Benign tumor-like lesions of the prostate are often over-diagnosed as prostate cancer or atypical small acinar proliferations\u003c\/li\u003e\n\u003cli\u003eSecondary tumors involving the prostate are frequently misdiagnosed as prostate cancer\u003c\/li\u003e\n\u003cli\u003eHistological variants of prostate cancer with important clinical significance are under-recognized\u003c\/li\u003e\n\u003cli\u003eTherapy-related changes in benign glands and prostate cancer are frequently missed\u003c\/li\u003e\n\u003cli\u003eExtra-prostatic extension in prostate needle core biopsies is frequently missed\u003c\/li\u003e\n\u003cli\u003eRecently described renal carcinomas are not well-appreciated\u003c\/li\u003e\n\u003cli\u003eSecondary tumors involving the kidney are occasionally misinterpreted as primary tumors\u003c\/li\u003e\n\u003cli\u003e Some variants of urothelial carcinoma are under-recognized\u003c\/li\u003e\n\u003cli\u003eBenign entities that mimic urothelial carcinoma are frequently misdiagnosed\u003c\/li\u003e\n\u003cli\u003eTesticular tumors still continue to pose diagnostic challenges\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003ePracticing academic and community pathologists, and pathologists-in-training\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eUpon completion of this educational activity, learners will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eRecognize the most common benign mimickers of prostate cancer, identify therapy-related changes in the prostate and be aware of traps and pitfalls\u003c\/li\u003e\n\u003cli\u003e Identify secondary tumors involving the prostate, tumors arising from the prostatic urethra, and histologic variants of prostate cancer\u003c\/li\u003e\n\u003cli\u003e Update pathologists on newly-described entities in renal neoplasia, including guidelines for using immunohistochemistry in the work-up of renal tumors\u003c\/li\u003e\n\u003cli\u003eDevelop a systematic approach to the diagnosis of bladder lesions, primary and secondary bladder tumors, benign mimickers of malignancy and staging criteria\u003c\/li\u003e\n\u003cli\u003eIntroduce the new concepts and entities presented in the WHO 2016 Classification of Testicular Tumors including differential diagnoses, morphologic mimics and prognostic significance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eTopics\/Speakers: \u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003ePractical Issues in Prostate Pathology - Adeboye O. Osunkoya, MD\u003c\/li\u003e\n\u003cli\u003e Practical Issues in Kidney Pathology - Kiril Trpkov, MD\u003c\/li\u003e\n\u003cli\u003e Practical Issues in Bladder Pathology - Lakshmi Priya Kunju, MD\u003c\/li\u003e\n\u003cli\u003ePractical Issues in Testicular Pathology - Steven S. Shen, MD, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eOriginal Release Date: October 30, 2021\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662552944969,"sku":"MED-AMB03451","price":80.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Practical-Issues-In-Urologic-Pathology-_E2_80_93-40-New-Cases-2021.png?v=1781873814"},{"product_id":"the-pathology-of-neoplastic-diseases-2024","title":"The Pathology of Neoplastic Diseases 2024","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cstrong\u003eThe Pathology of Neoplastic Diseases 2024 The Pathology of Neoplastic Diseases 2024 Throughout this four- and one-half-day course, faculty will provide an up-to-date review of the pathology of selected sub-specialty areas of neoplastic disease, including Genitourinary, Gastrointestinal, and Thoracic pathology.\u003c\/strong\u003e\n\u003cbr\u003e\u003ch2\u003e\u003cstrong style=\"color: #333333; font-size: 16px;\"\u003eDate \u0026amp; Location\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003eMonday, April 29, 2024, 8:00 AM – Friday, May 3, 2024, 12:30 PM, Rockefeller Research Laboratories, 430 East 67th Street, New York , NY\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eSpecialties\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Pathology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbr\u003eAppropriate use of advanced diagnostic techniques, such as immunohistochemistry and molecular pathology, will be incorporated into the lectures, including the assessment of therapeutic biomarkers. Case presentations will also be integrated into select sessions.\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThe Department of Pathology at Memorial Sloan Kettering Cancer Center has produced a course on the Surgical Pathology of Neoplastic Diseases for 40 years. We continue to expand the scope of the course to reflect the increasing contributions of cytopathology, immunopathology, and molecular pathology. The course faculty will include the attending pathology staff from Memorial Sloan Kettering Cancer Center, along with selected visiting lecturers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eOptional Interactive Slide Seminars\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eWe are pleased to offer attendees the option to register for \u003cstrong\u003emore intimate, interactive slide seminar sessions on selected topics in Genitourinary, Gastrointestinal, and Thoracic pathology\u003c\/strong\u003e. Registration is limited for the slide seminars and early registration is encouraged.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eWho Should Attend\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThe target audience for this course includes practicing pathologists, both in academic and private practice environments, as well as residents and fellows in pathology who wish to broaden their understanding of neoplastic diseases.\u003cbr\u003e\u003cbr\u003eThis course is set to be an \u003cstrong\u003eexclusively in-person event\u003c\/strong\u003e at Memorial Sloan Kettering’s Rockefeller Research Laboratories. A virtual option will not be available.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eLabel current classifications and diagnostic criteria for tumors and tumor-like lesions\u003c\/li\u003e\n\u003cli\u003eHighlight the appropriate use of ancillary diagnostic techniques\u003c\/li\u003e\n\u003cli\u003eDiscuss differential diagnoses and understand the practical, problem- oriented approach\u003c\/li\u003e\n\u003cli\u003eIdentify clinical pathological features of the various tumor entities\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp style=\"padding-left: 40px;\"\u003eAdult Adrenal Gland Tumors- A Practical Approach to Diagnosis.mp4\u003cbr\u003eAdult Adrenal Gland Tumors- A Practical Approach to Diagnosis.pdf\u003cbr\u003eAppendiceal Tumors- Adenocarcinoma, LAMN, HAMN, and Neoplasms of Uncertain Malignancy.mp4\u003cbr\u003eAppendiceal Tumors- Adenocarcinoma, LAMN, HAMN, and Neoplasms of Uncertain Malignancy.pdf\u003cbr\u003eAtypical Epithelial Proliferations- Reactive vs. Malignant.mp4\u003cbr\u003eAtypical Epithelial Proliferations- Reactive vs. Malignant.pdf\u003cbr\u003eBiomarkers for Gastrointestinal Tumors.mp4\u003cbr\u003eBiomarkers for Gastrointestinal Tumors.pdf\u003cbr\u003eBiomarkers in Urothelial Carcinoma- Are They Ready for Primetime..mp4\u003cbr\u003eBiomarkers in Urothelial Carcinoma- Are They Ready for Primetime..pdf\u003cbr\u003eChallenging Cases in Genitourinary Pathology.mp4\u003cbr\u003eChallenging Cases in Genitourinary Pathology.pdf\u003cbr\u003eClinicopathologic Challenges in Hereditary Kidney Cancer Detection.mp4\u003cbr\u003eClinicopathologic Challenges in Hereditary Kidney Cancer Detection.pdf\u003cbr\u003eColorectal Cancer Staging- Finding Solutions to Issues Old and New.mp4\u003cbr\u003eColorectal Cancer Staging- Finding Solutions to Issues Old and New.pdf\u003cbr\u003eCommon Pediatric Renal Tumors- A Practical Diagnostic Approach.mp4\u003cbr\u003eCommon Pediatric Renal Tumors- A Practical Diagnostic Approach.pdf\u003cbr\u003eCystic and Intraductal Neoplasms of the Pancreatobiliary System.mp4\u003cbr\u003eCystic and Intraductal Neoplasms of the Pancreatobiliary System.pdf\u003cbr\u003eCytology of Cystic Pancreatic Neoplasms.mp4\u003cbr\u003eCytology of Cystic Pancreatic Neoplasms.pdf\u003cbr\u003eDiagnosis of Lung Cancer in Cytology and Small Biopsies.mp4\u003cbr\u003eDiagnosis of Lung Cancer in Cytology and Small Biopsies.pdf\u003cbr\u003eDiagnostic Challenges in Nonsmall Cell Lung Cancer Diagnosis.mp4\u003cbr\u003eDiagnostic Challenges in Nonsmall Cell Lung Cancer Diagnosis.pdf\u003cbr\u003eEpithelial Neoplasms in the Adult Liver- A Practical Diagnostic Approach.mp4\u003cbr\u003eEpithelial Neoplasms in the Adult Liver- A Practical Diagnostic Approach.pdf\u003cbr\u003eGastric Polyps- From a Single Clinical Diagnosis to Multifaceted Pathologic Entities.mp4\u003cbr\u003eGastric Polyps- From a Single Clinical Diagnosis to Multifaceted Pathologic Entities.pdf\u003cbr\u003eHereditary Colorectal Cancer Syndromes- What’s New and What’s Particularly Relevant for Surgical Pathologists.mp4\u003cbr\u003eHereditary Colorectal Cancer Syndromes- What’s New and What’s Particularly Relevant for Surgical Pathologists.pdf\u003cbr\u003eHistopathologic and Molecular Features of Advanced Prostate Cancer in the Context of Current Therapeutics.mp4\u003cbr\u003eHistopathologic and Molecular Features of Advanced Prostate Cancer in the Context of Current Therapeutics.pdf\u003cbr\u003eImmunohistochemistry for Lung Tumor Diagnosis.mp4\u003cbr\u003eImmunohistochemistry for Lung Tumor Diagnosis.pdf\u003cbr\u003eImmunohistochemistry for Predictive Biomarkers in Lung Cancer.mp4\u003cbr\u003eImmunohistochemistry for Predictive Biomarkers in Lung Cancer.pdf\u003cbr\u003eIntraductal Carcinoma of the Prostate- Differential Diagnosis and Clinical Significance.mp4\u003cbr\u003eIntraductal Carcinoma of the Prostate- Differential Diagnosis and Clinical Significance.pdf\u003cbr\u003eLung Cancer Staging.mp4\u003cbr\u003eLung Cancer Staging.pdf\u003cbr\u003eMediastinal Tumors.mp4\u003cbr\u003eMediastinal Tumors.pdf\u003cbr\u003eMesenchymal Tumors of the GI System.mp4\u003cbr\u003eMesenchymal Tumors of the GI System.pdf\u003cbr\u003eMolecular Pathology of Lung Cancer.mp4\u003cbr\u003eMolecular Pathology of Lung Cancer.pdf\u003cbr\u003eMolecular Solutions to Challenges in Thoracic Pathology.mp4\u003cbr\u003eMolecular Solutions to Challenges in Thoracic Pathology.pdf\u003cbr\u003eMolecular Testing for Genitourinary Neoplasms- A Practical Guide to Tumor Classification and Biomarker-Directed Therapeutics.mp4\u003cbr\u003eMolecular Testing for Genitourinary Neoplasms- A Practical Guide to Tumor Classification and Biomarker-Directed Therapeutics.pdf\u003cbr\u003eMorphologic Heterogeneity in Kidney Cancer with Biomarker Correlates.mp4\u003cbr\u003eMorphologic Heterogeneity in Kidney Cancer with Biomarker Correlates.pdf\u003cbr\u003eNeoplastics2024_Brochure.pdf\u003cbr\u003eNeuroendocrine Neoplasms- NE Tumor vs. NE Carcinoma vs. NE Differentiation.mp4\u003cbr\u003eNeuroendocrine Neoplasms- NE Tumor vs. NE Carcinoma vs. NE Differentiation.pdf\u003cbr\u003eNeuroendocrine Tumors of the Lung.mp4\u003cbr\u003eNeuroendocrine Tumors of the Lung.pdf\u003cbr\u003ePleural Tumors.mp4\u003cbr\u003ePleural Tumors.pdf\u003cbr\u003ePremalignant and Putative Precursor Lesions of the Testis.mp4\u003cbr\u003ePremalignant and Putative Precursor Lesions of the Testis.pdf\u003cbr\u003eProstate Cancer Reporting in 2024 and Its Impact on Risk Stratification.mp4\u003cbr\u003eProstate Cancer Reporting in 2024 and Its Impact on Risk Stratification.pdf\u003cbr\u003ePulmonary Adenomas and Papillomas.mp4\u003cbr\u003ePulmonary Adenomas and Papillomas.pdf\u003cbr\u003eRenal Neoplasia with Eosinophilic Cytoplasm- New and Emerging Entities.mp4\u003cbr\u003eRenal Neoplasia with Eosinophilic Cytoplasm- New and Emerging Entities.pdf\u003cbr\u003eRenal Neoplasia with Papillary Architecture- Differential Diagnosis and WHO Updates.mp4\u003cbr\u003eRenal Neoplasia with Papillary Architecture- Differential Diagnosis and WHO Updates.pdf\u003cbr\u003eRole of Ancillary Methods in Risk Stratification and Dysplasia Diagnosis in Barrett’s Esophagus.mp4\u003cbr\u003eRole of Ancillary Methods in Risk Stratification and Dysplasia Diagnosis in Barrett’s Esophagus.pdf\u003cbr\u003eSarcomatoid Carcinomas of the Lung.mp4\u003cbr\u003eSarcomatoid Carcinomas of the Lung.pdf\u003cbr\u003eSolid Tumors of the Pancreas.mp4\u003cbr\u003eSolid Tumors of the Pancreas.pdf\u003cbr\u003eThe Evolution of Gastric Cancer Classification- From Morphology to Molecular Characterization.mp4\u003cbr\u003eThe Evolution of Gastric Cancer Classification- From Morphology to Molecular Characterization.pdf\u003cbr\u003eUpdate on Penile Pathology.mp4\u003cbr\u003eUpdate on Penile Pathology.pdf\u003cbr\u003eUpdates on the Divergent Differentiation and Histologic Subtypes in Urothelial Carcinoma.mp4\u003cbr\u003eUpdates on the Divergent Differentiation and Histologic Subtypes in Urothelial Carcinoma.pdf\u003c\/p\u003e","brand":"Medical Education Hub","offers":[{"title":"Full course","offer_id":54662553076041,"sku":"MED-AMB02771","price":80.0,"currency_code":"EUR","in_stock":true},{"title":"Thoracic pathology","offer_id":54662553108809,"sku":"MED-AMB02771","price":40.0,"currency_code":"EUR","in_stock":true},{"title":"Genitourinary","offer_id":54662553141577,"sku":"MED-AMB02771","price":40.0,"currency_code":"EUR","in_stock":true},{"title":"Gastrointestinal","offer_id":54662553174345,"sku":"MED-AMB02771","price":40.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/The-Pathology-of-Neoplastic-Diseases-2024-1_003cee55-682d-4977-b46c-6e52232c13be.jpg?v=1781873812"},{"product_id":"10th-regional-scientific-meeting","title":"10th Regional Scientific Meeting Of Paediatric Dermatology And 46th Malaysian Annual Dermatological Conference 2021","description":"\u003ch3 class=\"product_title entry-title\"\u003e10th Regional Scientific Meeting Of Paediatric Dermatology And 46th Malaysian Annual Dermatological Conference 2021\u003c\/h3\u003e\n\u003ch3 class=\"detail-title\"\u003eOVERVIEW\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e Include: 38 videos + 2 pdfs, size: 27.7 GB\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Target Audience: dermatologist, pediatric physician\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"details-desc\"\u003e\n\u003cdiv\u003e\n\u003cbr\u003e\u003cbr\u003e10th Regional Scientific Meeting for Paediatric Dermatology (RSMPD) in conjunction with the 46th Malaysian Annual Dermatological Conference is organized by Malaysian Paediatric Association (MPA) and will be held from Jul 29 - Aug 01, 2021.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTarget Audience:\u003c\/strong\u003e\u003cbr\u003eThe Organising Committee is drawing up an academically stimulating scientific programme which will focus on recent advances in the field of paediatric dermatology targetted at dermatologists, paediatricians and general practitioners as well as allied healthcare professionals.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e Topics:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eSee the conference details at this link:  \u003ca href=\"https:\/\/mqp6-my.sharepoint.com\/:b:\/g\/personal\/06_mqp6_onmicrosoft_com\/EdKBEQjTbEVGuIGFX7bSc5cBL-aaDZnGALDhrk83i2pQBg\"\u003ehttps:\/\/mqp6-my.sharepoint.com\/:b:\/g\/personal\/06_mqp6_onmicrosoft_com\/EdKBEQjTbEVGuIGFX7bSc5cBL-aaDZnGALDhrk83i2pQBg\u003c\/a\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e1 August – GRAND ROUND WITH EXPERTS.mp4\u003c\/li\u003e\n\u003cli\u003e1 August – PLENARY 3.mp4\u003c\/li\u003e\n\u003cli\u003e1 August – POSTER \u0026amp; FREE PAPERS WINNERS ANNOUNCEMENT.mp4\u003c\/li\u003e\n\u003cli\u003e1 August – POSTER FINALISTS PRESENTATION AND JUDGING.mp4\u003c\/li\u003e\n\u003cli\u003e1 August – SYMPOSIUM 13 Hot Topics in Paediatric.mp4\u003c\/li\u003e\n\u003cli\u003e1 August – SYMPOSIUM 14 Hair \u0026amp; Nail Disorders in Children.mp4\u003c\/li\u003e\n\u003cli\u003e1 August – TEA SYMPOSIUM 6 (Kyowa Kirin).mp4\u003c\/li\u003e\n\u003cli\u003e1 August – TEA SYMPOSIUM 7 (Johnson \u0026amp; Johnson).mp4\u003c\/li\u003e\n\u003cli\u003e29 July – ADVANCED CLASS ON ATOPIC DERMATITIS.mp4\u003c\/li\u003e\n\u003cli\u003e29 July – CPC of Paediatric Dermatopathology.mp4\u003c\/li\u003e\n\u003cli\u003e29 July – MASTERCLASS ON ATOPIC DERMATITIS.mp4\u003c\/li\u003e\n\u003cli\u003e29 July – Pre-Congress Workshop – Atopic Dermatitis (AD) – Masterclass and Advanced Class.mp4\u003c\/li\u003e\n\u003cli\u003e30 July – LUNCH SYMPOSIUM 1 (Beiersdorf).mp4\u003c\/li\u003e\n\u003cli\u003e30 July – LUNCH SYMPOSIUM 2 (Novartis).mp4\u003c\/li\u003e\n\u003cli\u003e30 July – OPENING CEREMONY.mp4\u003c\/li\u003e\n\u003cli\u003e30 July – PLENARY 1 Ganesapillai Memorial Lecture.mp4\u003c\/li\u003e\n\u003cli\u003e30 July – SYMPOSIUM 1 Atopic Eczema – What’s New.mp4\u003c\/li\u003e\n\u003cli\u003e30 July – SYMPOSIUM 2 Adverse Cutaneous Drug Reactions.mp4\u003c\/li\u003e\n\u003cli\u003e30 July – SYMPOSIUM 3 Pigmentary Disorders.mp4\u003c\/li\u003e\n\u003cli\u003e30 July – SYMPOSIUM 4 Neonatal Dermatoses.mp4\u003c\/li\u003e\n\u003cli\u003e30 July – SYMPOSIUM 5 Cutaneous Infections.mp4\u003c\/li\u003e\n\u003cli\u003e30 July – SYMPOSIUM 6 Gene and Skin.mp4\u003c\/li\u003e\n\u003cli\u003e30 July – TEA SYMPOSIUM 1 (Hyphens).mp4\u003c\/li\u003e\n\u003cli\u003e30 July – TEA SYMPOSIUM 2 (Sanofi).mp4\u003c\/li\u003e\n\u003cli\u003e31 July – FREE PAPER 1.mp4\u003c\/li\u003e\n\u003cli\u003e31 July – FREE PAPER 2.mp4\u003c\/li\u003e\n\u003cli\u003e31 July – LUNCH SYMPOSIUM 3 (LEO Pharma).mp4\u003c\/li\u003e\n\u003cli\u003e31 July – PLENARY 2 Arnold Oranje Memorial Lecture.mp4\u003c\/li\u003e\n\u003cli\u003e31 July – SYMPOSIUM 10 ABC of Laser Therapy.mp4\u003c\/li\u003e\n\u003cli\u003e31 July – SYMPOSIUM 11 Office Paediatrc Dermatology.mp4\u003c\/li\u003e\n\u003cli\u003e31 July – SYMPOSIUM 12 Skin and Other System.mp4\u003c\/li\u003e\n\u003cli\u003e31 July – SYMPOSIUM 7 Paediatric Allergy.mp4\u003c\/li\u003e\n\u003cli\u003e31 July – SYMPOSIUM 8 Vascular Anomalies – What’s New.mp4\u003c\/li\u003e\n\u003cli\u003e31 July – SYMPOSIUM 9 Immune \u0026amp; Connective Tissue.mp4\u003c\/li\u003e\n\u003cli\u003e31 July – TEA SYMPOSIUM 3 (Johnson \u0026amp; Johnson).mp4\u003c\/li\u003e\n\u003cli\u003e31 July – TEA SYMPOSIUM 4 (Viatris).mp4\u003c\/li\u003e\n\u003cli\u003e31 July – TEA SYMPOSIUM 5 (AbbVie).mp4\u003c\/li\u003e\n\u003cli\u003eOpening.mp4\u003c\/li\u003e\n\u003cli\u003eRSMPD2021_SPAB.pdf\u003c\/li\u003e\n\u003cli\u003eRSMPD21_DailyProgramme.pdf\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662553207113,"sku":"MED-AMB02132","price":10.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/10th-Regional-Scientific-Meeting-Of-Paediatric-Dermatology-And-46th-Malaysian-Annual-Dermatological-Conference-2021-1.webp?v=1781873812"},{"product_id":"uscap-crash-course-in-cytopathology","title":"USCAP Crash Course in Cytopathology: Thorax, Soft Tissue, Head and Neck, Liver, Pancreatobiliary and Genitourinary Tract 2024","description":"\u003cdiv class=\"outer-wrapper\"\u003e\u003csection class=\"main-container\" id=\"main-container\"\u003e\u003csection class=\"course\" data-id=\"68739\" data-role=\"course\"\u003e\u003csection class=\"product\"\u003e\u003csection\u003e\u003csection class=\"content\" tabindex=\"0\"\u003e\n\u003cdiv class=\"description\"\u003e\n\u003cdiv id=\"course-item-description-wrapper\"\u003e\n\u003cdiv class=\"item-description\" data-role=\"course-item-description\"\u003e\n\u003ch2\u003eUSCAP Crash Course in Cytopathology: Thorax, Soft Tissue, Head and Neck, Liver, Pancreatobiliary and Genitourinary Tract 2024\u003c\/h2\u003e\n\u003ch2\u003eVideos +PDFS\u003c\/h2\u003e\n\u003cp class=\"\"\u003e\u003cstrong\u003eOriginal release date: \u003c\/strong\u003eMay 3, 2024\u003cbr\u003e\u003cstrong\u003eAccess to this course expires on:\u003c\/strong\u003e  April 8, 2027 at 11:59 PM Pacific Time\u003cbr\u003e\u003cstrong\u003eCME \u003c\/strong\u003e11.5\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCourse Description\u003c\/strong\u003e\u003cbr\u003eUSCAP Crash Course in Cytopathology: Thorax, Soft Tissue, Head and Neck, Liver, Pancreatobiliary and Genitourinary Tract 2024 Multiple revisions and updates have\u003c\/li\u003e\n\u003cli\u003erecently been created for the standardized reporting and classification of cytologic samples from non-neoplastic and neoplastic processes involving the pancreatobiliary\u003c\/li\u003e\n\u003cli\u003etract, liver, thyroid, head and neck (including salivary gland), urine, kidneys, adrenal gland, serous fluids, lung and soft tissue.\u003c\/li\u003e\n\u003cli\u003eThese standardized reporting schemes provide a framework for the consistent categorization of cytopathology reports and allow cytopathologists to convey clear and\u003c\/li\u003e\n\u003cli\u003econsistent diagnostic information, in language uniformly understood by pathologists and clinicians the world over. New developments in the diagnosis, grading and\u003c\/li\u003e\n\u003cli\u003enomenclature are not fully appreciated in the community, often leading to errors in diagnosis and delayed or inappropriate patient management.\u003c\/li\u003e\n\u003cli\u003eThis case-based course illustrates new guidelines, practical clues, daily challenges, diagnostic pearls and pitfalls, as well as the proper handling of specimens from these\u003c\/li\u003e\n\u003cli\u003esites along with accurate cytologic diagnosis of neoplasms, as well as their distinction from, key cytomorphologic mimics. This course emphasizes the new guidelines\u003c\/li\u003e\n\u003cli\u003e(including WHO), pearls, and common pitfalls and offers pathologists a unique perspective into the key diagnostic cytomorphometric signatures of common entities, which\u003c\/li\u003e\n\u003cli\u003ethey can apply to daily signout in any practice setting.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdetails open=\"open\"\u003e\u003csummary\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/summary\u003ePracticing academic and community pathologists, and pathologists-in-training\u003cbr\u003e\u003cbr\u003e\u003c\/details\u003e\u003cdetails open=\"open\"\u003e\u003csummary\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003c\/summary\u003eUpon completion of this educational activity, learners will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eLearn new concepts and terminological guidelines in the cytologic classification of neoplastic and non-neoplastic lesions from multiple sites including lung, mediastinum, bone and soft tissue, serous fluids, pancreatobiliary tract, liver, genitourinary tract, adrenal, thyroid, salivary gland and head and neck region.\u003c\/li\u003e\n\u003cli\u003eLearn when and how to integrate clinical findings and ancillary tests in precise cytologic diagnosis of lesions from these sites.\u003c\/li\u003e\n\u003cli\u003eRecognize the limitations and pitfalls in using\/interpreting ancillary studies in the cytologic diagnosis of neoplastic and non-neoplastic lesions in the lung, mediastinum, bone and soft tissue, serous fluids, pancreatobiliary tract, liver, genitourinary tract, adrenal, thyroid, salivary gland and head and neck region.\u003c\/li\u003e\n\u003cli\u003eUse an algorithmic approach to the differential diagnosis for cystic and solid neoplasms in the lung, mediastinum, bone and soft tissue, serous fluids, pancreatobiliary tract, liver, lung, mediastinum, bone and soft tissue, serous fluids, pancreatobiliary tract, liver, genitourinary tract, adrenal, thyroid, salivary gland and head and neck region.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/details\u003e\n\u003c\/div\u003e\n\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"696544\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/696544\" data-updated-at=\"2024-06-12 16:35:40 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003chgroup\u003e\n\u003ch3\u003eUrine, Kidney, and Adrenal Cytopathology – Adebowale J. Adeniran, MD\u003c\/h3\u003e\n\u003c\/hgroup\u003e\n\u003cbr\u003e\u003cdiv class=\"meta\" style=\"padding-left: 40px;\"\u003eSection: 1 Presentation 1 Document 1 Certificate 1 Survey\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"696547\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/696547\" data-updated-at=\"2024-06-12 16:35:40 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"prerequisite-indent-box\" style=\"padding-left: 40px;\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eSerous Fluid Cytopathology – Adebowale J. Adeniran, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"meta\" style=\"padding-left: 40px;\"\u003eSection: 1 Presentation 1 Document\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"696548\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/696548\" data-updated-at=\"2024-06-12 16:35:40 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"prerequisite-indent-box\" style=\"padding-left: 40px;\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eLung and Mediastinum Cytopathology – Lester J. Layfield, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"meta\" style=\"padding-left: 40px;\"\u003eSection: 1 Presentation 1 Document\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"696551\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/696551\" data-updated-at=\"2024-06-12 16:35:40 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"prerequisite-indent-box\" style=\"padding-left: 40px;\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eSoft Tissue Cytopathology – Lester J. Layfield, MD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"meta\" style=\"padding-left: 40px;\"\u003eSection: 1 Presentation 1 Document\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"696552\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/696552\" data-updated-at=\"2024-06-12 16:35:40 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"prerequisite-indent-box\" style=\"padding-left: 40px;\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003ePancreas Cytopathology – Michelle D. Reid, MD, MSc\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"meta\" style=\"padding-left: 40px;\"\u003eSection: 1 Presentation 2 Documents\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"696553\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/696553\" data-updated-at=\"2024-06-12 16:35:40 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"prerequisite-indent-box\" style=\"padding-left: 40px;\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eBile Duct and Liver Cytopathology – Michelle D. Reid, MD, MSc\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"meta\" style=\"padding-left: 40px;\"\u003eSection: 1 Presentation 2 Documents\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"696554\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/696554\" data-updated-at=\"2024-06-12 16:35:40 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"prerequisite-indent-box\" style=\"padding-left: 40px;\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eThyroid Cytopathology – William C. Faquin, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"meta\" style=\"padding-left: 40px;\"\u003eSection: 1 Presentation 1 Document\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview\" data-id=\"696555\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/696555\" data-updated-at=\"2024-06-12 16:35:40 UTC\" role=\"link\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"prerequisite-indent-box\" style=\"padding-left: 40px;\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"state-notices-block\" style=\"padding-left: 40px;\"\u003eHead and Neck, and Salivary Gland Cytopathology – William C. Faquin, MD, PhD\u003c\/div\u003e\n\u003cdiv class=\"inner-wrapper\" style=\"padding-left: 40px;\"\u003e\n\u003cdiv class=\"meta\" style=\"padding-left: 40px;\"\u003eSection: 1 Presentation 1 Document\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/section\u003e\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662553043273,"sku":"MED-AMB02257","price":55.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/USCAP-Crash-Course-in-Cytopathology-Thorax-Soft-Tissue-Head-and-Neck-Liver-Pancreatobiliary-and-Genitourinary-Tract-2024.png?v=1781873812"},{"product_id":"aap-experience-national","title":"AAP Experience National Conference \u0026 Exhibition 2023","description":"AAP Experience National Conference \u0026amp; Exhibition 2023 American Academy of Pediatrics Experience National Conference \u0026amp; Exhibition 2023The American Academy of Pediatrics (AAP) Section on Urology (SOU) will be returning to the 2023 National Conference and Exhibition scheduled to take place \u003cstrong\u003eOctober 20-22, 2023 in Washington, DC\u003c\/strong\u003e. The AAP SOU has a fantastic schedule planned which is included in the message below. There is also a call for abstracts which closes on Friday, April 14\u003csup\u003eth\u003c\/sup\u003e.\u003cbr\u003e\u003ch2\u003eDescription\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e Include: 44 videos + 1 pdf, size: 38.8 GB\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Target Audience: pediatric physican\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003eJoin us for the 2023 AAP National Conference \u0026amp; Exhibition taking place October 20-24 in Washington, DC! The National Conference \u0026amp; Exhibition is the premier venue for pediatric health care professionals to engage and share their passion for the health of all children.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cbr\u003eThe American Academy of Pediatrics (AAP) Section on Urology (SOU) will be returning to the 2023 National Conference and Exhibition scheduled to take place \u003cstrong\u003eOctober 20-22, 2023 in Washington, DC\u003c\/strong\u003e. The AAP SOU has a fantastic schedule planned which is included in the message below. There is also a call for abstracts which closes on Friday, April 14\u003csup\u003eth\u003c\/sup\u003e.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eCall for Abstracts\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eThe SOU will be participating in the call for abstracts. \u003cstrong\u003eAbstract submissions may be submitted as original research only\u003c\/strong\u003e and will be featured as a poster presentation.\u003c\/li\u003e\n\u003cli\u003eBest abstract recipients for each of the topic areas noted below will also be presented orally during the educational programming of the same topic area. If selected as a best abstract recipient, you will need to ensure your availability on the programming date and time. All presenting authors must be fully registered attendees and must attend the 2023 National Conference in-person in Washington, DC.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eOct 20 Appy Hour a Current Update on Pediatric Appendicitis.mp4\u003c\/li\u003e\n\u003cli\u003eOct 20 Do You See What I See Recognizing Medical Child Abuse.mp4\u003c\/li\u003e\n\u003cli\u003eOct 20 Genetic \u0026amp; Metabolic Unknowns How Many Do You Recognize.mp4\u003c\/li\u003e\n\u003cli\u003eOct 20 Groans from the Groin Scrotal and Testicular Pain.mp4\u003c\/li\u003e\n\u003cli\u003eOct 20 Improved Prescribing Generics and Biosimilars.mp4\u003c\/li\u003e\n\u003cli\u003eOct 20 Neurodiversity How Do We Integrate Diverse Thinking and Perspectives into Practice.mp4\u003c\/li\u003e\n\u003cli\u003eOct 21 Acne Vulgaris Update on Approach to Treatment (Repeat).mp4\u003c\/li\u003e\n\u003cli\u003eOct 21 ADHD Uncovering the Complex.mp4\u003c\/li\u003e\n\u003cli\u003eOct 21 Basic Coding in the Office for Well Visits and Vaccines.mp4\u003c\/li\u003e\n\u003cli\u003eOct 21 Connecting School System and Health Systems Successes and Opportunities.mp4\u003c\/li\u003e\n\u003cli\u003eOct 21 Constipation Getting it to Work Out in the End.mp4\u003c\/li\u003e\n\u003cli\u003eOct 21 Healthcare Disparities in Management of Type 1 Diabetes and Diabetes Technology.mp4\u003c\/li\u003e\n\u003cli\u003eOct 21 Opening Plenary Session.mp4\u003c\/li\u003e\n\u003cli\u003eOct 21 Pediatric Obesity and Food Insecurity- Next Steps Beyond Screening.mp4\u003c\/li\u003e\n\u003cli\u003eOct 21 Protecting Mothers and Infants Through Maternal Immunization.mp4\u003c\/li\u003e\n\u003cli\u003eOct 21 Surviving a Social Media Attack.mp4\u003c\/li\u003e\n\u003cli\u003eOct 21 They’re Back The Return of Almost Forgotten Vaccine-Preventable Diseases.mp4\u003c\/li\u003e\n\u003cli\u003eOct 22 Chief Complaint I Need a Neurologist.mp4\u003c\/li\u003e\n\u003cli\u003eOct 22 Clinical Practice Guideline for the Assessment and Treatment of Pediatric Obesity.mp4\u003c\/li\u003e\n\u003cli\u003eOct 22 Council Showcase Federal Vision Overview of the Blueprint for Change.mp4\u003c\/li\u003e\n\u003cli\u003eOct 22 Council Showcase Pediatricians and School Attendance Innovative Approaches to Prevent Chronic Absenteeism.mp4\u003c\/li\u003e\n\u003cli\u003eOct 22 COVID-19 Epidemiology, Prevention, Management, and Sequelae (MIS-C and long COVID).mp4\u003c\/li\u003e\n\u003cli\u003eOct 22 Eliminating the Pain of Treating a Child with Functional Abdominal Pain.mp4\u003c\/li\u003e\n\u003cli\u003eOct 22 Healthy Homes for Healthy Kids Environmental Health Strategies to Address Asthma Disparities (Repeat).mp4\u003c\/li\u003e\n\u003cli\u003eOct 22 Improving Health Literacy. One Social Media Platform at a Time.mp4\u003c\/li\u003e\n\u003cli\u003eOct 22 Pediatric Hearing Loss What’s New in Diagnostics, Prevention and Treatments.mp4\u003c\/li\u003e\n\u003cli\u003eOct 22 Section Showcase Male Allyship to Promote Gender Equity in Medicine.mp4\u003c\/li\u003e\n\u003cli\u003eOct 22 Sunday Plenary Session.mp4\u003c\/li\u003e\n\u003cli\u003eOct 23 Beyond our Biases Understanding and Overcoming Biases within the Child Welfare System.mp4\u003c\/li\u003e\n\u003cli\u003eOct 23 Bullying and What Pediatricians Can Do About It.mp4\u003c\/li\u003e\n\u003cli\u003eOct 23 C. difficile Treatment in 2023 Best Practices and What’s on the Horizon.mp4\u003c\/li\u003e\n\u003cli\u003eOct 23 Children with Disabilities in Crisis in the Emergency Department.mp4\u003c\/li\u003e\n\u003cli\u003eOct 23 Common Seizure Types and Paroxysmal Nonepileptic Events in Children.mp4\u003c\/li\u003e\n\u003cli\u003eOct 23 Council Showcase Climate Change Advocacy Local, Regional, and National.mp4\u003c\/li\u003e\n\u003cli\u003eOct 23 Council Showcase Mental Health in the Young Athlete.mp4\u003c\/li\u003e\n\u003cli\u003eOct 23 Monday Plenary Session.mp4\u003c\/li\u003e\n\u003cli\u003eOct 23 Preventing and Responding to Dental Trauma in the Pediatric Office.mp4\u003c\/li\u003e\n\u003cli\u003eOct 23 Section Showcase New and Emerging Tobacco Products-Epidemiology, Health Effects and Evidence Based Treatment.mp4\u003c\/li\u003e\n\u003cli\u003eOct 23 Section Showcase Polio Eradication and Current Challenges.mp4\u003c\/li\u003e\n\u003cli\u003eOct 24 Allergy Tests How to Properly Use and Avoid Harm.mp4\u003c\/li\u003e\n\u003cli\u003eOct 24 Pediatric Skin of Color.mp4\u003c\/li\u003e\n\u003cli\u003eOct 24 Section Showcase Applying Ethics Principles and Tools to Advocate for Vulnerable Populations.mp4\u003c\/li\u003e\n\u003cli\u003eOct 24 Taking the Pain Out of Pain Management.mp4\u003c\/li\u003e\n\u003cli\u003eOct 24 Tuesday Plenary Session.mp4\u003c\/li\u003e\n\u003cli\u003eVirtual-Only Schedule.pdf\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662553338185,"sku":"MED-AMB02128","price":30.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/AAP-Experience-National-Conference-Exhibition-2023.png?v=1781873813"},{"product_id":"hackensack-meridian-childrens-health-2nd","title":"Hackensack Meridian Children’s Health 2nd Annual Virtual Pediatric Urology Symposium 2022","description":"\u003ch2\u003e[\u003c\/h2\u003e\n\u003ch2\u003eHackensack Meridian Children’s Health 2nd Annual Virtual Pediatric Urology Symposium 2022\u003c\/h2\u003e\u003cbr\u003eHackensack Meridian Hackensack University Medical Center’s Department of Urology presented 26 abstracts at the American Urological Association’s (AUA) 2022 Annual Meeting, held in New Orleans, LA, from May 13-16, 2022. Department physicians also won three first-place awards for poster and video presentations, participated in seven sessions as moderators, debaters or lecturers, and served on the faculty of two AUA instructional courses.\u003cbr\u003e\u003ch2\u003eDescription\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e Include: 2 videos, size: 5 GB\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Target Audience: pediatric physician, uronologist\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSample video: \u003cspan style=\"color: #0000ff;\"\u003e\u003ca href=\"https:\/\/medicalamboss.com\/contact-us\/\" style=\"color: #0000ff;\"\u003econtact me\u003c\/a\u003e\u003c\/span\u003e for sample video\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003eno information\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cstrong\u003e Topics:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eOct 12 Part 1.mp4 (3 hours)\u003cbr\u003eOct 12 Part 2.mp4 (4 hours)\u003cbr\u003e\u003cbr\u003e]","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662553370953,"sku":"MED-AMB02125","price":20.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/Hackensack-Meridian-Childrens-Health-2nd-Annual-Virtual-Pediatric-Urology-Symposium-2022-scaled-1.jpg?v=1781873813"},{"product_id":"uscap-gynecological-pathology-2024-essential-knowledge-for-diagnostic-practice","title":"USCAP Gynecological Pathology 2024: Essential Knowledge for Diagnostic Practice","description":"\u003ch2\u003eUSCAP Gynecological Pathology 2024: Essential Knowledge for Diagnostic Practice\u003c\/h2\u003e\u003cbr\u003eUSCAP Gynecological Pathology 2024: Essential Knowledge for Diagnostic Practice  As a major clinical subspecialty, diagnostic gynecological pathology involves a large number of disease entities and often complex histological variants. Recent developments, particularly molecular genetic discoveries, have introduced new and reclassified entities as well as refined diagnostic criteria for many existing disease processes, calling for knowledge update for practicing pathologists. Comprehensive review course is essential and highly desirable.\u003cbr\u003e\u003ch2\u003eFormat : 12 MP4 + PDF\u003c\/h2\u003e\u003cbr\u003eThis unique training course offers an engaged learning experience around multi-headed microscope with world-class faculty delegated by the International Society of Gynecological Pathologists (ISGyP). While providing a comprehensive coverage, the course emphasizes knowledge gains in morphologic recognition and using ancillary studies in the most challenging areas, particularly new disease classifications\/diagnostic criteria.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003cbr\u003eUpon completion of this educational activity, learners will be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eRecognize updated diagnostic criteria and disease classifications in gynecological pathology.\u003c\/li\u003e\n\u003cli\u003eRecognize unusual but important gynecological disease entities.\u003c\/li\u003e\n\u003cli\u003eApply immunohistochemical and molecular genetic studies for diagnosis and differential diagnoses.\u003c\/li\u003e\n\u003cli\u003eUnderstand the clinical implications when applying new diagnostic knowledge in gynecological pathology.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003csection class=\"content\" tabindex=\"0\"\u003e\n\u003cdiv class=\"description\"\u003e\n\u003ch2\u003eEpithelial Malignancies of the Vulva and Cervix – C. Blake Gilks, MD\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\u003csection class=\"included\" data-role=\"course-items-list\"\u003e\n\u003cdiv class=\"media ui-sortable\" data-parent=\"course\" id=\"67671\"\u003e\n\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"685113\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/685113\" data-updated-at=\"2024-05-03 22:51:11 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cdiv class=\"meta\"\u003eSection: 2 Presentations 1 Document 1\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"690797\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/690797\" data-updated-at=\"2024-05-03 22:51:11 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cdiv class=\"sellable-buttons\"\u003e\n\u003cdiv class=\"ecommerce\" data-id=\"76034\" data-type=\"Section\"\u003e\n\u003cdiv class=\"price-list\"\u003e\n\u003cdiv class=\"price-box price-tooltiped\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chgroup\u003e\n\u003ch3\u003eOvarian Neoplasms – Teri A. Longacre, MD\u003c\/h3\u003e\n\u003c\/hgroup\u003e\n\u003cbr\u003e\u003cdiv class=\"meta\"\u003eSection: 2 Presentations 1 Document 1\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"690808\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/690808\" data-updated-at=\"2024-05-03 22:51:11 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cdiv class=\"sellable-buttons\"\u003e\n\u003cdiv class=\"ecommerce\" data-id=\"76037\" data-type=\"Section\"\u003e\n\u003cdiv class=\"price-list\"\u003e\n\u003cdiv class=\"price-box price-tooltiped\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chgroup\u003e\n\u003ch3\u003eMesenchymal Neoplasms of the Uterine Corpus – Jennifer A. Bennett, MD\u003c\/h3\u003e\n\u003c\/hgroup\u003e\n\u003cbr\u003e\u003cdiv class=\"meta\"\u003eSection: 2 Presentations 2 Documents 1\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"690809\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/690809\" data-updated-at=\"2024-05-03 22:51:11 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cdiv class=\"sellable-buttons\"\u003e\n\u003cdiv class=\"ecommerce\" data-id=\"76038\" data-type=\"Section\"\u003e\n\u003cdiv class=\"price-list\"\u003e\n\u003cdiv class=\"price-box price-tooltiped\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chgroup\u003e\n\u003ch3\u003eGestational Trophoblastic Disease and Focused Contemporary Topics – Pei Hui, MD, PhD\u003c\/h3\u003e\n\u003c\/hgroup\u003e\n\u003cbr\u003e\u003cdiv class=\"meta\"\u003eSection: 2 Presentations 2 Documents 1\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"690810\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/690810\" data-updated-at=\"2024-05-03 22:51:11 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cdiv class=\"sellable-buttons\"\u003e\n\u003cdiv class=\"ecommerce\" data-id=\"76039\" data-type=\"Section\"\u003e\n\u003cdiv class=\"price-list\"\u003e\n\u003cdiv class=\"price-box price-tooltiped\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chgroup\u003e\n\u003ch3\u003eEpithelial Neoplasms of the Uterine Corpus – Elizabeth D. Euscher, MD\u003c\/h3\u003e\n\u003c\/hgroup\u003e\n\u003cbr\u003e\u003cdiv class=\"meta\"\u003eSection: 2 Presentations 2 Documents 1\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\u003carticle class=\"item-preview sortable-item-preview section-preview section-item-preview product\" data-id=\"690812\" data-locked=\"false\" data-type=\"Section\" data-update-url=\"\/course_items\/690812\" data-updated-at=\"2024-05-03 22:51:11 UTC\" role=\"link\"\u003e\n\u003cdiv class=\"inner-wrapper\"\u003e\n\u003cdiv class=\"sellable-buttons\"\u003e\n\u003cdiv class=\"ecommerce\" data-id=\"76040\" data-type=\"Section\"\u003e\n\u003cdiv class=\"price-list\"\u003e\n\u003cdiv class=\"price-box price-tooltiped\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chgroup\u003e\n\u003ch3\u003eBenign Lesions and Non-Epithelial Malignancies of the Lower Gential Tract – Glenn McCluggage, FRCPath\u003c\/h3\u003e\n\u003c\/hgroup\u003e\n\u003cbr\u003e\u003cdiv class=\"meta\"\u003eSection: 2 Presentations 1 Document 1\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662553436489,"sku":"MED-AMB02048","price":120.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/USCAP-Gynecological-Pathology-2024-Essential-Knowledge-for-Diagnostic-Practice-1.png?v=1781873813"},{"product_id":"2023-econtouring-for-prostate","title":"2023 ECONTOURING FOR PROSTATE - FOCAL BOOST RADIOTHERAPY - WEBINAR","description":"\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"field field-name-field-course-summary field-type-text-with-summary field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003e2023 ECONTOURING FOR PROSTATE - FOCAL BOOST RADIOTHERAPY - WEBINAR This covers the clinical evidence and rationale for focal dose escalation to the MRI-defined GTV in prostate cancer. We will also review real clinical cases to learn the best way to identify the GTV and contour for radiotherapy planning. Dosimetric constraints and pitfalls will be considered.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eThis Webinar Was Sponsored By The ROI Juan A. Del Regato Fund. The ROI Is ASTRO’s Research Foundation And More Information Can Be Found \u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis activity is available from October 19, 2023, through 11:59 p.m. Eastern time on October 18, 2025.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003ch2\u003eTARGET AUDIENCE\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-target-audience field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eThis course is designed to meet the interest of radiation oncologists and radiation oncology residents.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-learning-objectives field-group-div\"\u003e\n\u003ch2\u003eLEARNING OBJECTIVES\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-learning-objectives field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eUpon completion of this live activity, participants should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDescribe the patient cohort most likely to benefit from a focal boost to the prostate.\u003c\/li\u003e\n\u003cli\u003eHave a framework for assessing multiparametric prostate MRIs for the purposes of defining a boost.\u003c\/li\u003e\n\u003cli\u003ePractice boost delineation with the opportunity for peer feedback.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662553600329,"sku":"MED-AMB01984","price":15.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/2023-ECONTOURING-FOR-PROSTATE-FOCAL-BOOST-RADIOTHERAPY-WEBINAR.jpg?v=1781873813"},{"product_id":"aua-update-series-volume-43-2024","title":"AUA Update Series Volume 43 (2024) (Audios + PDF)","description":"\u003ch1\u003eAUA Update Series Volume 43 (2024) (Audios + PDF)\u003c\/h1\u003e\u003cbr\u003eAUA Update Series Volume 43 Now in its 43rd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.\u003cbr\u003e\u003ch1\u003eUpdate Series Volume 43 (2024)\u003c\/h1\u003e\n\u003ch2\u003eProgram\u003c\/h2\u003e\u003cbr\u003e \u003cbr\u003e\u003ch3\u003eAudio Playlist\u003c\/h3\u003e\n\u003ch3\u003eTest Your Knowledge Lessons 1-5\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eLesson 1: A Case-Based Discussion of Priapism Guidelines\u003c\/li\u003e\n\u003cli\u003eLesson 2: Deintensification of Active Surveillance in Low-Risk Prostate Cancer\u003c\/li\u003e\n\u003cli\u003eLesson 3: A Urologist's Guide to Administration of Checkpoint Inhibitors and Administration of Targeted Cancer Therapies in the Clinic\u003c\/li\u003e\n\u003cli\u003eLesson 4: Medicolegal Considerations in Urology: Most Common Urology Issues Leading to Litigation\u003c\/li\u003e\n\u003cli\u003eLesson 5: Complications of Surgical Positioning\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eTest Your Knowledge Lessons 6-10\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eLesson 6: AUA Localized Renal Mass Guidelines Update\u003c\/li\u003e\n\u003cli\u003eLesson 7: Updates in Critical Care Management in the Urologic Patient\u003c\/li\u003e\n\u003cli\u003eLesson 8: Common Pediatric Urologic Emergencies: Not Just Testicular Torsion\u003c\/li\u003e\n\u003cli\u003eLesson 9: Abuse of Appearance- and Performance-Enhancing Drugs (APEDs): What the Urologist Needs to Know\u003c\/li\u003e\n\u003cli\u003eLesson 10: Management Approach to the Cancer Patient with Hydronephrosis\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eTest Your Knowledge Lessons 11-15\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eLesson 11: Strategies and Techniques for Palliative and End-of-Life Care\u003c\/li\u003e\n\u003cli\u003eLesson 12: Technical Aspects of Botulinum Toxin Injections\u003c\/li\u003e\n\u003cli\u003eLesson 13: Nutrition and Prostate Cancer\u003c\/li\u003e\n\u003cli\u003eLesson 14: Penile Implant Dissatisfaction: Managing Device Issues\u003c\/li\u003e\n\u003cli\u003eLesson 15: Getting More out of the Electronic Medical Record\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eFOR THE MOST TIMELY TOPICS AND LATEST SURGICAL TECHNIQUES IN UROLOGY, YOU WON'T WANT TO MISS THE 2024 AUA UPDATE SERIES—AUA'S MOST POPULAR SELF-STUDY CME PRODUCT.\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eConcise, practical lessons on timely topics including state-of-the-art surgical techniques\u003c\/li\u003e\n\u003cli\u003eAuthors and Editors are among the best in their specialties\u003c\/li\u003e\n\u003cli\u003eStudy questions available within the \u003cem\u003eTest Your Knowledge\u003c\/em\u003e activities\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eNow in its 43rd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.\u003cbr\u003e\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003ch2\u003eTARGET AUDIENCE\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-target-audience field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cul\u003e\n\u003cli\u003eUrologists\u003c\/li\u003e\n\u003cli\u003eBoard candidates\u003c\/li\u003e\n\u003cli\u003eResidents\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"group-learning-objectives field-group-div\"\u003e\n\u003ch2\u003eLEARNING OBJECTIVES\u003c\/h2\u003e\n\u003cdiv class=\"field field-name-field-learning-objectives field-type-text-long field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cbr\u003e\u003cbr\u003eAfter completing all 40 lessons, participants will be able to apply their knowledge and competencies on the urologic topics covered in each article. Each of the 40 lessons has a specific objective specific to the related article.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003ch2\u003e\u003cimg alt=\"\" class=\"media-element file-wysiwyg\" data-delta=\"15\" height=\"136\" src=\"https:\/\/auau.auanet.org\/sites\/default\/files\/media\/2024-01\/EDU-23-8736%20Digital%20Ads%20990x122.png\" width=\"1104\"\u003e\u003c\/h2\u003e\n\u003ch2\u003e\u003cstrong\u003eFOR THE MOST TIMELY TOPICS AND LATEST SURGICAL TECHNIQUES IN UROLOGY, YOU WON'T WANT TO MISS THE 2024 AUA UPDATE SERIES—AUA'S MOST POPULAR SELF-STUDY CME PRODUCT.\u003c\/strong\u003e\u003c\/h2\u003e\u003cbr\u003e \u003cbr\u003e\u003cul\u003e\n\u003cli\u003eConcise, practical lessons on timely topics including state-of-the-art surgical techniques\u003c\/li\u003e\n\u003cli\u003eAuthors and Editors are among the best in their specialties\u003c\/li\u003e\n\u003cli\u003eStudy questions available within the \u003cem\u003eTest Your Knowledge\u003c\/em\u003e activities\u003c\/li\u003e\n\u003cli\u003e40 hours of CME credit\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eNow in its 43rd installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology.","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662553534793,"sku":"MED-AMB01988","price":40.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/AUA-Update-Series-Volume-43-2024-1.webp?v=1781873812"},{"product_id":"2024-classic-lectures-in-pathology","title":"2024 Classic Lectures in Pathology: What You Need to Know: Genitourinary – A Video CME Teaching Activity","description":"\u003csection class=\"content\" tabindex=\"0\"\u003e\n\u003cdiv class=\"description\" data-role=\"course-description\"\u003e\n\u003cdiv\u003e\n\u003cbr\u003e\u003cbr\u003e2024 Classic Lectures in Pathology: What You Need to Know: Genitourinary – A Video CME Teaching ActivityThis pathology CME video activity offers a practical review of genitourinary pathology combining basic to advanced techniques, pearls and pitfalls to pathologic diagnosis and case reviews.\u003cbr\u003e\u003ch3\u003e\u003cspan class=\"main\"\u003eEducational Objectives ▼\u003c\/span\u003e\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"one\" id=\"eo\"\u003e\n\u003cbr\u003e\u003cbr\u003eAt the completion of this CME teaching activity, you should be able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eEmploy the diagnostic approach to assessing difficult prostate needle biopsy specimen.\u003c\/li\u003e\n\u003cli\u003eReview updates in prostate cancer grading.\u003c\/li\u003e\n\u003cli\u003eDiscuss the challenges encountered in testicular tumor assessment.\u003c\/li\u003e\n\u003cli\u003eExplain the nomenclature and diagnostic approach to flat and papillary lesions of the urinary bladder.\u003c\/li\u003e\n\u003cli\u003eDescribe the newest classification of kidney and bladder tumors.\u003c\/li\u003e\n\u003cli\u003eUse a pattern-based approach to diagnose kidney and bladder tumors.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eNo special educational preparation is required for this CME activity.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cstrong\u003etopics author and length \u003c\/strong\u003e\n\u003cbr\u003e\u003ctable style=\"height: 1608px;\" width=\"1033\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable style=\"height: 69px;\" width=\"547\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eBiopsies and Biomarkers in Genitourinary Pathology\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.25 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eMichelle S. Hirsch, M.D., Ph.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable style=\"height: 55px;\" width=\"472\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eA Pattern-Based Approach to Renal Tumor Classification\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.00 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eSean R. Williamson, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable style=\"height: 81px;\" width=\"551\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eNew Developments in Kidney Carcinoma: What’s Important and Why\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e0.75 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eKiril Trpkov, M.D., FRCPC\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable style=\"height: 51px;\" width=\"507\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003ePink Renal Tumors: How Far Can You Go With Morphology\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.00 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eCristina Magi-Galluzzi, M.D., Ph.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable style=\"height: 82px;\" width=\"750\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eThe Differential Diagnosis of Eosinophilic Renal Epithelial Neoplasms\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.25 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eMichelle S. Hirsch, M.D., Ph.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable style=\"height: 57px;\" width=\"760\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eDiagnosis, Staging, and Grading of Urothelial Carcinoma\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.00 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eJonathan I. Epstein, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable style=\"height: 81px;\" width=\"759\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eRecent Advances in Bladder Cancer Classification, Grading, Staging and Reporting\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e0.75 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eCristina Magi-Galluzzi, M.D., Ph.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable style=\"height: 28px;\" width=\"672\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eSelected Differential Diagnoses in Kidney Pathology\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.00 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eJonathan I. Epstein, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable style=\"height: 80px;\" width=\"797\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eUrothelial Carcinoma: Common Diagnostic Challenges and Variants Not to be Missed in Practice\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e0.75 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eKiril Trpkov, M.D., FRCPC\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eWhat’s New in Prostate Pathology?\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.00 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eSean R. Williamson, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eIntraductal Lesions of the Prostate\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.00 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eJonathan I. Epstein, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable style=\"height: 96px;\" width=\"675\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eFalse Positive, False Negative and Atypical: (Uncertain) Diagnoses in Prostate Pathology – Important Traps to Avoid\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.00 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eKiril Trpkov, M.D., FRCPC\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eUpdate on Prostate Cancer Grading\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e0.75 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eJonathan I. Epstein, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eProstate Cancer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.00 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eCristina Magi-Galluzzi, M.D., Ph.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eMimickers of Prostate Cancer\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.00 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eJonathan I. Epstein, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable style=\"height: 57px;\" width=\"546\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eTesticular Tumors: Updates and Most Common Diagnostic Challenges\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.00 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eSean R. Williamson, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003e\n\u003ctable style=\"height: 57px;\" width=\"548\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003ePitfalls in the Assessment of Testicular Pathology\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/td\u003e\n\u003ctd rowspan=\"2\" width=\"64\"\u003e1.00 Hrs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"270\"\u003eJonathan I. Epstein, M.D.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Medical Education Hub","offers":[{"title":"Default Title","offer_id":54662553567561,"sku":"MED-AMB01948","price":50.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1019\/0382\/7273\/files\/2024-Classic-Lectures-in-Pathology-What-You-Need-to-Know-Genitourinary-_E2_80_93-A-Video-CME-Teaching-Activity.jpg?v=1781873813"}],"url":"https:\/\/medicalducation.com\/collections\/urology.oembed","provider":"Medical Education Hub","version":"1.0","type":"link"}